BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252-7259. [PMID: 15534099 DOI: 10.1158/1078-0432.ccr-04-0713] [Cited by in Crossref: 1947] [Cited by in F6Publishing: 2172] [Article Influence: 108.2] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Liu L, Ning Z, Che L, Li X. The neutrophil-lymphocyte ratio to predict poor prognosis of critical acute myocardial infarction patients: a retrospective cohort study. Biochem Med (Zagreb) 2023;33:010702. [PMID: 36627973 DOI: 10.11613/BM.2023.010702] [Reference Citation Analysis]
2 Panoutsopoulou K, Magkou P, Dreyer T, Dorn J, Obermayr E, Mahner S, van Gorp T, Braicu I, Magdolen V, Zeillinger R, Avgeris M, Scorilas A. tRNA-derived small RNA 3'U-tRF(ValCAC) promotes tumour migration and early progression in ovarian cancer. Eur J Cancer 2023;180:134-45. [PMID: 36599181 DOI: 10.1016/j.ejca.2022.11.033] [Reference Citation Analysis]
3 Liao Y, Wang R, Wen F. Diagnostic and prognostic value of secreted phosphoprotein 1 for idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Biomarkers 2023;28:87-96. [PMID: 36377416 DOI: 10.1080/1354750X.2022.2148744] [Reference Citation Analysis]
4 Gu Y, Fu Y, Pan X, Zhou Y, Ji C, Zhao T, Miao H, Lv H, Da J, Ge J, Wang L, Qu L, Ge S, Guo H, Zhou W. Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1117595] [Reference Citation Analysis]
5 Deng G, Ren J, Wang H, Deng L, Chen Z, Fan Y, Tang Y, Zhang T, Tang D. Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.977111] [Reference Citation Analysis]
6 Huang N, Zhang J, Kuang S, Li Z, Zhao H, Wu J, Liu M, Wang L. Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma. Cancer Med 2023. [PMID: 36680322 DOI: 10.1002/cam4.5597] [Reference Citation Analysis]
7 Zheng H, Ge C, Lin H, Zhou S, Tang W, Wang Q, Zhang X, Jin X, Xu X, Du J, Fu J. The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups. PLoS One 2023;18:e0280474. [PMID: 36652446 DOI: 10.1371/journal.pone.0280474] [Reference Citation Analysis]
8 Gui Z, Hu W, Kong Q, Liu C, Xu Y, Wang F. Esophageal stenosis as an independent factor of poor prognosis in patients with ESCC treated with definitive chemoradiotherapy. Future Oncol 2023. [PMID: 36651337 DOI: 10.2217/fon-2022-0125] [Reference Citation Analysis]
9 Li Z, Li C, Yang D, Zhou Z, Kang M. Nomogram to Predict Long-Term Overall Survival and Cancer-Specific Survival of Radiotherapy Patients with Nasopharyngeal Carcinoma. BioMed Research International 2023;2023:1-18. [DOI: 10.1155/2023/7126881] [Reference Citation Analysis]
10 Yang X, Wang A, Li J, Zhou K, Ji K, Ji X, Zhang J, Wu X, Bu Z. Prognostic significance of preoperative serum tumor markers in hepatoid adenocarcinoma of stomach (HAS). BMC Cancer 2023;23:53. [PMID: 36647059 DOI: 10.1186/s12885-023-10516-y] [Reference Citation Analysis]
11 Liang W, Li L, Wang M, Liu Y, Qiu Y, Zhang B, Wu Q, Wei Y. Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study. Clin Transl Oncol 2023. [PMID: 36640207 DOI: 10.1007/s12094-023-03076-x] [Reference Citation Analysis]
12 Huang C, Li W, Chen C, Xu W, Fei L, Tao S, Hu Q, Xie X, Cao X, Zhang XY, Chen L, Li Q, Huang Y. CHINAT-CD4 Score Predicts Transplant-Free Survival in Patients with Acute-on-Chronic Liver Failure. J Inflamm Res 2023;16:197-207. [PMID: 36660376 DOI: 10.2147/JIR.S389789] [Reference Citation Analysis]
13 Zhang Y, Wang J, Ding L, Zheng Y, Wu C, Wang K, Xia W, Ge P. Development and validation of a novel risk model in newly diagnosed de novo bone metastatic prostate cancer (M1b): a retrospective study. PeerJ 2023;11:e14615. [PMID: 36650836 DOI: 10.7717/peerj.14615] [Reference Citation Analysis]
14 Zeng H, Zhang D, Yang Z, Hu Z, Yang Z, Fu Y, Hou J, Ngai S, Wang J, Chen J, Hu D, Zhou Z, Chen M, Zhang Y, Pan Y. Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients. Int Immunopharmacol 2023;115:109651. [PMID: 36638663 DOI: 10.1016/j.intimp.2022.109651] [Reference Citation Analysis]
15 Guo Z, Zhang K, Wei X, Li Y, Ma X, Li Y, Han D, Du Q, Zhang T, Chen X, Wei H, Yan C, Zhang W, Pang Q, Wang P. Radiotherapy plus camrelizumab affects peripheral CD8 T-cell differentiation subsets expressing PD-1, TIGIT, and CTLA-4 in esophageal squamous cell carcinoma. Journal of Leukocyte Biology 2023;113:11-17. [DOI: 10.1093/jleuko/qiac018] [Reference Citation Analysis]
16 Ma J, Wu N, Yuan Z, Chen Y, Li C, Xie W, Zhang Z, Li Y, Zhong L. Prognostic value of interleukin-34 and interleukin-38 in patients with newly diagnosed atrial fibrillation. Front Cardiovasc Med 2022;9:1072164. [PMID: 36698935 DOI: 10.3389/fcvm.2022.1072164] [Reference Citation Analysis]
17 He Y, Xiong Z, Tian D, Zhang J, Chen J, Li Z. Natural progression of persistent pure ground-glass nodules 10 mm or smaller: long-term observation and risk factor assessment. Jpn J Radiol 2023. [PMID: 36607551 DOI: 10.1007/s11604-022-01382-y] [Reference Citation Analysis]
18 Zhou Q, Deng G, Wang Z, Dai G. Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection. Front Surg 2022;9:1002075. [PMID: 36684178 DOI: 10.3389/fsurg.2022.1002075] [Reference Citation Analysis]
19 Tang J, Fang Y, Xu Z. Establishment of prognostic models of adrenocortical carcinoma using machine learning and big data. Front Surg 2022;9:966307. [PMID: 36684185 DOI: 10.3389/fsurg.2022.966307] [Reference Citation Analysis]
20 Zhang Q, Liu Z, Liu S, Wang M, Li X, Xun J, Wang X, Yang Q, Wang X, Zhang D. A novel nomogram for adult primary perihilar cholangiocarcinoma and considerations concerning lymph node dissection. Front Surg 2022;9:965401. [PMID: 36684342 DOI: 10.3389/fsurg.2022.965401] [Reference Citation Analysis]
21 Wang L, Zhu L, Yan J, Qin W, Wang C, Xi W, Xu Z, Chen Y, Jiang J, Huang S, Yan C, Zhang H, Pan Z, Zhang J. CT-Based Radiomic Score: A Risk Stratifier in Far-Advanced Gastric Cancer Patients. Acad Radiol 2023:S1076-6332(22)00688-2. [PMID: 36610930 DOI: 10.1016/j.acra.2022.12.034] [Reference Citation Analysis]
22 Hu X, Jiang L, Wu J, Mao W. Prognostic value of log odds of positive lymph nodes, lymph node ratio, and N stage in patients with colorectal signet ring cell carcinoma: A retrospective cohort study. Front Surg 2022;9:1019454. [PMID: 36684239 DOI: 10.3389/fsurg.2022.1019454] [Reference Citation Analysis]
23 Yang X, Ni H, Lu Z, Zhang J, Zhang Q, Ning S, Qi L, Xiang B. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma. BMC Cancer 2023;23:10. [PMID: 36600214 DOI: 10.1186/s12885-023-10503-3] [Reference Citation Analysis]
24 Guo G, Sun M, Li Y, Yang W, Wang X, Yu Z, Li C, Hui Y, Fan X, Jiang K, Sun C. Serum Ferritin Has Limited Prognostic Value on Mortality Risk in Patients with Decompensated Cirrhosis: A Propensity Score Matching Analysis. Lab Med 2023;54:47-55. [PMID: 35960775 DOI: 10.1093/labmed/lmac064] [Reference Citation Analysis]
25 He S, Huang X, Zhao P, Zhang P. The prognosis difference between elderly and younger patients with adrenocortical carcinoma. Front Genet 2022;13:1029155. [PMID: 36685908 DOI: 10.3389/fgene.2022.1029155] [Reference Citation Analysis]
26 Wu Q, Chen P, Shu C, Chen L, Jin Z, Huang J, Wang X, Li X, Wei M, Yang T, Deng X, Wu A, He Y, Wang Z. Survival outcomes of stage I colorectal cancer: development and validation of the ACEPLY model using two prospective cohorts. BMC Med 2023;21:3. [PMID: 36600277 DOI: 10.1186/s12916-022-02693-7] [Reference Citation Analysis]
27 Fan Z, Liu B, Shang P. Development and validation of a nomogram prediction model based on albumin-to-alkaline phosphatase ratio for predicting the prognosis of gallbladder carcinoma. Pathol Oncol Res 2022;28:1610818. [PMID: 36685104 DOI: 10.3389/pore.2022.1610818] [Reference Citation Analysis]
28 Yuan X, Feng H, Huang H, Li J, Wu S, Yuan Y, Cui L, Lin D, Chen Z, Lu W, Liu X, Peng X, Wang F. Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2023. [PMID: 36595043 DOI: 10.1007/s00432-022-04506-z] [Reference Citation Analysis]
29 Zhang R, Hu C, Zhang J, Zhang Y, Yuan L, Yu P, Wang Y, Bao Z, Cao M, Ruan R, Cheng X, Xu Z. Prognostic significance of inflammatory and nutritional markers in perioperative period for patients with advanced gastric cancer. BMC Cancer 2023;23:5. [PMID: 36597055 DOI: 10.1186/s12885-022-10479-6] [Reference Citation Analysis]
30 Tong X, Li M, Jin J, Li Y, Li L, Peng Y, Huang L, Xu B, Meng F, Mao X, Huang L, Huang W, Zhang D. Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. Int J Cancer 2023. [PMID: 36594582 DOI: 10.1002/ijc.34419] [Reference Citation Analysis]
31 Ding T, Li W, Liu Y, Liu L, Dong Y. Prognostic Value of Preoperative Controlling Nutritional Status in Hypopharyngeal Cancer Patients Undergoing Surgery-Oriented Comprehensive Treatment. Ear Nose Throat J 2023;:1455613221148314. [PMID: 36593089 DOI: 10.1177/01455613221148314] [Reference Citation Analysis]
32 Zheng H, Lin J, Shen L, Yang H, Xu B, Xue Z, Wu D, Huang J, Lin G, Zheng C, Li P, Xie J, Wang J, Lin J, Chen Q, Cao L, Lu J, Huang C. The GLIM criteria as an effective tool for survival prediction in gastric cancer patients. European Journal of Surgical Oncology 2023. [DOI: 10.1016/j.ejso.2023.01.009] [Reference Citation Analysis]
33 Zhu L, Wang L, Gao Z, Zeng Y, Tao K, Wang Q, Li X, Zhang H, Shen Z, Zhou J, Shen K, Ye Y, Wu A. Examined lymph node numbers influence prognosis in rectal cancer treated with neoadjuvant therapy. Cancer Pathogenesis and Therapy 2023. [DOI: 10.1016/j.cpt.2023.01.001] [Reference Citation Analysis]
34 Lue K, Chen Y, Wu Y, Liu S. Influence of the methodological aspects of the dichotomization of total metabolic tumor volume measured through baseline fluorine-18 fluorodeoxyglucose PET on survival prediction in lymphoma. Nuclear Medicine Communications 2023;44:74-80. [DOI: 10.1097/mnm.0000000000001640] [Reference Citation Analysis]
35 Qu Y, Liu H. Construction of a predictive model for clinical survival in male patients with non-metastatic rectal adenocarcinoma. Asian J Surg 2023;46:132-42. [PMID: 35227564 DOI: 10.1016/j.asjsur.2022.02.004] [Reference Citation Analysis]
36 Chen Y, Gao L, Kong L, Guan X, Yang H, Li Y, Lv Z, Zhang X, Liang H, Chen H, Wu Y, Huang J, Yang J. The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patients. Cancer Treatment and Research Communications 2023. [DOI: 10.1016/j.ctarc.2023.100684] [Reference Citation Analysis]
37 Liu B, Wang Z, Zhao H, Gao S, Wang H, Zhang Y, Fan K, Tao R, Li Y, Feng J, Sun Y, Zhang J, Zhang G. The Value of Radiotherapy in Patients With Resectable Stage IIIA Non-Small-Cell Lung Cancer in the Era of Individualized Treatment: A Population-Based Analysis. Clin Lung Cancer 2023;24:18-28. [PMID: 36446703 DOI: 10.1016/j.cllc.2022.09.011] [Reference Citation Analysis]
38 Yang H, Fang Z, Liu T, Zhu X, Luo L. Prognostic significance of examined lymph node count in older patients with stage T1N0M0 pulmonary carcinoid tumours: a population-based propensity score-matched analysis. Aging Clin Exp Res 2023;35:203-12. [PMID: 36319940 DOI: 10.1007/s40520-022-02293-8] [Reference Citation Analysis]
39 Huang JM, Zhuang LP, Wang HG, Zhong LY, Xue SJ, Tian FX, Lin HY. Radiomics signature for prediction of long-term survival and recurrence patterns in patients with gastric cancer after radical gastrectomy: A multicenter study. Saudi J Gastroenterol 2023;29:21-30. [PMID: 36588364 DOI: 10.4103/sjg.sjg_253_22] [Reference Citation Analysis]
40 Guo Q, Dong Z, Jiang L, Zhang L, Li Z, Wang D. Establishment and validation of an ultrasound-based nomogram with risk stratification for short disease-free survival in breast cancer. J Clin Ultrasound 2023;51:134-47. [PMID: 36054346 DOI: 10.1002/jcu.23296] [Reference Citation Analysis]
41 Mao S, Shan Y, Yu X, Huang J, Fang J, Wang M, Fan R, Wu S, Lu C. A new prognostic model predicting hepatocellular carcinoma early recurrence in patients with microvascular invasion who received postoperative adjuvant transcatheter arterial chemoembolization. Eur J Surg Oncol 2023;49:129-36. [PMID: 36031472 DOI: 10.1016/j.ejso.2022.08.013] [Reference Citation Analysis]
42 Liu Y, Ma Y, Shayan G, Sun S, Huang X, Wang K, Qu Y, Chen X, Wu R, Zhang Y, Liu Q, Zhang J, Luo J, Xiao J, Li Y, Yi J, Wang J. Improved Cancer-Specific Risk Stratification by the Lymph Node Ratio-Based Nomogram: A Potential Role in Guiding Postoperative Management Decisions for Oral Cavity Carcinoma. JCO Precis Oncol 2023;7:e2200365. [PMID: 36603173 DOI: 10.1200/PO.22.00365] [Reference Citation Analysis]
43 Guo Y, Ren Y, Wu F, Dong X, Zheng C. Prognostic impact of sarcopenia in patients with hepatocellular carcinoma treated with PD-1 inhibitor. Therap Adv Gastroenterol 2022;15:17562848221142417. [PMID: 36600683 DOI: 10.1177/17562848221142417] [Reference Citation Analysis]
44 Yilmaz H, Cinar NB, Avci IE, Telli E, Uslubas AK, Teke K, Dillioglugil O. The systemic inflammation response index: An independent predictive factor for survival outcomes of bladder cancer stronger than other inflammatory markers. Urol Oncol 2022:S1078-1439(22)00468-9. [PMID: 36577568 DOI: 10.1016/j.urolonc.2022.11.011] [Reference Citation Analysis]
45 Matsuzaki Y, Naito Y, Miura N, Mori T, Watabe Y, Yoshimoto S, Shibahara T, Takano M, Honda K. RIOK2 Contributes to Cell Growth and Protein Synthesis in Human Oral Squamous Cell Carcinoma. Curr Oncol 2022;30:381-91. [PMID: 36661680 DOI: 10.3390/curroncol30010031] [Reference Citation Analysis]
46 Jiang YJ, Zhang TT, Zhu YQ, Cai HQ, Chang C, Hao JJ, Cai Y, Wang MR, Liang JW, Zhang Y. Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC. Transl Oncol 2023;28:101609. [PMID: 36571988 DOI: 10.1016/j.tranon.2022.101609] [Reference Citation Analysis]
47 Feng Y, Li P, Yang F, Xu K. Establishment of a prognostic prediction system based on tumor microenvironment of pancreatic cancer. Medicine (Baltimore) 2022;101:e32364. [PMID: 36595826 DOI: 10.1097/MD.0000000000032364] [Reference Citation Analysis]
48 Chen JB, Liu ZN, Wang YK, Shan F, Li SX, Jia YN, Xue K, Miao RL, Li ZM, Wu ZQ, Ying XJ, Zhang Y, Li ZY, Ji JF. The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer. Front Oncol 2022;12:956706. [PMID: 36620591 DOI: 10.3389/fonc.2022.956706] [Reference Citation Analysis]
49 Wu Z, Ou J, Liu N, Wang Z, Chen J, Cai Z, Liu X, Yu X, Dai M, Zhou H. Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia. Cancer Medicine 2022. [DOI: 10.1002/cam4.5549] [Reference Citation Analysis]
50 Zhang Y, Zhang Z, Wei L, Wei S. Construction and validation of nomograms combined with novel machine learning algorithms to predict early death of patients with metastatic colorectal cancer. Front Public Health 2022;10:1008137. [PMID: 36605237 DOI: 10.3389/fpubh.2022.1008137] [Reference Citation Analysis]
51 Qiao X, Ma B, Sun W, Zhang N, Liu Y, Jia L, Liu C. JAG1 is associated with the prognosis and metastasis in breast cancer. Sci Rep 2022;12:21986. [PMID: 36539520 DOI: 10.1038/s41598-022-26241-8] [Reference Citation Analysis]
52 Liu Y, Zhang Y, Wang J, Huang X, Wang K, Qu Y, Chen X, Liu Q, Zhang J, Luo J, Li Y, Wu R, Yi J. Caudal distribution pattern of metastatic neck lymph nodes in nasopharyngeal carcinoma and prognostic significance of nodal spread distances. Radiother Oncol 2022;179:109443. [PMID: 36549339 DOI: 10.1016/j.radonc.2022.109443] [Reference Citation Analysis]
53 Liu Q, Yang J, Chen X, Yang J, Zhao X, Huang Y, Lin Y, Pu J. Prognostic significance of sarcopenia and systemic inflammation for patients with renal cell carcinoma following nephrectomy. Front Oncol 2022;12:1047515. [PMID: 36591466 DOI: 10.3389/fonc.2022.1047515] [Reference Citation Analysis]
54 He Y, Zhou H, Huang X, Qu Y, Wang Y, Pei W, Zhang R, Chen S, You H. Infiltration of LPAR5(+) macrophages in osteosarcoma tumor microenvironment predicts better outcomes. Front Immunol 2022;13:909932. [PMID: 36591220 DOI: 10.3389/fimmu.2022.909932] [Reference Citation Analysis]
55 Riley-gillis B, Tsaih S, King E, Wollenhaupt S, Reeb J, Peck AR, Wackman K, Lemke A, Rui H, Dezso Z, Flister MJ. Machine Learning Reveals Genetic Modifiers of the Immune Microenvironment of Cancer.. [DOI: 10.1101/2022.12.13.520300] [Reference Citation Analysis]
56 He J, Wang Y, Chen X, Chen W, Zhou J. Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study.. [DOI: 10.21203/rs.3.rs-2354888/v1] [Reference Citation Analysis]
57 Parvathareddy SK, Siraj AK, Bu R, Iqbal K, Al-Rasheed M, Al-Haqawi W, Annaiyappanaidu P, Siraj N, Ahmed SO, Al-Sobhi SS, Al-Dayel F, Al-Kuraya KS. X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in BRAFV600E mutant papillary thyroid carcinoma in middle eastern patients. Front Endocrinol (Lausanne) 2022;13:1054882. [PMID: 36578953 DOI: 10.3389/fendo.2022.1054882] [Reference Citation Analysis]
58 Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, Zhou K, Li W, Hu J, Fu C, Aziz T, Li H, Li J, Yang Y, Han L, Zhang S, Ma Y, Sun M, Wu H, Zhang Z, Wunderlich M, Robinson S, Braas D, Hoeve JT, Zhang B, Marcucci G, Mulloy JC, Zhou K, Tao HF, Deng X, Horne D, Wei M, Huang H, Chen J. The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell 2022;40:1566-1582.e10. [PMID: 36306790 DOI: 10.1016/j.ccell.2022.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Mei T, Yang X, Yu M, Tian X, Deng Q, Chen X, Gong Y. Impact of antibiotic use before definitive concurrent chemoradiation in patients with locally advanced non-small cell lung cancer. Strahlenther Onkol 2022. [DOI: 10.1007/s00066-022-02027-9] [Reference Citation Analysis]
60 Sun YG, Chen F, Sun QL, Tian JY, He XC. The number of metastatic lymph nodes optimizes staging in patients aged 55 years or older with papillary thyroid cancer. Front Endocrinol (Lausanne) 2022;13:1026737. [PMID: 36568092 DOI: 10.3389/fendo.2022.1026737] [Reference Citation Analysis]
61 Zhang H, Li X, Zhang T, Zhou Q, Zhang C. Establishment and validation of a predictive model of preeclampsia based on transcriptional signatures of 43 genes in decidua basalis and peripheral blood. BMC Bioinformatics 2022;23:527. [PMID: 36476092 DOI: 10.1186/s12859-022-05086-y] [Reference Citation Analysis]
62 Ding L, Wang X, Deng X, Xia W, Wang K, Yu X, Huang Y, Wang J. Preoperative systemic immune‐inflammation index as a significant prognostic factor after TURBT in patients with non‐muscle‐invasive bladder cancer: A retrospective study based on propensity score matching analysis. Cancer Medicine 2022. [DOI: 10.1002/cam4.5501] [Reference Citation Analysis]
63 Hu C, Shi F, Zhang Z, Zhang L, Liu R, Sun X, Zheng L, She J. Development and validation of a new stage-specific nomogram model for predicting cancer-specific survival in patients in different stages of colon cancer: A SEER population-based study and external validation. Front Oncol 2022;12:1024467. [PMID: 36568209 DOI: 10.3389/fonc.2022.1024467] [Reference Citation Analysis]
64 Gristina V, Barraco N, La Mantia M, Castellana L, Insalaco L, Bono M, Perez A, Sardo D, Inguglia S, Iacono F, Cutaia S, Bazan Russo TD, Francini E, Incorvaia L, Badalamenti G, Russo A, Galvano A, Bazan V. Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study. Cancers (Basel) 2022;14. [PMID: 36497493 DOI: 10.3390/cancers14236013] [Reference Citation Analysis]
65 Du J, Cheng Y, Hu D, Xing Y, Yue L, He R, Li H, Liu C, Liang X, Yang Y. A nomogram-based overall survival stratification to identify uterine sarcoma patients without distant metastases who may benefit from adjuvant radiotherapy. Gynecol Oncol 2022;169:17-26. [PMID: 36469973 DOI: 10.1016/j.ygyno.2022.11.023] [Reference Citation Analysis]
66 Luo Y, Hong CQ, Huang BL, Ding TY, Chu LY, Zhang B, Qu QQ, Li XH, Liu CT, Peng YH, Guo HP, Xu YW. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma. Ann Med 2022;54:2153-66. [PMID: 35930383 DOI: 10.1080/07853890.2022.2104921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Panoutsopoulou K, Liu Y, Avgeris M, Dreyer T, Dorn J, Magdolen V, Scorilas A. Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer. Clinical Biochemistry 2022. [DOI: 10.1016/j.clinbiochem.2022.12.004] [Reference Citation Analysis]
68 Zhou H, Wang S, Cai Z, Qiu E, Chen Q, Rao X, Han S, Li Z. Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis. Int J Colorectal Dis 2022;37:2481-9. [PMID: 36334109 DOI: 10.1007/s00384-022-04278-5] [Reference Citation Analysis]
69 Yang Y, Zhou Y, Zhou C, Zhang X, Ma X. MRI-Based Computer-Aided Diagnostic Model to Predict Tumor Grading and Clinical Outcomes in Patients With Soft Tissue Sarcoma. J Magn Reson Imaging 2022;56:1733-45. [PMID: 35303756 DOI: 10.1002/jmri.28160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Mao F, Yang C, Luo W, Wang Y, Xie J, Wang H. Peripheral blood lymphocyte subsets are associated with the clinical outcomes of prostate cancer patients. International Immunopharmacology 2022;113:109287. [DOI: 10.1016/j.intimp.2022.109287] [Reference Citation Analysis]
71 Yang H, Liu T, Li M, Fang Z, Luo L. Does Examined Lymph Node Count Influence Survival in Surgically Resected Early‑stage Pulmonary Typical Carcinoid Tumors? Am J Clin Oncol 2022;45:506-13. [PMID: 36413680 DOI: 10.1097/COC.0000000000000958] [Reference Citation Analysis]
72 Wu X, Wang B, Su Y, He D, Mo H, Zheng M, Meng Z, Ren L, Zhang X, Ren D, Li C. ALG8 Fuels Stemness Through Glycosylation of the WNT/Beta-Catenin Signaling Pathway in Colon Cancer. DNA and Cell Biology 2022. [DOI: 10.1089/dna.2022.0165] [Reference Citation Analysis]
73 Zheng Q, Yang R, Ni X, Yang S, Jiao P, Wu J, Xiong L, Wang J, Jian J, Jiang Z, Wang L, Chen Z, Liu X. Quantitative Assessment of Tumor-Infiltrating Lymphocytes Using Machine Learning Predicts Survival in Muscle-Invasive Bladder Cancer. J Clin Med 2022;11. [PMID: 36498655 DOI: 10.3390/jcm11237081] [Reference Citation Analysis]
74 Hu XS, Yang HY, Leng C, Zhang ZW. Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number. World J Gastroenterol 2022; 28(44): 6271-6281 [DOI: 10.3748/wjg.v28.i44.6271] [Reference Citation Analysis]
75 Wang H, Yin X, Lou SH, Fang TY, Han BL, Gao JL, Wang YF, Zhang DX, Wang XB, Lu ZF, Wu JP, Zhang JQ, Wang YM, Zhang Y, Xue YW. Metastatic lymph nodes and prognosis assessed by the number of retrieved lymph nodes in gastric cancer. World J Gastrointest Surg 2022; 14(11): 1230-1249 [DOI: 10.4240/wjgs.v14.i11.1230] [Reference Citation Analysis]
76 Chen Y, Chen Y, Lue K, Chu S, Chang B, Wang L, Li M, Lin C. Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma. Ann Nucl Med 2022. [DOI: 10.1007/s12149-022-01811-y] [Reference Citation Analysis]
77 Ma X, Xing Y, Li Z, Qiu S, Wu W, Bai J. Construction and validation of a prognostic nomogram in metastatic breast cancer patients of childbearing age: A study based on the SEER database and a Chinese cohort. Front Oncol 2022;12:999873. [PMID: 36505800 DOI: 10.3389/fonc.2022.999873] [Reference Citation Analysis]
78 He LN, Fu S, Ma H, Chen C, Zhang X, Li H, Du W, Chen T, Jiang Y, Wang Y, Wang Y, Zhou Y, Lin Z, Yang Y, Huang Y, Zhao H, Fang W, Zhang H, Zhang L, Hong S. Early on-treatment tumor growth rate (EOT-TGR) determines treatment outcomes of advanced non-small-cell lung cancer patients treated with programmed cell death protein 1 axis inhibitor. ESMO Open 2022;7:100630. [PMID: 36442353 DOI: 10.1016/j.esmoop.2022.100630] [Reference Citation Analysis]
79 Ouyang D, Shi M, Wang Y, Luo L, Huang L. Prognostic analysis of pT1-T2aN0M0 cervical adenocarcinoma based on random survival forest analysis and the generation of a predictive nomogram. Front Oncol 2022;12:1049097. [PMID: 36505859 DOI: 10.3389/fonc.2022.1049097] [Reference Citation Analysis]
80 Calderillo Ruiz G, Lopez Basave H, Vazquez Renteria RS, Castillo Morales A, Guijosa A, Castillo Morales C, Herrera M, Diaz C, Vazquez Cortes E, Ruiz-garcia E, Munoz Montano WR. The Prognostic Significance of HALP Index for Colon Cancer Patients in a Hispanic-Based Population. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/4324635] [Reference Citation Analysis]
81 Zhang C, Li Z, Shang X, Zhao C, Wang H. Intratumor heterogeneity is associated with less CD8+ T cell infiltration and worse survival in patients with small cell lung cancer. Clin Transl Oncol 2022. [DOI: 10.1007/s12094-022-03010-7] [Reference Citation Analysis]
82 Meng X, Lu J, Zeng H, Chen Z, Guo X, Gao C, Pei Y, Hu S, Ye M, Sun Q, Yang G, Cai J, Huang P, Yv L, Zhang L, Shi Y, Ke A, Zhou J, Fan J, Chen Y, Huang X, Shi G. The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion. Hepatol Int 2022. [DOI: 10.1007/s12072-022-10445-1] [Reference Citation Analysis]
83 Ding T, Peng Y, Hong C, Huang B, Liu C, Luo Y, Chu L, Zhang B, Li X, Qu Q, Xu Y, Wu F. Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma. Discov Onc 2022;13:128. [DOI: 10.1007/s12672-022-00591-1] [Reference Citation Analysis]
84 Li L, Li S, Zhou H. Expression of STAT family and its potency to prognosis in uterine corpus endometrial carcinoma.. [DOI: 10.21203/rs.3.rs-2270275/v1] [Reference Citation Analysis]
85 Tang M, Gao L, He B, Yang Y. Machine learning based prognostic model of Chinese medicine affecting the recurrence and metastasis of I-III stage colorectal cancer: A retrospective study in China. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1044344] [Reference Citation Analysis]
86 Wang P, Yang S, Li C, Han X, Hong D, Shao H. Nomogram-based development and evaluation for predictions of 30-day and 1-year survival in patients with spontaneously ruptured hepatocellular carcinoma. BMC Cancer 2022;22:1177. [DOI: 10.1186/s12885-022-10290-3] [Reference Citation Analysis]
87 Wang X, Zheng X, Zhu J, Li Z, Wei T. A nomogram and risk classification system for predicting cancer-specific survival in tall cell variant of papillary thyroid cancer: a SEER-based study. J Endocrinol Invest 2022. [DOI: 10.1007/s40618-022-01949-6] [Reference Citation Analysis]
88 Song J, Lin Y, Zhang J, Liu S, Zhou J, Zeng Q, Lin Z, Fu R, Qiu M, Hu Z. Effect of the Age-Adjusted Charlson Comorbidity Index on the Survival of Esophageal Squamous Cell Carcinoma Patients after Radical Esophagectomy. J Clin Med 2022;11. [PMID: 36431214 DOI: 10.3390/jcm11226737] [Reference Citation Analysis]
89 Sun Q, Chen Y, Li T, Zhu X, Zhu G, Ni B, Gao R, Li J. Prognostic Nomogram for Gastrointestinal Stromal Tumors after Surgery Based on the SEER Database. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/5639174] [Reference Citation Analysis]
90 Li S, Zhu J, He Z, Ashok R, Xue N, Liu Z, Ding L, Zhu H. Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.982833] [Reference Citation Analysis]
91 Gao B, Ou X, Li M, Wang M, Huang F. Risk stratification system and visualized dynamic nomogram constructed for predicting diagnosis and prognosis in rare male breast cancer patients with bone metastases. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1013338] [Reference Citation Analysis]
92 Chen X, Yuan W, Xu Z, Yang Y, Dong S, Liu L, Zeng M, Hou Y, Rao S. Prognostic value of preoperative CT features for disease-free survival in patients with primary gastric gastrointestinal stromal tumors after resection. Abdom Radiol 2022. [DOI: 10.1007/s00261-022-03725-9] [Reference Citation Analysis]
93 Li Y, Xiu L, Ma M, Seery S, Lou X, Li K, Wu Y, Liang S, Wu Y, Cui W. Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.940601] [Reference Citation Analysis]
94 Lin J, Lin J, Hong Q, Zhang P, Zhang Z, He L, Wang Q, Shang L, Wang L, Sun Y, Li Z, Liu J, Ding F, Lin E, Fu Y, Lin S, Li P, Wang Z, Zheng C, Huang C, Xie J. Nomogram to Predict Recurrence and Guide a Pragmatic Surveillance Strategy After Resection of Hepatoid Adenocarcinoma of the Stomach: A Retrospective Multicenter Study. Ann Surg Oncol 2022. [DOI: 10.1245/s10434-022-12757-w] [Reference Citation Analysis]
95 Cheng J, Li Q, Xiao S, Nie L, Liao J, Jiang Q, Xiang B, Zhang H, Jiang Y, Yao C. The advanced lung cancer inflammation index predicts chemotherapy response and infection risk in multiple myeloma patients receiving induction chemotherapy. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1047326] [Reference Citation Analysis]
96 Tang M, Zhang W, Qin W, Zou C, Yan Y, He B, Xu Y, Zhang Y, Liu J, Sun H, Yang Y. Association between Oral Chinese Herbal Medicine and Recurrence and Metastasis in Patients with Stages II and III Colorectal Cancer: A Cohort Study in China. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-11. [DOI: 10.1155/2022/8529395] [Reference Citation Analysis]
97 Song Y, Cheng D, Yi X, Rao Y, Qiu K, Mao M, Pang W, Li J, Zheng Y, Feng R, Song X, Huang S, Liu G, Xu W, Zhao Y, Ren J. The role of HPV status in patients with overlapping grey zone cancer in oral cavity and oropharynx. Eur Arch Otorhinolaryngol 2022. [DOI: 10.1007/s00405-022-07713-z] [Reference Citation Analysis]
98 Li Y, Zhang Y, Fu Y, Yang W, Wang X, Duan L, Niu L, Chen J, Zhou W, Liu J, Wang J, Fan D, Hong L. Development and validation of a prognostic model to predict the prognosis of patients with colorectal gastrointestinal stromal tumor: A large international population-based cohort study. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1004662] [Reference Citation Analysis]
99 Zhou J, Li T, Chen H, Jiang Y, Zhao Y, Huang J, Chen Z, Tang X, Huang Z, Yang Z. ADAMTS10 inhibits aggressiveness via JAK/STAT/c-MYC pathway and reprograms macrophage to create an anti-malignant microenvironment in gastric cancer. Gastric Cancer 2022;25:1002-16. [PMID: 35925524 DOI: 10.1007/s10120-022-01319-4] [Reference Citation Analysis]
100 Zhou Z, Zhuang X, Liu M, Jian B, Fu G, Liao X, Wu Z, Liang M. Left ventricular volume change and long-term outcomes in ischaemic cardiomyopathy with or without surgical revascularisation: A post-hoc analysis of a randomised controlled trial. eClinicalMedicine 2022;53:101626. [DOI: 10.1016/j.eclinm.2022.101626] [Reference Citation Analysis]
101 Zhou Y, Chen J, Li S, Chen A, Dai C, Liu M, Lu D, Chen Z, Wang X, Qian J, Ge J. Prognostic implication of lipidomics in patients with coronary total occlusion undergoing PCI. Eur J Clin Invest 2022;52:e13826. [PMID: 35723949 DOI: 10.1111/eci.13826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Albrecht LJ, Höwner A, Griewank K, Lueong SS, von Neuhoff N, Horn PA, Sucker A, Paschen A, Livingstone E, Ugurel S, Zimmer L, Horn S, Siveke JT, Schadendorf D, Váraljai R, Roesch A. Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype. Clin Transl Med 2022;12:e1090. [PMID: 36320118 DOI: 10.1002/ctm2.1090] [Reference Citation Analysis]
103 Ni J, Wang M, Wang T, Yan C, Ren C, Li G, Ding Y, Li H, Du L, Jiang Y, Chen J, Wang Y, Xu D, Zhu M, Dai J, Ma H, Hu Z, Shen H, Wei Q, Jin G. Construction and evaluation of a polygenic hazard score for prognostic assessment in localized gastric cancer. Fundamental Research 2022. [DOI: 10.1016/j.fmre.2022.09.031] [Reference Citation Analysis]
104 Rui Zhang, Ying Wei, Feng Shi, Jing Ren, Qing Zhou, Weimin Li, Bojiang Chen. The diagnostic and prognostic value of radiomics and deep learning technologies for patients with solid pulmonary nodules in chest CT images. BMC Cancer 2022;22:1118. [PMID: 36319968 DOI: 10.1186/s12885-022-10224-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Lei Wang, Huiqiong Han, Liwen Feng, Yanru Qin. Development and validation of a nomogram for patients with stage II/III gastric adenocarcinoma after radical surgery. Front Surg 2022;9:956256. [PMID: 36386541 DOI: 10.3389/fsurg.2022.956256] [Reference Citation Analysis]
106 Peng JY, Cai DK, Zeng RL, Zhang CY, Li GC, Chen SF, Yuan XQ, Peng L. Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma. Adv Sci (Weinh) 2022;10:e2204711. [PMID: 36307901 DOI: 10.1002/advs.202204711] [Reference Citation Analysis]
107 Cai Z, Chen D, Qiu W, Liang C, Huang Y, Zhou J, Zhan Z, Xiang Y, Guo X, Lv X. Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04355-w] [Reference Citation Analysis]
108 Zhou M, Yan JQ, Chen QX, Yang YZ, Li YL, Ren YX, Weng ZJ, Zhang XF, Guan JX, Tang LY, Ren ZF. Association of H3K9me3 with breast cancer prognosis by estrogen receptor status. Clin Epigenetics 2022;14:135. [PMID: 36303253 DOI: 10.1186/s13148-022-01363-y] [Reference Citation Analysis]
109 Shen D, Zhou G, Zhao J, Wang G, Jiang Z, Liu J, Wang H, Deng Z, Ma C, Li J. A novel nomogram based on the prognostic nutritional index for predicting postoperative outcomes in patients with stage I–III gastric cancer undergoing robotic radical gastrectomy. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.928659] [Reference Citation Analysis]
110 Wang Z, Li B, Li S, Lin W, Wang Z, Wang S, Chen W, Shi W, Chen T, Zhou H, Yinwang E, Zhang W, Mou H, Chai X, Zhang J, Lu Z, Ye Z. Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion. Nat Commun 2022;13:6308. [PMID: 36274066 DOI: 10.1038/s41467-022-34064-4] [Reference Citation Analysis]
111 Huang C, Yu QP, Ding Z, Zhou Z, Shi X. The clinical characteristics, novel predictive tool, and risk classification system for primary Ewing sarcoma patients that underwent chemotherapy: A large population-based retrospective cohort study. Cancer Med 2022. [PMID: 36271609 DOI: 10.1002/cam4.5379] [Reference Citation Analysis]
112 Zhao X, Wu X, Yu H, Wang H, Sun S, Hu Z, Liu C, Zhang J, Shao Y, Wang J. Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors. Front Immunol 2022;13:1003581. [DOI: 10.3389/fimmu.2022.1003581] [Reference Citation Analysis]
113 He S, Jiang R, Sun H, Yang J, Ye C, Liu W, Yang X, Cai X, Xiao J. Surgical efficacy and survival prediction of patients with unspecified malignant bone tumors. BMC Cancer 2022;22:1078. [PMID: 36266614 DOI: 10.1186/s12885-022-10153-x] [Reference Citation Analysis]
114 Xing L, Wang Y, Jin Z, Sha Y, Qiu T, Wang L, Fan L, Zhu H, Xu W, Li J, Miao Y. Clinical significance of prolymphocytes in Chinese patients with chronic lymphocytic leukemia including those treated with BTK inhibitors.. [DOI: 10.21203/rs.3.rs-2168937/v1] [Reference Citation Analysis]
115 Zhang Z, Tang Y, Li L, Yang W, Xu Y, Zhou J, Ma K, Zhang K, Zhuang H, Gong Y, Gong K, Bonam SR. Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma. Journal of Immunology Research 2022;2022:1-19. [DOI: 10.1155/2022/4946197] [Reference Citation Analysis]
116 Wang K, Liu Z, Yu H, Cheng Y, Xiang Y, Zhong J, Ni Q, Zhou L, Liang C, Zhou H, Pan W, Guo W, Shi J, Lau WY, Cheng S. Gemcitabine plus Oxaliplatin (GEMOX) combined with Atezolizumab and Bevacizumab for Advanced Biliary Tract Cancer: A Preliminary Observational Study.. [DOI: 10.21203/rs.3.rs-2149321/v1] [Reference Citation Analysis]
117 Liu X, Li J, Wang Q, Bai L, Xing J, Hu X, Li S, Li Q. Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq. Front Immunol 2022;13:1012303. [DOI: 10.3389/fimmu.2022.1012303] [Reference Citation Analysis]
118 Liu Y, Sun M, Xiong Y, Gu X, Zhang K, Liu L. Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study. Technol Cancer Res Treat 2022;21:15330338221132035. [PMID: 36217877 DOI: 10.1177/15330338221132035] [Reference Citation Analysis]
119 Li W, Liu Y, Wang C, Yong C, Lin C, Yen Y. Radiographic tumor burden score is useful for stratifying the overall survival of hepatocellular carcinoma patients undergoing resection at different Barcelona Clinic Liver.. [DOI: 10.21203/rs.3.rs-2121956/v1] [Reference Citation Analysis]
120 Sun T, Huang S, Jiang Y, Yuan H, Wu J, Liu C, Zhang X, Tang Y, Ben X, Tang J, Zhou H, Zhang D, Xie L, Chen G, Zhao Y, Wang S, Xu H, Qiao G. Dynamic alteration in SULmax predicts early pathological tumor response and short-term prognosis in non-small cell lung cancer treated with neoadjuvant immunochemotherapy. Front Bioeng Biotechnol 2022;10:1010672. [DOI: 10.3389/fbioe.2022.1010672] [Reference Citation Analysis]
121 Hu Y, Xu S, Qi Q, Wang X, Meng J, Zhou J, Hao Z, Liang Q, Feng X, Liang C. A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study. Front Public Health 2022;10:989566. [PMID: 36276376 DOI: 10.3389/fpubh.2022.989566] [Reference Citation Analysis]
122 Shi J, Liu S, Cao J, Shan S, Zhang J, Wang Y. Development and validation of lymph node ratio-based nomograms for primary duodenal adenocarcinoma after surgery. Front Oncol 2022;12:962381. [DOI: 10.3389/fonc.2022.962381] [Reference Citation Analysis]
123 Guan B, Huang X, Xia H, Guan G, Xu B. Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study. Front Oncol 2022;12:941786. [DOI: 10.3389/fonc.2022.941786] [Reference Citation Analysis]
124 Jiang S, Zhang J, Zhang L, Xu Y, Zhao H, Sang X, Lu X. A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery. Sci Rep 2022;12:16466. [PMID: 36183006 DOI: 10.1038/s41598-022-20933-x] [Reference Citation Analysis]
125 Wu F, Zhang P, Li L, Lin S, Liu J, Sun Y, Wang Y, Luo C, Huang Y, Yan X, Zhang M, Liu G, Li K. Inadvertent radical nephrectomy leads to worse prognosis in renal pelvic urothelial carcinoma patients: A propensity score-matched study. Front Oncol 2022;12:948223. [DOI: 10.3389/fonc.2022.948223] [Reference Citation Analysis]
126 Zhang X, Wang X, Li W, Sun T, Dang C, Diao D. D-dimer, a predictor of bad outcome in gastric cancer patients undergoing radical resection. Sci Rep 2022;12:16432. [PMID: 36180481 DOI: 10.1038/s41598-022-16582-9] [Reference Citation Analysis]
127 Matsuyama A, Wood GA, Speare R, Schott CR, Mutsaers AJ. Prognostic significance of the urokinase plasminogen activator system in tissue and serum of dogs with appendicular osteosarcoma. PLoS ONE 2022;17:e0273811. [DOI: 10.1371/journal.pone.0273811] [Reference Citation Analysis]
128 Liu Y, Cui H, Xu X, Liang W. Prognostic value of lymph node density on cancer staging system for gastric cancer without distal metastasis: a population-based analysis of SEER database. World J Surg Oncol 2022;20:325. [PMID: 36175896 DOI: 10.1186/s12957-022-02795-9] [Reference Citation Analysis]
129 Qu G, Xu Y, Lu Z, Nie H, Tang C, Hou J, Wen X, Jovicic N. Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1-39. [DOI: 10.1155/2022/4754935] [Reference Citation Analysis]
130 Ni J, Li Z, Song W, Zhang H, Wang Y, Zhang Y, Zhang H, Yang G, Xie J, Wang K, Peng B, Mao W. Prognostic value of glucose to lymphocyte ratio for patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A multi-institutional, propensity score matching cohort study. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.911411] [Reference Citation Analysis]
131 Fan S, Jiang W, Fang Z, Li R, Li Y, Chen Y, Zhang Q. Relationship between lymph nodes examined and survival benefits with postoperative radiotherapy in oral cavity squamous cell carcinoma patients with stage T1-2N1M0. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.928455] [Reference Citation Analysis]
132 Liu Y, Zheng R, Liu Y, Yang L, Li T, Li Y, Jiang Z, Liu Y, Wang C, Wang S. An easy-to-use nomogram predicting overall survival of adult acute lymphoblastic leukemia. Front Oncol 2022;12:977119. [DOI: 10.3389/fonc.2022.977119] [Reference Citation Analysis]
133 Zeng S, Zhang H, Zhang D, Hu X, Song L. Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator FDX1 in Clear Cell Renal Cell Carcinoma. Genes 2022;13:1725. [DOI: 10.3390/genes13101725] [Reference Citation Analysis]
134 Peng S, Xiao Y, Li X, Wu Z. A nomogram for predicting overall survival rate in patients with brain metastatic non-small cell lung cancer. Medicine 2022;101:e30824. [DOI: 10.1097/md.0000000000030824] [Reference Citation Analysis]
135 Tan X, Liu Z, Wang Y, Wu Z, Zou Y, Luo S, Tang Y, Chen D, Yuan G, Yao K. miR-138-5p-mediated HOXD11 promotes cell invasion and metastasis by activating the FN1/MMP2/MMP9 pathway and predicts poor prognosis in penile squamous cell carcinoma. Cell Death Dis 2022;13:816. [PMID: 36151071 DOI: 10.1038/s41419-022-05261-2] [Reference Citation Analysis]
136 Wang S, Wei J, Guo Y, Xu Q, Lv X, Yu Y, Liu M. Construction and validation of nomograms based on the log odds of positive lymph nodes to predict the prognosis of lung neuroendocrine tumors. Front Immunol 2022;13:987881. [DOI: 10.3389/fimmu.2022.987881] [Reference Citation Analysis]
137 Zhang R, Hu C, Zhang J, Zhang Y, Li Y, Yu P, Wang Y, Bao Z, Cao M, Ruan R, Cheng X, Xu Z. Prognostic significance of Inflammatory and Nutritional Markers in Perioperative Period for Patients with Advanced Gastric Cancer.. [DOI: 10.21203/rs.3.rs-2063388/v1] [Reference Citation Analysis]
138 Robles J, Pintado-Berninches L, Boukich I, Escudero B, de Los Rios V, Bartolomé RA, Jaén M, Martín-Regalado Á, Fernandez-Aceñero MJ, Imbaud JI, Casal JI. A prognostic six-gene expression risk-score derived from proteomic profiling of the metastatic colorectal cancer secretome. J Pathol Clin Res 2022;8:495-508. [PMID: 36134447 DOI: 10.1002/cjp2.294] [Reference Citation Analysis]
139 Cai Y, Xue S, Li J, Xiao H, Lan T, Wu H. A novel nutritional score based on serum triglyceride and protein levels predicts outcomes of intrahepatic cholangiocarcinoma after curative hepatectomy: A multi-center study of 631 patients. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.964591] [Reference Citation Analysis]
140 Lin J, Luo B, Yu X, Yang Z, Wang M, Cai W. Copper metabolism patterns and tumor microenvironment characterization in colon adenocarcinoma. Front Oncol 2022;12:959273. [DOI: 10.3389/fonc.2022.959273] [Reference Citation Analysis]
141 Wang H, Liu Y, Xu N, Sun Y, Fu S, Wu Y, Liu C, Cui L, Liu Z, Chang Z, Li S, Deng K, Song J. Development and validation of a deep learning model for survival prognosis of transcatheter arterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma. Eur J Radiol 2022;156:110527. [PMID: 36152524 DOI: 10.1016/j.ejrad.2022.110527] [Reference Citation Analysis]
142 Zheng C, Zhang G, Xie K, Diao Y, Luo C, Wang Y, Shen Y, Xue Q. Pan-Cancer Analysis and Experimental Validation Identify ACOT7 as a Novel Oncogene and Potential Therapeutic Target in Lung Adenocarcinoma. Cancers (Basel) 2022;14:4522. [PMID: 36139682 DOI: 10.3390/cancers14184522] [Reference Citation Analysis]
143 Lai Y, Wang C, Yang X, He S, Wang Y, Chen Y. The impairment of induction chemotherapy for stage II nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy with or without concurrent chemotherapy: A propensity score‐matched analysis. Cancer Medicine. [DOI: 10.1002/cam4.5199] [Reference Citation Analysis]
144 Li J, Liu X, Qi Y, Liu Y, Du E, Zhang Z. A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma. Front Immunol 2022;13:922929. [DOI: 10.3389/fimmu.2022.922929] [Reference Citation Analysis]
145 Wang Z, Liu J, Han J, Yang Z, Wang Q. Analysis of prognostic factors of undifferentiated pleomorphic sarcoma and construction and validation of a prediction nomogram based on SEER database. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00810-z] [Reference Citation Analysis]
146 Kong J, Lu S, Zhang L, Yao Y, Zhang J, Shen Z, Luo M, Liu B, Zheng J, Lin T. m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent. Front Immunol 2022;13:1014861. [DOI: 10.3389/fimmu.2022.1014861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Zhang Z, Wu Y, Li L, Zhai X, Liang P. Clinically applicable 39 genes targeted mutational analysis predicts recurrence in pediatric medulloblastoma: a monocenter cohort study.. [DOI: 10.21203/rs.3.rs-2053751/v1] [Reference Citation Analysis]
148 Rana R, Huirem RS, Kant R, Chauhan K, Sharma S, Yashavarddhan MH, Chhabra SS, Acharya R, Kalra SK, Gupta A, Jain S, Ganguly NK. Cytochrome C as a potential clinical marker for diagnosis and treatment of glioma. Front Oncol 2022;12:960787. [DOI: 10.3389/fonc.2022.960787] [Reference Citation Analysis]
149 Jin S, Liu H, Yang J, Zhou J, Peng D, Liu X, Zhang H, Zeng Z, Ye Y. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis. Front Endocrinol 2022;13:882279. [DOI: 10.3389/fendo.2022.882279] [Reference Citation Analysis]
150 Cao Z, Lin J, Fu G, Niu L, Yang Z, Cai W. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration. Front Immunol 2022;13:959967. [DOI: 10.3389/fimmu.2022.959967] [Reference Citation Analysis]
151 Zuo Y, Fu S, Zhao Z, Li Z, Wu Y, Qi T, Zheng J, Du Q, Xu Z, Yu N. Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma. Front Genet 2022;13:985641. [DOI: 10.3389/fgene.2022.985641] [Reference Citation Analysis]
152 Shen Z, Hu L, Zhang S, Sun Q, Li W, Yan D, Cai G, Sang W. Visceral fat area and albumin based nutrition-related prognostic index model could better stratify the prognosis of diffuse large B-cell lymphoma in rituximab era. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.981433] [Reference Citation Analysis]
153 Lv C, Han S, Wu B, Liang Z, Li Y, Zhang Y, Lang Q, Zhong C, Fu L, Yu Y, Xu F, Tian Y. Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer. Front Immunol 2022;13:984172. [DOI: 10.3389/fimmu.2022.984172] [Reference Citation Analysis]
154 Yang T, Huang S, Chen B, Chen Y, Liang W. A modified survival model for patients with esophageal squamous cell carcinoma based on lymph nodes: A study based on SEER database and external validation. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.989408] [Reference Citation Analysis]
155 Zhu S, Ni Y, Wang Z, Zhang X, Zhang Y, Zhao F, Dai J, Wang Z, Zhu X, Chen J, Zhao J, Zeng Y, Chen N, Zeng P, Shen P, Sun G, Zeng H. Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer. Oncologist 2022;27:e870-7. [PMID: 36067250 DOI: 10.1093/oncolo/oyac177] [Reference Citation Analysis]
156 Li G, Wu S, Zhao H, Guan W, Zhou Y, Shi B. Non-invasive prognostic biomarker of lung cancer patients with brain metastases: Recurrence quantification analysis of heart rate variability. Front Physiol 2022;13:987835. [DOI: 10.3389/fphys.2022.987835] [Reference Citation Analysis]
157 Guo Z, Liang J. Lipid-Based Factors: A Promising New Biomarker for Predicting Prognosis and Conditional Survival Probability in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2022;9:869-83. [PMID: 36051861 DOI: 10.2147/JHC.S360871] [Reference Citation Analysis]
158 Xu X, Li D, Song L, Liu P, Wu Z, Wang L, Zhang L, Zhang J, Wu Z. Nomogram for predicting an individual prospective hemorrhage risk in untreated brainstem cavernous malformations. Journal of Neurosurgery 2022. [DOI: 10.3171/2022.8.jns221228] [Reference Citation Analysis]
159 Zhuang BW, Li W, Qiao B, Zhang N, Lin MX, Wang W, Kuang M, Lu MD, Xie XY, Xie XH. Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation. Int J Hyperthermia 2022;39:1143-51. [PMID: 36039777 DOI: 10.1080/02656736.2022.2116491] [Reference Citation Analysis]
160 He R, Feng X, Yang K, Zhou X, Li W, Zeng J. Construction of a 5-methylcytosine-Related Molecular Signature to Inform the Prognosis and Immunotherapy of Lung Squamous Cell Carcinoma. Expert Rev Mol Diagn 2022;22:905-13. [PMID: 36197838 DOI: 10.1080/14737159.2022.2131396] [Reference Citation Analysis]
161 Wei Z, Zhang F, Ma X, He W, Gou X, Zhang X, Xie Y. Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma. Transl Oncol 2022;23:101486. [PMID: 35839619 DOI: 10.1016/j.tranon.2022.101486] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
162 Xiong L, Jiang Y, Hu T. Prognostic nomograms for lung neuroendocrine carcinomas based on lymph node ratio: a SEER database analysis. J Int Med Res 2022;50:3000605221115160. [PMID: 36076355 DOI: 10.1177/03000605221115160] [Reference Citation Analysis]
163 Deng K, Wang L, Liu Y, Li X, Hou Q, Cao M, Ng NN, Wang H, Chen H, Yeom KW, Zhao M, Wu N, Gao P, Shi J, Liu Z, Li W, Tian J, Song J. A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study. EClinicalMedicine 2022;51:101541. [PMID: 35813093 DOI: 10.1016/j.eclinm.2022.101541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
164 Xu Z, Zhang X, Jin Y, Wang S, Gu Y, Ma J, Wen X, Leng J, Mao Z, Lin J, Qian J. Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia. Molecular Therapy - Oncolytics 2022;26:88-104. [DOI: 10.1016/j.omto.2022.05.011] [Reference Citation Analysis]
165 Zheng J, Li S, Zhao Y, Tao Z, Li L, Li Z, Li M, Chen X. Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study. BMJ Open 2022;12:e062129. [PMID: 36581979 DOI: 10.1136/bmjopen-2022-062129] [Reference Citation Analysis]
166 Tang H, Qiao C, Wang Y, Bai C, Qian X. Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma. Canadian Respiratory Journal 2022;2022:1-12. [DOI: 10.1155/2022/3676547] [Reference Citation Analysis]
167 Xu T, Ma D, Chen S, Tang R, Yang J, Meng C, Feng Y, Liu L, Wang J, Luo H, Yu K. High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes. NPJ Breast Cancer 2022;8:100. [PMID: 36042244 DOI: 10.1038/s41523-022-00472-4] [Reference Citation Analysis]
168 Luo D, Feng W, Ma Y, Jiang Z. Identification and validation of a novel prognostic model of inflammation-related gene signature of lung adenocarcinoma. Sci Rep 2022;12:14729. [PMID: 36042374 DOI: 10.1038/s41598-022-19105-8] [Reference Citation Analysis]
169 Yu T, Cheng W, Wang T, Chen Z, Ding Y, Feng J, Duan Y, Hu A, Li M, Zhang H, Li Y, Ma F, Guo B, Min J. Survival Outcomes of Breast-Conserving Therapy versus Mastectomy in Early-Stage Breast Cancer, Including Centrally Located Breast Cancer: A SEER-Based Study. The Breast Journal 2022;2022:1-13. [DOI: 10.1155/2022/5325556] [Reference Citation Analysis]
170 Huang C, Huang Z, Zhou Z, Liu X. A Novel Prognostic Nomogram and Risk Classification System for Predicting Cancer-Specific Survival of Postoperative Fibrosarcoma Patients: A Large Cohort Retrospective Study. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/7831001] [Reference Citation Analysis]
171 Xu M, Cheng A, Yu L, Wei W, Li J, Cai C. AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas. Acta Biochim Biophys Sin (Shanghai) 2022;54:1708-19. [PMID: 36017889 DOI: 10.3724/abbs.2022112] [Reference Citation Analysis]
172 Huang C, Huang Z, Ding Z, Zhou Z. A Novel Clinical Tool to Predict Cancer-specific Survival in Postoperative Patients With Primary Spinal and Pelvic Sarcomas: A Large Population-Based Retrospective Cohort Study. Global Spine J 2022;:21925682221121269. [PMID: 36003041 DOI: 10.1177/21925682221121269] [Reference Citation Analysis]
173 Huang C, Ding Z, Li H, Zhou Z, Yu M. A novel nomogram for predicting long-term heart-disease specific survival among older female primary breast cancer patients that underwent chemotherapy: A real-world data retrospective cohort study. Front Public Health 2022;10:964609. [PMID: 36091523 DOI: 10.3389/fpubh.2022.964609] [Reference Citation Analysis]
174 Rout ED, Fernandez M, Yoshimoto JA, Hughes KL, Avery AC, Burton JH. Clinical outcome and Ki67 evaluation in dogs with nodal small cell B-cell lymphoma diagnosed by flow cytometry. J Vet Intern Med 2022. [PMID: 35996942 DOI: 10.1111/jvim.16515] [Reference Citation Analysis]
175 Liu S, Yang S, Yu H, Luo H, Chen G, Gao Y, Sun R, Xiao W. A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer. Front Med 2022;9. [DOI: 10.3389/fmed.2022.977652] [Reference Citation Analysis]
176 Liu C, Liu J, Shao J, Huang C, Dai X, Shen Y, Hou W, Shen Y, Yu Y. MAGED4B Promotes Glioma Progression via Inactivation of the TNF-α-induced Apoptotic Pathway by Down-regulating TRIM27 Expression. Neurosci Bull . [DOI: 10.1007/s12264-022-00926-6] [Reference Citation Analysis]
177 Liu X, Wang L, Song J, Liu S, Yan J, Yang S, Zhang Y. A novel prognostic model for cervical cancer patients with lymph node metastases: based on SEER database and an independent cohort.. [DOI: 10.21203/rs.3.rs-1901970/v1] [Reference Citation Analysis]
178 Ma Y, Lyu J, Yang B, Yan T, Ma Q, Wu Z, Wang Z, He H. Incidence and risk factors of suicide among patients with pancreatic cancer: A population-based analysis from 2000 to 2018. Front Oncol 2022;12:972908. [DOI: 10.3389/fonc.2022.972908] [Reference Citation Analysis]
179 Xu C, Peng Y, Zhu W, Chen Z, Li J, Tan W, Zhang Z, Chen X. An automated approach for predicting glioma grade and survival of LGG patients using CNN and radiomics. Front Oncol 2022;12:969907. [DOI: 10.3389/fonc.2022.969907] [Reference Citation Analysis]
180 Ren C, Ma Y, Jin J, Ding J, Jiang Y, Wu Y, Li W, Yang X, Han L, Ma Q, Wu Z, Shi Y, Wang Z. Development and external validation of a dynamic nomogram to predict the survival for adenosquamous carcinoma of the pancreas. Front Oncol 2022;12:927107. [DOI: 10.3389/fonc.2022.927107] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Chen W, Zhang M, Chen C, Pang X, Pan J. Prognostic Nutritional Index and Neutrophil/Lymphocyte Ratio Can Serve as Independent Predictors of the Prognosis of Hepatocellular Carcinoma Patients Receiving Targeted Therapy. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/1389049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Ledenko M, Antwi SO, Arima S, Driscoll J, Furuse J, Klümpen H, Larsen FO, Lau DK, Maderer A, Markussen A, Moehler M, Nooijen LE, Shaib WL, Tebbutt NC, André T, Ueno M, Woodford R, Yoo C, Zalupski MM, Patel T. Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials. Front Oncol 2022;12:963753. [DOI: 10.3389/fonc.2022.963753] [Reference Citation Analysis]
183 Jiang S, Ding X, Wu Q, Cheng T, Xu M, Huang J. Identifying immune cells-related phenotype to predict immunotherapy and clinical outcome in gastric cancer. Front Immunol 2022;13:980986. [DOI: 10.3389/fimmu.2022.980986] [Reference Citation Analysis]
184 Zhou S, Cai Y, Xu Z, Peng B, Liang Q, Peng J, Yan Y. Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma. Front Endocrinol 2022;13:964362. [DOI: 10.3389/fendo.2022.964362] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
185 Ibrahim A, Toss M, Saleem MA, Atalla N, Green A, Rakha E. Breast cancer risk stratification based on combined analysis of proliferation and apoptosis.. [DOI: 10.21203/rs.3.rs-1910854/v1] [Reference Citation Analysis]
186 Wu L, Wang D, Chen Y, Qian M, Xu X, Zhang T, Bi N, Wang L. Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy. Front Immunol 2022;13:906815. [DOI: 10.3389/fimmu.2022.906815] [Reference Citation Analysis]
187 Wang J, Wang Q, Du X, Zhu X, Nie C, Han X, Tian W, Li H, Zhou H. Risk factors associated with cardiovascular mortality among gastric cancer patients: a population-based analysis. Jpn J Clin Oncol 2022:hyac132. [PMID: 35946330 DOI: 10.1093/jjco/hyac132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Sui S, Li Z, Tan J, Wang L, Luo G, Zeng C, Luo OJ, Chen C, Li Y, Liu B. Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/2787426] [Reference Citation Analysis]
189 Peng W, Shen J, Dai J, Leng S, Xie F, Zhang Y, Ran S, Sun X, Wen T. Preoperative aspartate aminotransferase to albumin ratio correlates with tumor characteristics and predicts outcome of hepatocellular carcinoma patients after curative hepatectomy: a multicenter study. BMC Surg 2022;22:307. [PMID: 35945520 DOI: 10.1186/s12893-022-01751-4] [Reference Citation Analysis]
190 Liang Y, Zhang Z, Zhong D, Lai C, Dai Z, Zou H, Feng T, Shang J, Shi Y, Huang X. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients. Front Oncol 2022;12:913731. [DOI: 10.3389/fonc.2022.913731] [Reference Citation Analysis]
191 Yang SC, Wang WY, Zhou JJ, Wu L, Zhang MJ, Yang QC, Deng WW, Sun ZJ. Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma. Int Immunopharmacol 2022;111:109113. [PMID: 35944462 DOI: 10.1016/j.intimp.2022.109113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Gao B, Wang M, Li Y, Huang F. Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection. Front Public Health 2022;10:949500. [DOI: 10.3389/fpubh.2022.949500] [Reference Citation Analysis]
193 Yuan X, Yang H, Zeng F, Zhou S, Wu S, Yuan Y, Cui L, Feng H, Lin D, Chen Z, Liu X, Chen J, Wang F. Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA. BMC Cancer 2022;22:858. [PMID: 35932022 DOI: 10.1186/s12885-022-09942-1] [Reference Citation Analysis]
194 Chen P, Mao X, Ma N, Wang C, Yao G, Ye G, Zhou D. Dynamic changes in intrinsic subtype, immunity status, and risk score before and after neoadjuvant chemo- and HER2-targeted therapy without pCR in HER2-positive breast cancers: A cross-sectional analysis. Medicine (Baltimore) 2022;101:e29877. [PMID: 35945759 DOI: 10.1097/MD.0000000000029877] [Reference Citation Analysis]
195 Jia J, Zeng X, Li C, Yang L, Huang Y, Tong X, Jiang Q, Zhang P, Tao K. A Combination of Preoperative Computed Tomography-Defined Sarcopenia and Systemic Inflammation on Survival in Patients with Poorly Differentiated Neuroendocrine Neoplasms Following Radical Resection. Nutr Cancer 2023;75:186-96. [PMID: 35920394 DOI: 10.1080/01635581.2022.2102660] [Reference Citation Analysis]
196 Xia J, Li X, Gui G, Wu J, Gong S, Shang Y, Fan J. Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation. Front Cell Infect Microbiol 2022;12:954420. [DOI: 10.3389/fcimb.2022.954420] [Reference Citation Analysis]
197 Deng Y, Sun Y, Lin Y, Huang Y, Chi P. Clinical implication of the advanced lung cancer inflammation index in patients with right-sided colon cancer after complete mesocolic excision: a propensity score-matched analysis. World J Surg Oncol 2022;20:246. [PMID: 35909159 DOI: 10.1186/s12957-022-02712-0] [Reference Citation Analysis]
198 You D, Zhang S, Yan S, Ding Y, Li C, Cheng X, Wu L, Wang W, Zhang T, Li Z, He Y. SAMHD1 as a prognostic and predictive biomarker in stage II colorectal cancer: A multicenter cohort study. Front Oncol 2022;12:939982. [DOI: 10.3389/fonc.2022.939982] [Reference Citation Analysis]
199 Li ZC, Yan J, Zhang S, Liang C, Lv X, Zou Y, Zhang H, Liang D, Zhang Z, Chen Y. Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network: a multicenter study. Eur Radiol 2022;32:5719-29. [PMID: 35278123 DOI: 10.1007/s00330-022-08640-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Meng Y, Yu J, Zhu M, Zhou J, Li N, Liu F, Zhang H, Fang X, Li J, Feng X, Wang L, Jiang H, Lu J, Shao C, Bian Y. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma. Abdom Radiol (NY) 2022;47:2822-34. [PMID: 35451626 DOI: 10.1007/s00261-022-03512-6] [Reference Citation Analysis]
201 Moutafi MK, Molero M, Martinez Morilla S, Baena J, Vathiotis IA, Gavrielatou N, Castro-Labrador L, de Garibay GR, Adradas V, Orive D, Valencia K, Calvo A, Montuenga LM, Ponce Aix S, Schalper KA, Herbst RS, Paz-Ares L, Rimm DL, Zugazagoitia J. Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer. J Immunother Cancer 2022;10:e004757. [PMID: 36002182 DOI: 10.1136/jitc-2022-004757] [Reference Citation Analysis]
202 Aung TN, Shafi S, Wilmott JS, Nourmohammadi S, Vathiotis I, Gavrielatou N, Fernandez A, Yaghoobi V, Sinnberg T, Amaral T, Ikenberg K, Khosrotehrani K, Osman I, Acs B, Bai Y, Martinez-morilla S, Moutafi M, Thompson JF, Scolyer RA, Rimm DL. Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms. eBioMedicine 2022;82:104143. [DOI: 10.1016/j.ebiom.2022.104143] [Reference Citation Analysis]
203 Jiang S, Yang F, Zhang L, Sang X, Lu X, Zheng Y, Xu Y. A prognostic nomogram based on log odds of positive lymph nodes to predict the overall survival in biliary neuroendocrine neoplasms (NENs) patients after surgery. J Endocrinol Invest 2022. [PMID: 35908009 DOI: 10.1007/s40618-022-01874-8] [Reference Citation Analysis]
204 Luo Y, Weng X, Huang J, Hu X, Wei L, Lin Y, Ding T, Zhang B, Chu L, Liu C, Peng Y, Xu Y, Wu F. Nomogram constructed by immunological and inflammatory indicators for predicting prognosis of patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy plus surgery. Front Oncol 2022;12:882900. [DOI: 10.3389/fonc.2022.882900] [Reference Citation Analysis]
205 Wu Z, Zhao P, Wang Z, Huang X, Wu C, Li M, Wang L, Tian B. Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single center. Front Oncol 2022;12:966256. [DOI: 10.3389/fonc.2022.966256] [Reference Citation Analysis]
206 Li H, Wang M, Zhang Y, Hu F, Wang K, Wang C, Gao Z. Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT. Front Oncol 2022;12:943151. [DOI: 10.3389/fonc.2022.943151] [Reference Citation Analysis]
207 Aiyappa-Maudsley R, Storr SJ, Rakha EA, Green AR, Ellis IO, Martin SG. CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer. J Pathol Clin Res 2022;8:550-66. [PMID: 35902379 DOI: 10.1002/cjp2.291] [Reference Citation Analysis]
208 Hong Z, Huang Z, Chen Z, Kang M. Prognostic Value of Carcinoembryonic Antigen Changes Before and After Operation for Esophageal Squamous Cell Carcinoma. World J Surg 2022. [PMID: 35882638 DOI: 10.1007/s00268-022-06672-0] [Reference Citation Analysis]
209 Jin Z, Zhang Q, Wang C, Wang S, Lin L, Zou R, Sun G, Zeng K, Zhou B, Tong Y, Chen B, Zhao Y. High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer. Acta Biochim Biophys Sin (Shanghai) 2022. [PMID: 35838199 DOI: 10.3724/abbs.2022083] [Reference Citation Analysis]
210 Zhang Y, Wang D, Wu N, Chen X, Yuan Z, Jia X, Li C, Hu Q, Chen Y, Zhang Z, Zhong L, Li Y. Role of circulating long non-coding RNA for the improvement of the predictive ability of the CHA2DS2–VASc score in patients with atrial fibrillation. Chinese Medical Journal 2022;Publish Ahead of Print. [DOI: 10.1097/cm9.0000000000002213] [Reference Citation Analysis]
211 Huang Z, Wang Y, Wu Y, Guo C, Li W, Kong Q, Zhang Z. A Novel Tool to Predict the Overall Survival of High-Grade Osteosarcoma Patients after Neoadjuvant Chemotherapy: A Large Population-Based Cohort Study. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/8189610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Ji X, Zhou B, Ding W, Wang J, Jiang W, Li Y, Hu J, Sun X. Efficacy of stereotactic body radiation therapy for locoregional recurrent pancreatic cancer after radical resection. Front Oncol 2022;12:925043. [DOI: 10.3389/fonc.2022.925043] [Reference Citation Analysis]
213 Milovanović J, Todorović-Raković N, Vujasinović T, Greenman J, Mandušić V, Radulovic M. Can granulysin provide prognostic value in primary breast cancer? Pathol Res Pract 2022;237:154039. [PMID: 35905663 DOI: 10.1016/j.prp.2022.154039] [Reference Citation Analysis]
214 Zhao Z, Yin XN, Wang J, Chen X, Cai ZL, Zhang B. Prognostic significance of hemoglobin, albumin, lymphocyte, platelet in gastrointestinal stromal tumors: A propensity matched retrospective cohort study. World J Gastroenterol 2022; 28(27): 3476-3487 [DOI: 10.3748/wjg.v28.i27.3476] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Wang Q, Wang S, Sun Z, Cao M, Zhao X. Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study. BMC Cancer 2022;22:801. [PMID: 35858848 DOI: 10.1186/s12885-022-09908-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Zhang Y, Zou J, Chen R. An M0 macrophage-related prognostic model for hepatocellular carcinoma. BMC Cancer 2022;22:791. [PMID: 35854246 DOI: 10.1186/s12885-022-09872-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Chen T, Zhan X, Chen X, Jiang M, Wan H, Fu B, Chen L. Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy. Front Oncol 2022;12:895413. [DOI: 10.3389/fonc.2022.895413] [Reference Citation Analysis]
218 Lam LHT, Chu NT, Tran T, Do DT, Le NQK. A Radiomics-Based Machine Learning Model for Prediction of Tumor Mutational Burden in Lower-Grade Gliomas. Cancers 2022;14:3492. [DOI: 10.3390/cancers14143492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Ni H, Yang X, Yang C, Zhang Q, Xu J, Qi L, Xiang B, Apte U. Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/7305953] [Reference Citation Analysis]
220 Qiao H, Tan XR, Li H, Li JY, Chen XZ, Li YQ, Li WF, Tang LL, Zhou GQ, Zhang Y, Liang YL, He QM, Zhao Y, Huang SY, Gong S, Li Q, Ye ML, Chen KL, Sun Y, Ma J, Liu N. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China. JAMA Oncol 2022. [PMID: 35834269 DOI: 10.1001/jamaoncol.2022.2810] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Zhou L, Feng F, Yang Y, Zheng X, Yang Y. Prognostic predictors of non-small cell lung cancer treated with curative resection: the role of preoperative CT texture features, clinical features, and laboratory parameters. Clin Radiol 2022:S0009-9260(22)00317-8. [PMID: 35843728 DOI: 10.1016/j.crad.2022.06.012] [Reference Citation Analysis]
222 Deng ZJ, Lu J, Nie RC, Fang JM, Chen XJ, Liu JJ, Li XZ, Chen YB, Huang CM, Lian L, Peng JS, Chen S. Indications for Adjuvant Chemotherapy in Stage II Gastric Cancer After D2 Gastrectomy-A Chinese Multicenter Study. Ann Surg Oncol 2022. [PMID: 35798893 DOI: 10.1245/s10434-022-12108-9] [Reference Citation Analysis]
223 Liu C, Liu D, Wang F, Xie J, Liu Y, Wang H, Rong J, Xie J, Wang J, Zeng R, Zhou F, Xie Y. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Front Med 2022;9. [DOI: 10.3389/fmed.2022.925661] [Reference Citation Analysis]
224 Leng C, Cui Y, Chen J, Wang K, Yang H, Wen J, Fu J, Liu Q. A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical Resection. Front Oncol 2022;12:925685. [DOI: 10.3389/fonc.2022.925685] [Reference Citation Analysis]
225 Huang C, Su Q, Ding Z, Zeng W, Zhou Z. A novel clinical tool to predict cancer-specific survival in patients with primary pelvic sarcomas: A large population-based retrospective cohort study. Cancer Med 2022. [PMID: 35796258 DOI: 10.1002/cam4.4998] [Reference Citation Analysis]
226 Zhang S, Wan X, Lv M, Li C, Chu Q, Wang G. TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine. EPMA Journal. [DOI: 10.1007/s13167-022-00287-0] [Reference Citation Analysis]
227 Wu D, Chen M, Chen S, Zhang S, Chen Y, Zhao Q, Xue K, Xue F, Chen X, Zhou M, Li H, Zheng J, Le Y, Cao H. Enhanced tryptophan-kynurenine metabolism via indoleamine 2,3-dioxygenase 1 induction in dermatomyositis. Clin Rheumatol 2022. [PMID: 35778590 DOI: 10.1007/s10067-022-06263-3] [Reference Citation Analysis]
228 He Z, Li D, Xu Y, Wang H, Gao J, Zhang Z, Chen K. Prognostic significance of metastatic lymph node ratio in patients with gastric cancer after curative gastrectomy: a single-center retrospective study. Scand J Gastroenterol 2022;57:832-41. [PMID: 35293268 DOI: 10.1080/00365521.2022.2036807] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Truong SDA, Wongwattanakul M, Proungvitaya T, Limpaiboon T, Roytrakul S, Chua-on D, Tummanatsakun D, Proungvitaya S. Prediction of CIAPIN1 (Cytokine-Induced Apoptosis Inhibitor 1) Signaling Pathway and Its Role in Cholangiocarcinoma Metastasis. JCM 2022;11:3826. [DOI: 10.3390/jcm11133826] [Reference Citation Analysis]
230 Xu H, Cha YJ, Clemenceau JR, Choi J, Lee SH, Kang J, Hwang TH. Spatial analysis of tumor-infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma. J Pathol Clin Res 2022;8:327-39. [PMID: 35484698 DOI: 10.1002/cjp2.273] [Reference Citation Analysis]
231 Xie R, Wu J, Shang B, Cao C, Bi X, Shi H, Shou J, Guan Y, Zheng M. Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/3204189] [Reference Citation Analysis]
232 Zhou X, He Y, Liu D, Lin C, Liang D, Huang R, Wang L. An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma. Front Genet 2022;13:862179. [DOI: 10.3389/fgene.2022.862179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
233 Xing Z, Wang Y, Gong K, Chen Y. Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular complications in hemodialysis patients. BMC Nephrol 2022;23:232. [PMID: 35768780 DOI: 10.1186/s12882-022-02829-0] [Reference Citation Analysis]
234 Zhang Y, Gu D. Prognostic Impact of Serum CRP Level in Head and Neck Squamous Cell Carcinoma. Front Oncol 2022;12:889844. [DOI: 10.3389/fonc.2022.889844] [Reference Citation Analysis]
235 Zhao J, Zeng G, Lin E, Cai C, Li P, Zou B, Li J. Combined HIF-1α and SHH Up-Regulation Is a Potential Biomarker to Predict Poor Prognosis in Postoperative Hepatocellular Carcinoma. J Invest Surg 2022;:1-8. [PMID: 35768071 DOI: 10.1080/08941939.2022.2090034] [Reference Citation Analysis]
236 Zhan Z, Chen B, Yu J, Zheng J, Zeng Y, Sun M, Peng L, Guo Z, Wang X. Elevated Serum Alpha-Fetoprotein Is a Significant Prognostic Factor for Patients with Gastric Cancer: Results Based on a Large-Scale Retrospective Study. Front Oncol 2022;12:901061. [DOI: 10.3389/fonc.2022.901061] [Reference Citation Analysis]
237 Li Q, Zhang S, Wu QJ, Xiao J, Wang ZH, Mu XW, Zhang Y, Wang XN, You LL, Wang SN, Song JN, Zhao XN, Wang ZZ, Yan XY, Jin YX, Jiang BW, Liu SX. Serum total indoxyl sulfate levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study. BMC Nephrol 2022;23:231. [PMID: 35764943 DOI: 10.1186/s12882-022-02862-z] [Reference Citation Analysis]
238 Li Y, Wu G, Zhang Y, Yang W, Wang X, Duan L, Niu L, Chen J, Zhou W, Liu J, Fan D, Hong L. Effects of marital status on survival of retroperitoneal liposarcomas stratified by age and sex: A population-based study. Cancer Med 2022. [PMID: 35758717 DOI: 10.1002/cam4.4962] [Reference Citation Analysis]
239 Yang B, Liu C, Wu R, Zhong J, Li A, Ma L, Zhong J, Yin S, Zhou C, Ge Y, Tao X, Zhang L, Lu G. Development and Validation of a DeepSurv Nomogram to Predict Survival Outcomes and Guide Personalized Adjuvant Chemotherapy in Non-Small Cell Lung Cancer. Front Oncol 2022;12:895014. [DOI: 10.3389/fonc.2022.895014] [Reference Citation Analysis]
240 Lv M, Yan X, Tu Y. A Predictive Web-Based Nomogram for Elderly Patients Newly Diagnosed as Uveal Melanoma: A Population-Based Study. Front Med 2022;9:799083. [DOI: 10.3389/fmed.2022.799083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Morland D, Triumbari EKA, Maiolo E, Cuccaro A, Treglia G, Hohaus S, Annunziata S. Healthy Organs Uptake on Baseline 18F-FDG PET/CT as an Alternative to Total Metabolic Tumor Volume to Predict Event-Free Survival in Classical Hodgkin's Lymphoma. Front Med 2022;9:913866. [DOI: 10.3389/fmed.2022.913866] [Reference Citation Analysis]
242 Leetanaporn K, Hanprasertpong J. Predictive Value of the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Index on the Oncological Outcomes of Locally Advanced Cervical Cancer Patients. Cancer Manag Res 2022;14:1961-72. [PMID: 35726336 DOI: 10.2147/CMAR.S365612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
243 Li Y, Wu G, Zhang Y, Yang W, Wang X, Duan L, Niu L, Chen J, Zhou W, Liu J, Zhong H, Fan D, Hong L. Development and Validation of a Prognostic Model to Predict the Prognosis of Patients With Retroperitoneal Liposarcoma: A Large International Population-Based Cohort Study. Front Oncol 2022;12:857827. [PMID: 35719991 DOI: 10.3389/fonc.2022.857827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Luo C, Wang G, Hu L, Qiang Y, Zheng C, Shen Y. [Development and validation of a prognostic model based on SEER data for patients with esophageal carcinoma after esophagectomy]. Nan Fang Yi Ke Da Xue Xue Bao 2022;42:794-804. [PMID: 35790429 DOI: 10.12122/j.issn.1673-4254.2022.06.02] [Reference Citation Analysis]
245 Ruan H, Sun H, Guo Y, Ding Y, Liu Y, Ying S, Lin P. Prognostic nomogram and novel risk-scoring system for small cell lung cancer with different patterns of metastases. Gen Thorac Cardiovasc Surg 2022. [PMID: 35716296 DOI: 10.1007/s11748-022-01840-4] [Reference Citation Analysis]
246 Tian C, Wang Y, Song X. Prognostic Characteristics of Immune-Related Genes and the Related Regulatory Axis in Patients With Stage N+M0 Breast Cancer. Front Oncol 2022;12:878219. [DOI: 10.3389/fonc.2022.878219] [Reference Citation Analysis]
247 Wei Y, Wang Y, Li H, Wang C, Liu S, Huang Z, Wang G, Tao Y, Xia Y. A Nomogram to Predict Survival in Patients With Locoregional Recurrent Nasopharyngeal Carcinoma Receiving Comprehensive Treatment. Front Oncol 2022;12:892510. [DOI: 10.3389/fonc.2022.892510] [Reference Citation Analysis]
248 Xu Y, Yang Y, Li L, Ye F, Zhao X. The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy. Front Oncol 2022;12:905260. [PMID: 35686094 DOI: 10.3389/fonc.2022.905260] [Reference Citation Analysis]
249 Yang W, Zheng X, Wu M, Zhang F, Xu S, Wang X, Song M, You C, Zhang T, Jiang M, Ding C. Development and validation of postoperative and preoperative platelets ratio (PPR) to predict the prognosis of patients undergoing surgery for colorectal cancer: A dual-center retrospective cohort study. Cancer Med 2023;12:111-21. [PMID: 35689440 DOI: 10.1002/cam4.4930] [Reference Citation Analysis]
250 Luo B, Liu L, Bi J, Bao S, Zhang Y. Role of the pre- to postoperative alpha-fetoprotein ratio in the prognostic evaluation of liver cancer after radiofrequency ablation. Int J Biol Markers 2022;:3936155221101075. [PMID: 35686334 DOI: 10.1177/03936155221101075] [Reference Citation Analysis]
251 Xia F, Huang Z, Zhang Q, Ndhlovu E, Zhang M, Chen X, Zhang B, Zhu P. Early-Stage Ruptured Hepatocellular Carcinoma With Different Tumor Diameters: Small Tumors Have a Better Prognosis. Front Oncol 2022;12:865696. [PMID: 35656507 DOI: 10.3389/fonc.2022.865696] [Reference Citation Analysis]
252 Huang X, Luo Z, Liang W, Xie G, Lang X, Gou J, Liu C, Xu X, Fu D. Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort. Ann Surg Oncol. [DOI: 10.1245/s10434-022-11911-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
253 Zhang S, Ji B, Zhong X, Zhong L, Yang L, Yang C. A Dynamic Nomogram Predicting Portal Vein Thrombosis in Cirrhotic Patients During Primary Prophylaxis for Variceal Hemorrhage. Front Med 2022;9:887995. [DOI: 10.3389/fmed.2022.887995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
254 Lin J, Kong J, Luo M, Shen Z, Fang S, Hu J, Xu Z, Dong W, Huang J, Lin T. Development and Validation of Survival Nomograms in Patients with Primary Bladder Lymphoma. J Clin Med 2022;11:3188. [PMID: 35683570 DOI: 10.3390/jcm11113188] [Reference Citation Analysis]
255 Zhuang H, Chen B, Tang C, Chen X, Tan W, Yang L, Xie Z, Ma X, Wang Q, Zhang C, Shang C, Chen Y. Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma. Front Oncol 2022;12:871771. [PMID: 35646684 DOI: 10.3389/fonc.2022.871771] [Reference Citation Analysis]
256 Chauvistré H, Shannan B, Daignault-Mill SM, Ju RJ, Picard D, Egetemaier S, Váraljai R, Gibhardt CS, Sechi A, Kaschani F, Keminer O, Stehbens SJ, Liu Q, Yin X, Jeyakumar K, Vogel FCE, Krepler C, Rebecca VW, Kubat L, Lueong SS, Forster J, Horn S, Remke M, Ehrmann M, Paschen A, Becker JC, Helfrich I, Rauh D, Kaiser M, Gul S, Herlyn M, Bogeski I, Rodríguez-López JN, Haass NK, Schadendorf D, Roesch A. Persister state-directed transitioning and vulnerability in melanoma. Nat Commun 2022;13:3055. [PMID: 35650266 DOI: 10.1038/s41467-022-30641-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
257 Cao J, Luo F, Zeng K, Ma W, Lu F, Huang Y, Zhang L, Zhao H. Predictive Value of High Preoperative Serum Total Protein and Elevated Hematocrit in Patients with Non-Small-Cell Lung Cancer after Radical Resection. Nutr Cancer 2022;:1-13. [PMID: 35642624 DOI: 10.1080/01635581.2022.2079683] [Reference Citation Analysis]
258 Li J, Huang Y, Li Y, Liu P, Cheng H, Song H, Sun N, Shamil MA, Zhang W. A Web-Based Prognostic Model for Pediatric Genitourinary Rhabdomyosarcoma: Analysis of Population-Based Cohort With External Validation. Front Public Health 2022;10:870187. [PMID: 35619827 DOI: 10.3389/fpubh.2022.870187] [Reference Citation Analysis]
259 Wang L, Chen J, Zuo Q, Wu C, Yu T, Zheng P, Huang H, Deng J, Fang L, Liu H, Li C, Yu P, Zou Q, Zheng J. Calreticulin enhances gastric cancer metastasis by dimethylating H3K9 in the E-cadherin promoter region mediating by G9a. Oncogenesis 2022;11:29. [PMID: 35641480 DOI: 10.1038/s41389-022-00405-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
260 Rossi C, André M, Dupuis J, Morschhauser F, Joly B, Lazarovici J, Ghesquières H, Stamatoullas A, Nicolas-Virelizier E, Feugier P, Gac AC, Moatti H, Fornecker LM, Deau B, Joubert C, Fortpied C, Raemaekers J, Federico M, Kanoun S, Meignan M, Traverse-Glehen A, Cottereau AS, Casasnova RO. High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline. Haematologica 2022;107:2897-904. [PMID: 35638548 DOI: 10.3324/haematol.2021.280004] [Reference Citation Analysis]
261 Xu ZJ, Jin Y, Zhang XL, Xia PH, Wen XM, Ma JC, Lin J, Qian J. Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia. Cancer Med 2023;12:789-807. [PMID: 35642341 DOI: 10.1002/cam4.4905] [Reference Citation Analysis]
262 Wang H, Liu D, Liang H, Ba Z, Ma Y, Xu H, Wang J, Wang T, Tian T, Yang J, Gao X, Qiao S, Qu Y, Yang Z, Guo W, Zhao M, Ao H, Zheng X, Yuan J, Yang W. A Nomogram for Predicting Survival in Patients With Colorectal Cancer Incorporating Cardiovascular Comorbidities. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.875560] [Reference Citation Analysis]
263 Lai H, Zheng J, Li Y. Comparison of Four Lymph Node Staging Systems in Gastric Adenocarcinoma after Neoadjuvant Therapy – A Population-Based Study. Front Surg 2022;9:918198. [DOI: 10.3389/fsurg.2022.918198] [Reference Citation Analysis]
264 Xiao J, McGill JR, Nasir A, Lekan A, Johnson B, Wilkins DJ, Pearson GW, Tanner K, Goodarzi H, Glasgow E, Schlegel R, Agarwal S. Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231. Mol Biomed 2022;3:16. [PMID: 35614362 DOI: 10.1186/s43556-022-00080-5] [Reference Citation Analysis]
265 Li A, Wang Z, Lv Q, Ling Y, Gurzu S. Prognostic Utility of Platelet-to-Albumin Ratio among Critically Ill Patients with Colorectal Cancer: A Propensity Score Matching Study. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/6107997] [Reference Citation Analysis]
266 Liu R, Cao Z, Pan M, Wu M, Li X, Yuan H, Liu Z. A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes. Cancer Med 2022;11:4703-20. [PMID: 35608185 DOI: 10.1002/cam4.4836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
267 Konishi D, Umeda Y, Yoshida K, Shigeyasu K, Yano S, Toji T, Takeda S, Yoshida R, Yasui K, Fuji T, Matsumoto K, Kishimoto H, Michiue H, Teraishi F, Kato H, Tazawa H, Yanai H, Yagi T, Goel A, Fujiwara T. Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma. Br J Cancer 2022. [PMID: 35597869 DOI: 10.1038/s41416-022-01838-y] [Reference Citation Analysis]
268 Tao M, Luo S, Wang X, Jia M, Lu X. A Nomogram Predicting the Overall Survival and Cancer-Specific Survival in Patients with Parathyroid Cancer: A Retrospective Study. Front Endocrinol 2022;13:850457. [DOI: 10.3389/fendo.2022.850457] [Reference Citation Analysis]
269 Shin DW, Park J, Lee JC, Kim J, Kim YH, Hwang JH. Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2022;14:2476. [PMID: 35626080 DOI: 10.3390/cancers14102476] [Reference Citation Analysis]
270 Feng C, Yu H, Lei H, Cao H, Chen M, Liu S. A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer. BMC Palliat Care 2022;21:81. [PMID: 35585628 DOI: 10.1186/s12904-022-00972-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
271 Zheng Y, Lu J, Shuai Z, Wu Z, Qian Y. A novel nomogram and risk classification system predicting the Ewing sarcoma: a population-based study. Sci Rep 2022;12:8154. [PMID: 35581219 DOI: 10.1038/s41598-022-11827-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Wu L, Shi S, Sun H, Zhang H. Tumor Size Is an Independent Prognostic Factor for Stage I Ovarian Clear Cell Carcinoma: A Large Retrospective Cohort Study of 1,000 Patients. Front Oncol 2022;12:862944. [DOI: 10.3389/fonc.2022.862944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
273 Cui J, Tan L, Fang P, An Z, Du J, Yu L. Prediction of Survival Time in Advanced Lung Cancer: A Retrospective Study in Home-Based Palliative Care Unit. Am J Hosp Palliat Care 2022;:10499091221100501. [PMID: 35576493 DOI: 10.1177/10499091221100501] [Reference Citation Analysis]
274 Shi C, Gong S, Niu T, Li T, Wu A, Zheng X, Yang S, Ouyang G, Mu Q. The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes. Front Oncol 2022;12:877981. [PMID: 35558519 DOI: 10.3389/fonc.2022.877981] [Reference Citation Analysis]
275 Feng S, Li J, Fan F, Wang Z, Zhang Q, Zhang H, Dai Z, Zhang X, Luo P, Liu Z, Zhang J, Liu Z, Cheng Q. Prognostic Factors and Treatment Strategies for Elderly Patients with Malignant Meningioma: A SEER Population-Based Study. Front Oncol 2022;12:913254. [DOI: 10.3389/fonc.2022.913254] [Reference Citation Analysis]
276 Kang Y, Li G, Wang G, Huo Z, Feng X, Du L, Li Y, Yang Q, Ma X, Yu B, Xu B, Wu X. Development of a Risk Score Model for Osteosarcoma Based on DNA Methylation-Driven Differentially Expressed Genes. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/7596122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
277 Yang S, Zhang XS, Gale RP, Huang XJ, Jiang Q. Co-variates associated with outcomes of tyrosine kinase-inhibitor therapy in persons with chronic myeloid leukaemia initially presenting in accelerated phase. Leukemia 2022. [PMID: 35562407 DOI: 10.1038/s41375-022-01583-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
278 Tsiakanikas P, Adamopoulos PG, Tsirba D, Artemaki PI, Papadopoulos IN, Kontos CK, Scorilas A. High Expression of a tRNAPro Derivative Associates with Poor Survival and Independently Predicts Colorectal Cancer Recurrence. Biomedicines 2022;10:1120. [DOI: 10.3390/biomedicines10051120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
279 Huang Y, Wang C, Tang D, Chen B, Jiang Z, Miwa S. Development and Validation of Nomogram-Based Prognosis Tools for Patients with Extremity Osteosarcoma: A SEER Population Study. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/9053663] [Reference Citation Analysis]
280 Jiang W, Xu J, Chen J, Li G, Gao Y, Zhang Q, Chen Y. Prediction of Long-Term Survival Outcome by Lymph Node Ratio in Patients of Parotid Gland Cancer: A Retrospective study. Front Surg 2022;9:903576. [DOI: 10.3389/fsurg.2022.903576] [Reference Citation Analysis]
281 Tian X, Mei T, Yu M, Li Y, Ao R, Gong Y. The impact of antibiotic selection and interval time among advanced non-small cell lung cancer patients receiving prior antibacterial treatment and first-line chemotherapy. Cancer Med 2022. [PMID: 35543371 DOI: 10.1002/cam4.4815] [Reference Citation Analysis]
282 Zhao X, Chen H, Qiu Y, Cui L. FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1. Int J Oral Sci 2022;14:25. [PMID: 35538067 DOI: 10.1038/s41368-022-00174-4] [Reference Citation Analysis]
283 Jo Y, Lee J, Cho E, Lee HS, Shin S, Park EJ, Baik SH, Lee KY, Kang J. Clinical Significance of Early Carcinoembryonic Antigen Change in Patients With Nonmetastatic Colorectal Cancer. Front Oncol 2022;12:739614. [DOI: 10.3389/fonc.2022.739614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
284 Miligy IM, Toss MS, Gorringe KL, Ellis IO, Green AR, Rakha EA. Aurora Kinase A Is an Independent Predictor of Invasive Recurrence in Breast Ductal Carcinoma in situ. Pathobiology 2022;89:382-92. [PMID: 35533650 DOI: 10.1159/000522244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Li Z, Zhuang H, Chen X, Zhang Y, Ma Z, Wang S, Yan Q, Zhou Z, Huang S, Zhang C, Hou B, Wang J. Identification of MBOAT2 as an Unfavorable Biomarker Correlated with KRAS Activation and Reduced CD8+ T-Cell Infiltration in Pancreatic Cancer. Journal of Oncology 2022;2022:1-20. [DOI: 10.1155/2022/4269733] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
286 Li RY, Zheng ZY, Li ZM, Heng JH, Zheng YQ, Deng DX, Xu XE, Liao LD, Lin W, Xu HY, Huang HC, Li EM, Xu LY. Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer. Chem Biol Interact 2022;:109967. [PMID: 35525317 DOI: 10.1016/j.cbi.2022.109967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
287 Yan J, Wu X, Yu J, Kong Y, Cang S. An Immune-Related Gene Pair Index Predicts Clinical Response and Survival Outcome of Immune Checkpoint Inhibitors in Melanoma. Front Immunol 2022;13:839901. [PMID: 35280982 DOI: 10.3389/fimmu.2022.839901] [Reference Citation Analysis]
288 Lang C, Egger F, Alireza Hoda M, Saeed Querner A, Ferencz B, Lungu V, Szegedi R, Bogyo L, Torok K, Oberndorfer F, Klikovits T, Schwendenwein A, Boettiger K, Renyi-vamos F, Hoetzenecker K, Schelch K, Megyesfalvi Z, Dome B. Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: an international multicenter analysis. Lung Cancer 2022. [DOI: 10.1016/j.lungcan.2022.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
289 Xiang Y, Dai S, Li D, Zhu X, Su J, Chen B, Wu M. Brusatol inhibits the invasion and migration of pancreatic cancer cells by suppressing the NRF2/NF-κB/STAT3 signal cascade. Journal of Functional Foods 2022;92:105024. [DOI: 10.1016/j.jff.2022.105024] [Reference Citation Analysis]
290 Bian Y, Liu YF, Li J, Liu F, Fang X, Lu J, Shao C. Machine Learning for Computed Tomography Radiomics: Prediction of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma. Pancreas 2022;51:549-58. [PMID: 35877153 DOI: 10.1097/MPA.0000000000002069] [Reference Citation Analysis]
291 Li Z, Zhou C, Peng Q, Wang S, Qian G, Tang L, Zhou X, Yang Q, Shen Z, Huang G, Wang Y, Li H. Fibrinogen–Albumin Ratio Index Exhibits Predictive Value of Neoadjuvant Chemotherapy in Osteosarcoma. CMAR 2022;Volume 14:1671-82. [DOI: 10.2147/cmar.s358310] [Reference Citation Analysis]
292 Wan J, Wang B, Wu M, Li J, Gong R, Song L, Zhang H, Zhu G, Chen S, Cai J, Xing X, Wang Y, Yang Y, Cai C, Huang R, Liu H, Dai Z. MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215750] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
293 Yhim HY, Eshet Y, Metser U, Lajkosz K, Cooper M, Prica A, Kukreti V, Bhella S, Lang N, Xu W, Rodin D, Hodgson D, Tsang R, Crump M, Kuruvilla J, Kridel R. Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume. Am J Hematol 2022;97:583-91. [PMID: 35170780 DOI: 10.1002/ajh.26500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Chen Y, Jia Y, Peng Z, Wang G. The prognostic role of tumor size in stage T1 gastric cancer. World J Surg Oncol 2022;20:135. [PMID: 35477526 DOI: 10.1186/s12957-022-02596-0] [Reference Citation Analysis]
295 Han X, Liu H, Wang Y, Wang P, Wang X, Yi Y, Li X. A nomogram for predicting paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis among HIV-infected individuals in China. AIDS Res Ther 2022;19:20. [PMID: 35473805 DOI: 10.1186/s12981-022-00444-5] [Reference Citation Analysis]
296 He J, Chen Z, Xue Q, Sun P, Wang Y, Zhu C, Shi W. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature. J Transl Med 2022;20:186. [PMID: 35468826 DOI: 10.1186/s12967-022-03393-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
297 Xia F, Ndhlovu E, Liu Z, Chen X, Zhang B, Zhu P, Liu Z. Alpha-Fetoprotein+Alkaline Phosphatase (A-A) Score Can Predict the Prognosis of Patients with Ruptured Hepatocellular Carcinoma Underwent Hepatectomy. Disease Markers 2022;2022:1-16. [DOI: 10.1155/2022/9934189] [Reference Citation Analysis]
298 Zhang Z, Wang F, Zhang J, Zhan W, Zhang G, Li C, Zhang T, Yuan Q, Chen J, Guo M, Xu H, Yu F, Wang H, Wang X, Kong W. An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma. Front Pharmacol 2022;13:854851. [PMID: 35431958 DOI: 10.3389/fphar.2022.854851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
299 Xia F, Lyu J, Peng J, Zhao P. Repeated intravitreal ranibizumab for reactivated retinopathy of prematurity after intravitreal ranibizumab monotherapy: vascular development analysis. Graefes Arch Clin Exp Ophthalmol 2022. [PMID: 35438363 DOI: 10.1007/s00417-022-05628-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Fu N, Qin K, Li J, Jin J, Jiang Y, Deng X, Shen B. Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate-adjusted analysis at the pre-adjuvant chemotherapy timing. Cancer Med 2022. [PMID: 35434972 DOI: 10.1002/cam4.4698] [Reference Citation Analysis]
301 Zhang N, Wang JX, Wu XY, Cui Y, Zou ZH, Liu Y, Gao J. Correlation Analysis of Plasma Myeloperoxidase Level With Global Registry of Acute Coronary Events Score and Prognosis in Patients With Acute Non-ST-Segment Elevation Myocardial Infarction. Front Med (Lausanne) 2022;9:828174. [PMID: 35419382 DOI: 10.3389/fmed.2022.828174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Wu DZ, Zhong JM, Jiang WP, Liao ZS, Huang SH, Sun YW, Lin Y, Ye DX, Pan C, Jiang WZ. Preoperative combination score of neutrophils, monocytes, and lymphocytes as a predictor for locally advanced rectal cancer. Int J Colorectal Dis 2022. [PMID: 35419711 DOI: 10.1007/s00384-022-04143-5] [Reference Citation Analysis]
303 Wang G, Ding B, Sun L, Guo J, Wang S, Li W, Zhang Y, Lv J, Qiu W. Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma. Front Genet 2022;13:859544. [DOI: 10.3389/fgene.2022.859544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Zhuang A, Lu W, Fang Y, Ma L, Xu J, Wang J, Tong H, Zhang Y. Prognostic Factors and Nomogram Construction for First Local Recurrent Retroperitoneal Sarcoma Following Surgical Resection: A Single Asian Cohort of 169 Cases. Front Oncol 2022;12:856754. [DOI: 10.3389/fonc.2022.856754] [Reference Citation Analysis]
305 Zhang C, Zhao S, Wang X. Prognostic Nomogram for Early Gastric Cancer After Surgery to Assist Decision-Making for Treatment With Adjuvant Chemotherapy. Front Pharmacol 2022;13:845313. [DOI: 10.3389/fphar.2022.845313] [Reference Citation Analysis]
306 Zhang DY, Ku JW, Zhao XK, Zhang HY, Song X, Wu HF, Fan ZM, Xu RH, You D, Wang R, Zhou RX, Wang LD. Increased prognostic value of clinical–reproductive model in Chinese female patients with esophageal squamous cell carcinoma. World J Gastroenterol 2022; 28(13): 1347-1361 [DOI: 10.3748/wjg.v28.i13.1347] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
307 Chu F, Liu Y, Liu Q, Li W, Jia Z, Wang C, Wang Z, Lu S, Li P, Zhang Y, Liao Y, Xu M, Yao X, Wang S, Liu C, Zhang H, Wang S, Yan X, Kamel IR, Sun H, Yang G, Zhang Y, Qu J. Development and validation of MRI-based radiomics signatures models for prediction of disease-free survival and overall survival in patients with esophageal squamous cell carcinoma. Eur Radiol 2022. [PMID: 35384460 DOI: 10.1007/s00330-022-08776-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
308 Ding DY, Liu L, Li HL, Gan XJ, Ding WB, Gu FM, Sun DP, Li W, Pan ZY, Yuan SX, Zhou WP. Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00052-2. [PMID: 35428596 DOI: 10.1016/j.hbpd.2022.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 Jia S, Bi L, Chu Y, Liu X, Feng J, Xu L, Zhang T, Gu H, Yang L, Bai Q, Liang R, Tian B, Gao Y, Tang H, Gao G. Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities. Front Oncol 2022;12:805702. [PMID: 35372057 DOI: 10.3389/fonc.2022.805702] [Reference Citation Analysis]
310 Wang Z, Chong W, Zhang H, Liu X, Zhao Y, Guo Z, Fu L, Ma Y, Gu F. Breast Cancer Patients With Positive Apical or Infraclavicular/Ipsilateral Supraclavicular Lymph Nodes Should Be Excluded in the Application of the Lymph Node Ratio System. Front Cell Dev Biol 2022;10:784920. [DOI: 10.3389/fcell.2022.784920] [Reference Citation Analysis]
311 Tong Y, Cui Y, Jiang L, Zeng Y, Zhao D, Miwa S. Construction, Validation, and Visualization of Two Web-Based Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Elderly Patients with Primary Osseous Spinal Neoplasms. Journal of Oncology 2022;2022:1-21. [DOI: 10.1155/2022/7987967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
312 Cheng X, Liu Y, Wang J, Chen Y, Robertson AG, Zhang X, Jones SJM, Taubert S. cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines. Briefings in Bioinformatics. [DOI: 10.1093/bib/bbac090] [Reference Citation Analysis]
313 Tian S, Liu S, Qing X, Lin H, Peng Y, Wang B, Shao Z. A predictive model with a risk-classification system for cancer-specific survival in patients with primary osteosarcoma of long bone. Translational Oncology 2022;18:101349. [DOI: 10.1016/j.tranon.2022.101349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 Zhang W, Aryan M, Chen Z, Khan W, Thompson B, Kwenda E, Geller B, Morelli G. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol 2022;34:435-42. [PMID: 34750323 DOI: 10.1097/MEG.0000000000002295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Zhu J, Shi H, Ran H, Lai Q, Shao Y, Wu Q. Development and Validation of a Nomogram for Predicting Overall Survival in Patients with Second Primary Small Cell Lung Cancer After Non-Small Cell Lung Cancer: A SEER-Based Study. IJGM 2022;Volume 15:3613-24. [DOI: 10.2147/ijgm.s353045] [Reference Citation Analysis]
316 Ni H, Lu Z, Huang X, Ning S, Liang X, Zhang S, Xiang B. Combining Pre- and Postoperative Lymphocyte–C-Reactive Protein Ratios Can Better Predict Hepatocellular Carcinoma Prognosis After Partial Hepatectomy. JIR 2022;Volume 15:2229-41. [DOI: 10.2147/jir.s359498] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
317 Lin M, Huang T, Wang X, Li X, Ma J, Su L, Wu J. Non-Canonical NF-κB Signaling Stratifies LGG into Subtypes with Distinct Molecular and Cellular Characteristic and Survival Expectancy. IJGM 2022;Volume 15:3677-86. [DOI: 10.2147/ijgm.s347654] [Reference Citation Analysis]
318 Chen Q, Chen Y, Zhang Y, Zhang L, Chen K, He Z, Wang C, Yu L. Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes. Front Oncol 2022;12:846044. [DOI: 10.3389/fonc.2022.846044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
319 Wan S, Wei Y, Zhang X, Yang C, Hu F, Song B. Computed Tomography-Based Texture Features for the Risk Stratification of Portal Hypertension and Prediction of Survival in Patients With Cirrhosis: A Preliminary Study. Front Med 2022;9:863596. [DOI: 10.3389/fmed.2022.863596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
320 Zhang HM, Li XY, Lin N, Niu YX, Gu HX, Lu S, Yang Z, Qin L, Su Q. Lymphocytes ≥ 2.9 (10(9)/L) in Newly Diagnosed Diabetes Are A Predictor of Future CVD Events. Curr Med Sci 2022;42:327-32. [PMID: 35290604 DOI: 10.1007/s11596-022-2541-4] [Reference Citation Analysis]
321 Chen S, Wu Y, Wang S, Wu J, Wu X, Zheng Z. A risk model of gene signatures for predicting platinum response and survival in ovarian cancer. J Ovarian Res 2022;15:39. [PMID: 35361267 DOI: 10.1186/s13048-022-00969-3] [Reference Citation Analysis]
322 Rong H, Cai T, Peng Y, Wang X, Lan T, Ou Z, Qiu L, Li Q, Zhang L, Wu F, Lin H, Ren S, Li Z, Fan S, Li J. Correlation Between TCF7+ T Cells and Prognosis of Patients With Oral Squamous Cell Carcinoma. Front Oncol 2022;12:782058. [PMID: 35345446 DOI: 10.3389/fonc.2022.782058] [Reference Citation Analysis]
323 Yang H, Xiao X, Mei T, Zhou P. Long-term survival analysis of sublobar resection versus lobectomy for older patients with early-stage pulmonary carcinoid tumour: a database-based propensity score-matched study. Aging Clin Exp Res 2022. [PMID: 35347580 DOI: 10.1007/s40520-022-02112-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
324 Wu Z, Xu J, Tang R, Wang W, Zhang B, Yu X, Liu J, Shi S, Xu Y. The Role of PDGFRA in Predicting Oncological and Immune Characteristics in Pancreatic Ductal Adenocarcinoma. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/4148805] [Reference Citation Analysis]
325 Huang Z, Tong Y, Kong Q. Construction of a Tool to Predict Overall Survival of Patients With Primary Spinal Tumors After Surgical Resection: A Real-World Analysis Based on the Surveillance, Epidemiology, and End Results Database. Global Spine J 2022;:21925682221086539. [PMID: 35341359 DOI: 10.1177/21925682221086539] [Reference Citation Analysis]
326 Cheng W, Gao X, Yin G, Huang J, Man C, Qiu H. Characteristics and prognostic value of pleural effusion in secondary hemophagocytic lymphohistiocytosis. Int J Hematol 2022. [PMID: 35338447 DOI: 10.1007/s12185-022-03333-9] [Reference Citation Analysis]
327 Luo J, Liang X, Xin J, Li J, Li P, Zhou Q, Hao S, Zhang H, Lu Y, Wu T, Yang L, Li J, Li T, Ren K, Guo B, Zhou X, Chen J, He L, Yang H, Hu W, You S, Xin S, Jiang J, Shi D, Chen X, Li J; Chinese Group on the Study of Severe Hepatitis B (COSSH). Predicting the Onset of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00291-9. [PMID: 35337983 DOI: 10.1016/j.cgh.2022.03.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
328 Ma Y, Liu Y, Shayan G, Yi J, Wang J. Lymph node ratio-based nomogram for prognosis evaluation and treatment optimization of non-metastatic oral cavity squamous cell carcinoma. Transl Oncol 2022;20:101401. [PMID: 35339030 DOI: 10.1016/j.tranon.2022.101401] [Reference Citation Analysis]
329 Lequn T, Jie F, Yongbao Z, Chengjia Q, Xinnong L, Chenyang S. Perioperative inflammatory status predicts mid-term outcomes in patients undergoing femoropopliteal paclitaxel-coated balloon angioplasty. Ann Vasc Surg 2022:S0890-5096(22)00129-7. [PMID: 35337927 DOI: 10.1016/j.avsg.2022.02.029] [Reference Citation Analysis]
330 Luo LM, Wang Y, Lin PX, Su CH, Huang BT. The Clinical Outcomes, Prognostic Factors and Nomogram Models for Primary Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. Front Oncol 2022;12:863502. [PMID: 35299750 DOI: 10.3389/fonc.2022.863502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
331 Liu W, Zhou L, Zhao D, Wu X, Yue F, Yang H, Jin M, Xiong M, Hu K. Development and Validation of a Prognostic Nomogram in Lung Cancer With Obstructive Sleep Apnea Syndrome. Front Med 2022;9:810907. [DOI: 10.3389/fmed.2022.810907] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
332 Pan X, Wang X. Radiological Characterization and Deep Learning Deep Fusion Predict Disease-Free Survival in Rectal Cancer Patients. 2022 4th International Conference on Intelligent Medicine and Image Processing 2022. [DOI: 10.1145/3524086.3524101] [Reference Citation Analysis]
333 Du W, Chen C, Luo LF, He LN, Wang Y, Zhang X, Zhou Y, Lin Z, Hong S. Optimizing the tumor shrinkage threshold for evaluating immunotherapy efficacy for advanced non-small-cell lung cancer. J Cancer Res Clin Oncol 2022. [PMID: 35304630 DOI: 10.1007/s00432-022-03978-3] [Reference Citation Analysis]
334 Wang J, Zheng H, He H, Meng S, Han Y, Su Z, Yan H, Zhang Y, jin X. TPX2 Serves as a Cancer Susceptibility Gene and Is Closely Associated with the Poor Prognosis of Endometrial Cancer. Genetics Research 2022;2022:1-14. [DOI: 10.1155/2022/5401106] [Reference Citation Analysis]
335 Wu Y, Han Y, Li Q, Zhang P, Yuan P, Luo Y, Fan Y, Chen S, Cai R, Li Q, Xu H, Wang Y, Ma F, Wang J, Xu B. Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer. Breast Cancer Res Treat 2022. [PMID: 35297009 DOI: 10.1007/s10549-022-06559-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 Jiang R, Wang L, Zhao QH, Wu C, Yuan P, Wang S, Zhang R, Gong SG, Wu WH, He J, Qiu HL, Luo CJ, Liu JM, Jing ZC. Echocardiography Nomogram for Predicting Survival among Chronic Lung Disease Patients with Severe Pulmonary Hypertension. J Clin Med 2022;11:1603. [PMID: 35329931 DOI: 10.3390/jcm11061603] [Reference Citation Analysis]
337 Suvorov A. Simple method for cutoff point identification in descriptive high-throughput biological studies. BMC Genomics 2022;23:204. [PMID: 35287573 DOI: 10.1186/s12864-022-08427-6] [Reference Citation Analysis]
338 Ji G, Jiao C, Xu Z, Li X, Wang K, Wang X. Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09352-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
339 Mi J, Ma S, Chen W, Kang M, Xu M, Liu C, Li B, Wu F, Liu F, Zhang Y, Wang R, Jiang L. Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma. Front Oncol 2022;12:772816. [DOI: 10.3389/fonc.2022.772816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
340 Zhang W, Ji L, Wang X, Zhu S, Luo J, Zhang Y, Tong Y, Feng F, Kang Y, Bi Q. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis. Front Endocrinol 2022;12:752176. [DOI: 10.3389/fendo.2021.752176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
341 Li W, Gao Y, Jin X, Wang H, Lan T, Wei M, Yan W, Wang G, Li Z, Zhao Z, Jiang X. Comprehensive analysis of N6-methylandenosine regulators and m6A-related RNAs as prognosis factors in colorectal cancer. Mol Ther Nucleic Acids 2022;27:598-610. [PMID: 35070494 DOI: 10.1016/j.omtn.2021.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
342 Wu YY, Hsieh IS, Tung CH, Weng CH, Wu JE, Yu JS, Hong TM, Chen YL. A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2. Mol Ther Nucleic Acids 2022;27:956-68. [PMID: 35211356 DOI: 10.1016/j.omtn.2022.01.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
343 Song Z, Wang X, Zhou Y, Wang Y, Zhang D. Development and Validation of Prognostic Nomogram for Postpartum Hemorrhage After Vaginal Delivery: A Retrospective Cohort Study in China. Front Med 2022;9:804769. [DOI: 10.3389/fmed.2022.804769] [Reference Citation Analysis]
344 Mao S, Yu X, Sun J, Yang Y, Shan Y, Sun J, Mugaanyi J, Fan R, Wu S, Lu C. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection. BMC Cancer 2022;22:249. [PMID: 35255845 DOI: 10.1186/s12885-022-09345-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
345 Hong Y, Liu Z, Lin D, Peng J, Yuan Q, Zeng Y, Wang X, Luo C. Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer. Clin Radiol 2022:S0009-9260(22)00046-0. [PMID: 35264303 DOI: 10.1016/j.crad.2022.01.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
346 Zhang X, Xin Y, Yang Y, Chen Y, Cao X, Wang Y, Fan Q, Zhou X, Li X. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation. International Journal of Hyperthermia 2022;39:437-45. [DOI: 10.1080/02656736.2022.2043457] [Reference Citation Analysis]
347 Tong Z, Fang W, Xu M, Xia Y, Wang R, Li Y, Zha T, Xiao L, Pan S, Chai H, Zhao L, Wang H, Pan H, Chen X. DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02535-9] [Reference Citation Analysis]
348 Tao Y, Chen H, Zhou Y, He X, Qin Y, Liu P, Zhou S, Yang J, Zhou L, Zhang C, Yang S, Gui L, Shi Y. A new prognostic model including platelet/lymphocyte ratio and International Prognostic Score 3 for freedom from progression in patients with previously untreated advanced classical Hodgkin lymphoma. Asia Pac J Clin Oncol 2022. [PMID: 35238169 DOI: 10.1111/ajco.13770] [Reference Citation Analysis]
349 Cai J, Yang F, Wang X. Occult Non-Small Cell Lung Cancer: An Underappreciated Disease. J Clin Med 2022;11:1399. [PMID: 35268490 DOI: 10.3390/jcm11051399] [Reference Citation Analysis]
350 Du R, Ming J, Geng J, Zhu X, Zhang Y, Li S, Liu Z, Wang H, Wang Z, Tang L, Zhang X, Wu A, Bu Z, Yan Y, Li Z, Li Y, Li Z, Wang W. Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study. Radiat Oncol 2022;17:45. [PMID: 35241109 DOI: 10.1186/s13014-022-02016-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
351 Huang Z, Zheng Q, Yu Y, Zheng H, Wu Y, Wang Z, Liu L, Zhang M, Liu T, Li H, Li J. Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy. Sci Rep 2022;12:3535. [PMID: 35241740 DOI: 10.1038/s41598-022-07546-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Liang YJ, Liu LT, Li Y, Wang P, Luo MJ, Wen DX, Chen QY, Mai HQ. Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020. JAMA Netw Open 2022;5:e220173. [PMID: 35234882 DOI: 10.1001/jamanetworkopen.2022.0173] [Reference Citation Analysis]
353 Lou S, Wang Y, Zhang J, Yin X, Zhang Y, Wang Y, Xue Y. Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric Cancer. Front Immunol 2021;12:806324. [PMID: 35082793 DOI: 10.3389/fimmu.2021.806324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
354 Hussian Mangi F, Ahmed Shaikh T, Soria D, Muhammad Waryah A, Din Ujjan I, Naeem Qureshi J, Manzoor Syed B. Novel Molecular classification of colorectal cancer and correlation with survival. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.03.014] [Reference Citation Analysis]
355 Lombardi D, Tomasoni M, Lorini L, Gurizzan C, Tomasini D, Ardighieri L, Battocchio S, Bozzola A, Mattavelli D, Paderno A, Zamparini M, Farina D, Ravanelli M, Maroldi R, Maddalo M, Magrini S, Berruti A, Deganello A, Nicolai P, Bossi P, Piazza C. Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma. Oral Oncology 2022;126:105764. [DOI: 10.1016/j.oraloncology.2022.105764] [Reference Citation Analysis]
356 Koh HH, Choi S, Park CK, Ha SY. Down-regulation of TRPV6 Is Associated With Adverse Prognosis in Hepatocellular Carcinoma Treated With Curative Resection. Cancer Genomics Proteomics 2022;19:259-69. [PMID: 35181592 DOI: 10.21873/cgp.20318] [Reference Citation Analysis]
357 Cai JJ, Liu Y, Wang J, Wang JX, Wang Y, Xu SB, Cui Z, Gao J. Lactobacillus levels and prognosis of patients with acute myocardial infarction. J Geriatr Cardiol 2022;19:101-14. [PMID: 35317389 DOI: 10.11909/j.issn.1671-5411.2022.02.009] [Reference Citation Analysis]
358 Liu S, Yue Z, Zeng C, Huang X, Li J, Diao J, Chen X, Wei R, Yang W, Shi W. The Role of Symptom Duration and Serologic Factors in the Relapse of IgG4-Related Ophthalmic Disease following Surgery: A Retrospective Cohort Study. Disease Markers 2022;2022:1-9. [DOI: 10.1155/2022/5651506] [Reference Citation Analysis]
359 Naidoo M, Jones L, Conboy B, Hamarneh W, D'Souza D, Anthony K, Machado LR. Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma. Sci Rep 2022;12:3200. [PMID: 35217778 DOI: 10.1038/s41598-022-07223-2] [Reference Citation Analysis]
360 Narayan D, Jain A, Shrivastava A, Jindal G, Yadav K. Giant Ovarian Cyst Presenting as an Intra-Abdominal Mass. jemds 2022;11:428-430. [DOI: 10.14260/jemds/2022/83] [Reference Citation Analysis]
361 Sun Y, Yu D, Zhong J, Lin Y, Cheng N, Lin H, Jiang W, Huang Y, Chi P. Para-aortic lymph node dissection in left-sided colorectal cancer: Risk factors, prognostic impact, and therapeutic value. J Surg Oncol 2022. [PMID: 35201620 DOI: 10.1002/jso.26829] [Reference Citation Analysis]
362 Long J, Wang D, Wang A, Chen P, Lin Y, Bian J, Yang X, Zheng M, Zhang H, Zheng Y, Sang X, Zhao H. A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape. Genome Med 2022;14:20. [PMID: 35197093 DOI: 10.1186/s13073-022-01024-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
363 Feng W, Wang Q, Li C, Wu J, Kuang J, Yang J, Fan R. Significant Prediction of In-hospital Major Adverse Events by D-Dimer Level in Patients With Acute Type A Aortic Dissection. Front Cardiovasc Med 2022;9:821928. [DOI: 10.3389/fcvm.2022.821928] [Reference Citation Analysis]
364 Guo X, Jessel S, Qu R, Kluger Y, Chen TM, Hollander L, Safirstein R, Nelson B, Cha C, Bosenberg M, Jilaveanu LB, Rimm D, Rothlin CV, Kluger HM, Desir GV. Inhibition of renalase drives tumour rejection by promoting T cell activation. Eur J Cancer 2022;165:81-96. [PMID: 35219026 DOI: 10.1016/j.ejca.2022.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
365 Todorović-Raković N, Milovanović J, Greenman J, Radulovic M. The prognostic significance of serum interferon-gamma (IFN-γ) in hormonally dependent breast cancer. Cytokine 2022;152:155836. [PMID: 35219004 DOI: 10.1016/j.cyto.2022.155836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Luo C, He S, Zhang H, He S, Qi H, Wei A. Clinical and Biological Significance of DNA Methylation-Driven Differentially Expressed Genes in Biochemical Recurrence After Radical Prostatectomy. Front Genet 2022;13:727307. [PMID: 35186021 DOI: 10.3389/fgene.2022.727307] [Reference Citation Analysis]
367 Tan X, Yuan G, Wang Y, Zou Y, Luo S, Han H, Qin Z, Liu Z, Zhou F, Liu Y, Yao K. RAB20 Promotes Proliferation via G2/M Phase through the Chk1/cdc25c/cdc2-cyclinB1 Pathway in Penile Squamous Cell Carcinoma. Cancers (Basel) 2022;14:1106. [PMID: 35267417 DOI: 10.3390/cancers14051106] [Reference Citation Analysis]
368 Cicatiello AG, Sagliocchi S, Nappi A, Di Cicco E, Miro C, Murolo M, Stornaiuolo M, Dentice M. Thyroid hormone regulates glutamine metabolism and anaplerotic fluxes by inducing mitochondrial glutamate aminotransferase GPT2. Cell Rep 2022;38:110409. [PMID: 35196498 DOI: 10.1016/j.celrep.2022.110409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
369 Feng A, Ao X, Zhou N, Huang T, Li L, Zeng M, Lyu J, Saad K. A Novel Risk-Prediction Scoring System for Sepsis among Patients with Acute Pancreatitis: A Retrospective Analysis of a Large Clinical Database. International Journal of Clinical Practice 2022;2022:1-11. [DOI: 10.1155/2022/5435656] [Reference Citation Analysis]
370 Li S, Zhang G, Lu Y, Zhao T, Gao C, Liu W, Piao Y, Chen Y, Huang C, Chang A, Hao J. Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer. Front Oncol 2022;12:841819. [DOI: 10.3389/fonc.2022.841819] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
371 Karakatsanis S, Panitsas F, Arapaki M, Galopoulos D, Asimakopoulos JV, Liaskas A, Chatzidimitriou C, Belia M, Konstantinou E, Vassilopoulos I, Papadatos SS, Sachanas S, Efstathopoulou M, Yiakoumis X, Pardalis V, Iliakis T, Giannakopoulou N, Dimou M, Chatzidavid S, Boutsikas G, Petevi K, Kanellopoulos A, Gainaru G, Variamis E, Siakantaris MP, Kyrtsonis M, Plata E, Tsaftaridis P, Dimopoulou MN, Viniou N, Syrigos KN, Pangalis GA, Panayiotidis P, Konstantopoulos K, Angelopoulou MK, Vassilakopoulos TP. Serum ferritin levels in previously untreated classical Hodgkin lymphoma: correlations and prognostic significance. Leukemia & Lymphoma. [DOI: 10.1080/10428194.2021.2010054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
372 Tao Y, Zhou Y, Chen H, Qin Y, He X, Liu P, Zhou S, Yang J, Zhou L, Zhang C, Yang S, Gui L, Shi Y. Prognostic role of red blood cell distribution width and platelet/lymphocyte ratio in early-stage classical Hodgkin lymphoma. Future Oncol 2022. [PMID: 35179068 DOI: 10.2217/fon-2021-1398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
373 Zhang J, Zhang L, Wang J, Zhao J, Zhao X, Zhang C, Han P, Geng C. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis. Hum Cell 2022. [PMID: 35179718 DOI: 10.1007/s13577-022-00685-6] [Reference Citation Analysis]
374 Yang Y, Ding Y, Gong Y, Zhao S, Li M, Li X, Song G, Zhai B, Liu J, Shao Y, Zhu L, Pang J, Ma Y, Ou Q, Wu X, Zhang Z. The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification. BMC Cancer 2022;22:186. [PMID: 35180847 DOI: 10.1186/s12885-022-09279-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
375 Shen Z, Jin Y, Sun Q, Zhang S, Chen X, Hu L, He C, Wang Y, Liu Q, Zhang H, Liu X, Wang L, Jiao J, Miao Y, Gu W, Wang F, Wang C, Shi Y, Ye J, Zhu T, Sun C, Song X, Xu L, Yan D, Sun H, Cao J, Li D, Li Z, Wang Z, Huang S, Xu K, Sang W. A Novel Prognostic Index Model for Adult Hemophagocytic Lymphohistiocytosis: A Multicenter Retrospective Analysis in China. Front Immunol 2022;13:829878. [DOI: 10.3389/fimmu.2022.829878] [Reference Citation Analysis]
376 Lv W, Jia Y, Wang J, Duan Y, Wang X, Liu T, Hao S, Liu L. Long non-coding RNA SNHG10 upregulates BIN1 to suppress the tumorigenesis and epithelial-mesenchymal transition of epithelial ovarian cancer via sponging miR-200a-3p. Cell Death Discov 2022;8:60. [PMID: 35149697 DOI: 10.1038/s41420-022-00825-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
377 Lin Z, Zhao Y, Xiao L, Qi C, Chen Q, Li Y. Blood urea nitrogen to serum albumin ratio as a new prognostic indicator in critical patients with chronic heart failure. ESC Heart Fail 2022. [PMID: 35146943 DOI: 10.1002/ehf2.13825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
378 Chen X, Lu Y, Shi X, Han G, Zhao J, Gao Y, Wang X. Development and Validation of a Novel Model to Predict Regional Lymph Node Metastasis in Patients With Hepatocellular Carcinoma. Front Oncol 2022;12:835957. [DOI: 10.3389/fonc.2022.835957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
379 Wu H, Lu Y, Li J, Wu S, Chen X, Liu G. Prior Local or Systemic Treatment: A Predictive Model Could Guide Clinical Decision-Making for Locoregional Recurrent Breast Cancer. Front Oncol 2022;11:791995. [DOI: 10.3389/fonc.2021.791995] [Reference Citation Analysis]
380 Zhang Y, Lu L, He Z, Xu Z, Xiang Z, Nie R, Lin W, Chen W, Zhou J, Yin Y, Xie J, Zhang Y, Zheng X, Zhu T, Cai X, Li P, Chao X, Cai M. C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients. Front Immunol 2022;13:808101. [DOI: 10.3389/fimmu.2022.808101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
381 Dai W, Wang B, Li J, Luo Z, Ali HH. Identification of Prognostic lncRNA Related to the Immune Microenvironment of Soft Tissue Sarcoma. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/9471558] [Reference Citation Analysis]
382 Pieretti AC, Ozambela M, Westerman ME, Nogueras-gonzalez GM, Segarra LA, Zacharias NM, Vaporciyan A, Hofstetter W, Huynh T, Aldousari S, Matin SF, Karam JA. Predictors of Survival in Patients Undergoing Surgery for Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus. Clinical Genitourinary Cancer 2022. [DOI: 10.1016/j.clgc.2022.02.001] [Reference Citation Analysis]
383 Chen X, Tong X, Qiu Q, Sun F, Yin Y, Gong G, Xing L, Sun X. Radiomics Nomogram for Predicting Locoregional Failure in Locally Advanced Non-small Cell Lung Cancer Treated with Definitive Chemoradiotherapy. Acad Radiol 2022;29 Suppl 2:S53-61. [PMID: 33308945 DOI: 10.1016/j.acra.2020.11.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
384 Pan D, Rong X, Zhu Y, Ng WT, Chen D, Li H, Xu Y, Tang Y; Radiation Oncology Palliative Care Collaborative Group. A novel nomogram to predict overall survival in head and neck cancer survivors with radiation-induced brain necrosis. Radiother Oncol 2022:S0167-8140(22)00060-3. [PMID: 35121029 DOI: 10.1016/j.radonc.2022.01.033] [Reference Citation Analysis]
385 He Z, Liu Q, Yang K, Chen C, Zhang X, Wang W, Zeng H, Wang B, Liu Y, Luo M, Li L, Niu Q, Lu H, Luo T, Yao X, Guo H, Ji J, Cao M, Shi Y, Ping Y, Bian X. HOXA5 is amplified in glioblastoma stem cells and promotes tumor progression by transcriptionally activating PTPRZ1. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
386 Shi C, Gong S, Wu A, Yang S, Zou D, Zhang Y, Wu N, Ma C, Shi S, Chen Y, Wu Y, Zheng X, Huang Z, Ding J, Ouyang G, Mu Q. Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes. BMC Cancer 2022;22:127. [PMID: 35100989 DOI: 10.1186/s12885-022-09248-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
387 Qiu W, Jiang J, Zhan Z, Huang L, Deng J, Ye J, Li G, Liao K, Zhang H, Ding Y, Yuan Y, Zheng R. Prognostic impact of pretreatment serum superoxide dismutase activity in patients with locoregionally advanced nasopharyngeal carcinoma. Int J Biol Markers 2022;:17246008221075042. [PMID: 35099330 DOI: 10.1177/17246008221075042] [Reference Citation Analysis]
388 Lou S, Zhang J, Yin X, Zhang Y, Fang T, Wang Y, Xue Y. Comprehensive Characterization of Tumor Purity and Its Clinical Implications in Gastric Cancer. Front Cell Dev Biol 2021;9:782529. [PMID: 35083216 DOI: 10.3389/fcell.2021.782529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
389 Wu L, Zhong J, Zhu J, Kang L, Huang Y, Lin P, Long H, Zhang L, Ma Q, Qiu L, Ma G. Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09207-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
390 Hu Z, Zuo Z, Miao H, Ning Z, Deng Y. Incidence, Risk Factors and Prognosis of T4a Gastric Cancer: A Population-Based Study. Front Med (Lausanne) 2021;8:767904. [PMID: 35071261 DOI: 10.3389/fmed.2021.767904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Zou W, Luo W, Feng Y, Liu F, Liang S, Fang X, Liang Y, Liu N, Wang Y, Mao Y. Expression Profiles and Prognostic Value of Multiple Inhibitory Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma. Front Immunol 2022;13:818411. [DOI: 10.3389/fimmu.2022.818411] [Reference Citation Analysis]
392 Louarn N, Galicier L, Bertinchamp R, Lussato D, Montravers F, Oksenhendler É, Merlet P, Gérard L, Vercellino L. First Extensive Analysis of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in a Large Cohort of Patients With HIV-Associated Hodgkin Lymphoma: Baseline Total Metabolic Tumor Volume Affects Prognosis. J Clin Oncol 2022;:JCO2101228. [PMID: 35073166 DOI: 10.1200/JCO.21.01228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
393 Schnellhardt S, Hirneth J, Büttner-herold M, Daniel C, Haderlein M, Hartmann A, Fietkau R, Distel L. The Prognostic Value of FoxP3+ Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+ Cytotoxic T Cell Density. Front Immunol 2022;13:781222. [DOI: 10.3389/fimmu.2022.781222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
394 Feng Z, Liu Z, Peng K, Wu W. A Prognostic Model Based on Nine DNA Methylation-Driven Genes Predicts Overall Survival for Colorectal Cancer. Front Genet 2022;12:779383. [DOI: 10.3389/fgene.2021.779383] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Hu T, You S. Overall and Cancer-Specific Survival in Patients With Renal Pelvic Transitional Cell Carcinoma: A Population-Based Study. Front Med (Lausanne) 2021;8:719800. [PMID: 35047518 DOI: 10.3389/fmed.2021.719800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 Feng A, Yang N, Yu R, Liu J, Pang J, Wu X, Shao Y, Yang Z, Dai H. Prognostic Implications of Six Altered Genes in Asian Non-Surgical Esophageal Carcinoma Patients Treated with Chemoradiotherapy. Onco Targets Ther 2022;15:41-51. [PMID: 35046666 DOI: 10.2147/OTT.S334580] [Reference Citation Analysis]
397 Shen Z, Zhang S, Zhang M, Hu L, Sun Q, He C, Yan D, Ye J, Zhang H, Wang L, Gu W, Miao Y, Liu Q, Ouyang C, Zhu J, Wang C, Zhu T, Huang S, Sang W. The Addition of Ferritin Enhanced the Prognostic Value of International Prognostic Index in Diffuse Large B‐Cell Lymphoma. Front Oncol 2022;11:823079. [DOI: 10.3389/fonc.2021.823079] [Reference Citation Analysis]
398 Tang Y, Bai Y, Chen Y, Sun X, Shi Y, He T, Jiang M, Wang Y, Wu M, Peng Z, Liu S, Jiang W, Lu Y, Yuan H, Cai J. Development and validation of a novel risk score to predict 5-year mortality in patients with acute myocardial infarction in China: a retrospective study. PeerJ 2022;9:e12652. [PMID: 35036143 DOI: 10.7717/peerj.12652] [Reference Citation Analysis]
399 Tian X, Xu WH, Xu FJ, Li H, Anwaier A, Wang HK, Wan FN, Zhu Y, Cao DL, Zhu YP, Shi GH, Qu YY, Zhang HL, Ye DW. Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response. Ann Med 2022;54:211-26. [PMID: 35037540 DOI: 10.1080/07853890.2021.2011956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
400 Lee SY, Chung E, Cho ES, Lee JH, Park EJ, Shin SJ, Baik SH, Lee KY, Kang J. The Clinical Impact of Combining Neutrophil-to-Lymphocyte Ratio with Sarcopenia for Improved Discrimination of Progression-Free Survival in Patients with Colorectal Cancer. J Clin Med 2022;11:431. [PMID: 35054125 DOI: 10.3390/jcm11020431] [Reference Citation Analysis]
401 Li G, Zhang D. Development and Validation of Prognostic Nomogram for Elderly Breast Cancer: A Large-Cohort Retrospective Study. Int J Gen Med 2022;15:87-101. [PMID: 35018116 DOI: 10.2147/IJGM.S343850] [Reference Citation Analysis]
402 Tang M, Gao L, He B, Yang Y. Machine Learning-Based Prognostic Prediction Models of Non-Metastatic Colon Cancer: Analyses Based on Surveillance, Epidemiology and End Results Database and a Chinese Cohort. Cancer Manag Res 2022;14:25-35. [PMID: 35018119 DOI: 10.2147/CMAR.S340739] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
403 Sun L, Cen W, Tang W, Deng L, Wang F, Ji X, Yang J, Zhang R, Zhang X, Du Z, Mei J. Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy. Disease Markers 2022;2022:1-9. [DOI: 10.1155/2022/7640560] [Reference Citation Analysis]
404 Zhang C, Zhao S, Wang X. A Postsurgical Prognostic Nomogram for Locally Advanced Rectosigmoid Cancer to Assist in Patient Selection for Adjuvant Chemotherapy. Front Oncol 2021;11:772482. [PMID: 35004292 DOI: 10.3389/fonc.2021.772482] [Reference Citation Analysis]
405 Dai W, Wang J, Wang Z, Xiao Y, Li J, Hong L, Pei M, Zhang J, Yang P, Wu X, Tang W, Jiang X, Jiang P, Xiang L, Li A, Lin J, Liu S, Wang J. Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma. Front Oncol 2021;11:767644. [PMID: 35004288 DOI: 10.3389/fonc.2021.767644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
406 Lue KH, Huang CH, Hsieh TC, Liu SH, Wu YF, Chen YH. Systemic Inflammation Index and Tumor Glycolytic Heterogeneity Help Risk Stratify Patients with Advanced Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitor Therapy. Cancers (Basel) 2022;14:309. [PMID: 35053473 DOI: 10.3390/cancers14020309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
407 Zhang C, Liu Z, Tao J, Lin L, Zhai L. Development and External Validation of a Nomogram to Predict Cancer-Specific Survival in Patients with Primary Intestinal Non-Hodgkin Lymphomas. Cancer Manag Res 2021;13:9271-85. [PMID: 34992453 DOI: 10.2147/CMAR.S339907] [Reference Citation Analysis]
408 Li P, Li L, Li Z, Wang S, Li R, Zhao W, Feng Y, Huang S, Li L, Qiu H, Xia S. Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway. Cancer Cell Int 2022;22:7. [PMID: 34991599 DOI: 10.1186/s12935-021-02427-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
409 Hu T, Huang J, Fang K. Overall Survival in Patients with Mucinous Carcinoma of Breast: A Population-Based Study. Int J Gen Med 2021;14:9991-10001. [PMID: 34984023 DOI: 10.2147/IJGM.S343137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
410 Tang B, Yan R, Zhu J, Cheng S, Kong C, Chen W, Fang S, Wang Y, Yang Y, Qiu R, Lu C, Ji J. Integrative analysis of the molecular mechanisms, immunological features and immunotherapy response of ferroptosis regulators across 33 cancer types. Int J Biol Sci 2022;18:180-98. [PMID: 34975326 DOI: 10.7150/ijbs.64654] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
411 Liu S, Wu Q, Zhang S, Wang Z, Liu H, Teng L, Xiao P, Lu Y, Wang X, Dong C, Xiao J, Zhang J. Serum Galectin-3 levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study. BMC Nephrol 2022;23:5. [PMID: 34979958 DOI: 10.1186/s12882-021-02636-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
412 Yu J, Li Q, Zhang H, Meng Y, Liu YF, Jiang H, Ma C, Liu F, Fang X, Li J, Feng X, Shao C, Bian Y, Lu J. Contrast-enhanced computed tomography radiomics and multilayer perceptron network classifier: an approach for predicting CD20+ B cells in patients with pancreatic ductal adenocarcinoma. Abdom Radiol (NY) 2022;47:242-53. [PMID: 34708252 DOI: 10.1007/s00261-021-03285-4] [Reference Citation Analysis]
413 Cai M, Yao F, Ding J, Zheng R, Huang X, Yang Y, Lin F, Hu Z. MRI Radiomic Features: A Potential Biomarker for Progression-Free Survival Prediction of Patients With Locally Advanced Cervical Cancer Undergoing Surgery. Front Oncol 2021;11:749114. [PMID: 34970482 DOI: 10.3389/fonc.2021.749114] [Reference Citation Analysis]
414 Zheng RR, Cai MT, Lan L, Huang XW, Yang YJ, Powell M, Lin F. An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer. Br J Radiol 2022;95:20210838. [PMID: 34797703 DOI: 10.1259/bjr.20210838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
415 Zeng Y, Cao W, Wu C, Wang M, Xie Y, Chen W, Hu X, Zhou Y, Jing X, Cai X. Survival Prediction in Home Hospice Care Patients with Lung Cancer Based on LASSO Algorithm. Cancer Control 2022;29:10732748221124519. [PMID: 36039467 DOI: 10.1177/10732748221124519] [Reference Citation Analysis]
416 Luo Z, Jiao B, Huang T, Zhao H, Zhang G. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study. Technol Cancer Res Treat 2022;21:15330338221095667. [PMID: 35585719 DOI: 10.1177/15330338221095667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Luo F, Lu F, Cao J, Ma W, Xia Z, Zhan J, Zeng K, Huang Y, Zhao H, Zhang L. HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.01.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
418 Liu B, Wu J, Li C, Li Y, Qiu H, Lv A, Liu Q, Liu D, Wang Z, Hao C. The role of coeliac axis resection in resected ductal adenocarcinoma of the distal pancreas: A result of tumour topography or a prognostic factor? Pancreatology 2022;22:112-22. [PMID: 34764022 DOI: 10.1016/j.pan.2021.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
419 Cai K, Han D, Deng D, Ke M, Peng M, Lyu J, Xu A. Analysis of Prognostic Factors of Low-Grade Gliomas in Adults Using Time-Dependent Competing Risk Models: A Population Study Based on the Surveillance, Epidemiology, and End Results Database. Cancer Control 2022;29:10732748221143388. [PMID: 36461936 DOI: 10.1177/10732748221143388] [Reference Citation Analysis]
420 Gao J, Wang S, Li F, Xu H, Li X, Yan L, Zhu L. Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program. Adv Ther 2022;39:257-85. [PMID: 34716558 DOI: 10.1007/s12325-021-01955-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
421 He Z, Lei S, Liang F, Tan L, Zhang W, Xie L, Zheng H, Lu Y. Low-Dose Albendazole Inhibits Epithelial-Mesenchymal Transition of Melanoma Cells by Enhancing Phosphorylated GSK-3β/Tyr216 Accumulation. J Oncol 2021;2021:4475192. [PMID: 34966427 DOI: 10.1155/2021/4475192] [Reference Citation Analysis]
422 Wang Y, Hou K, Jin Y, Bao B, Tang S, Qi J, Yang Y, Che X, Liu Y, Hu X, Zheng C. Lung adenocarcinoma-specific three-integrin signature contributes to poor outcomes by metastasis and immune escape pathways. Journal of Translational Internal Medicine 2021;9:249-63. [DOI: 10.2478/jtim-2021-0046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
423 Yu Y, Wang S, Wang P, Xu Q, Zhang Y, Xiao J, Xue X, Yang Q, Xi W, Wang J, Huang R, Liu M, Wang Z. Predictive value of lymphocyte-to-monocyte ratio in critically Ill patients with atrial fibrillation: A propensity score matching analysis. J Clin Lab Anal 2021;:e24217. [PMID: 34970783 DOI: 10.1002/jcla.24217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
424 Wang K, Xiang YJ, Yu HM, Cheng YQ, Qin YY, Wang WJ, Zhang XP, Zheng YT, Shan YF, Cong WM, Dong H, Lau WY, Cheng SQ. A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion. Eur J Surg Oncol 2021:S0748-7983(21)01438-4. [PMID: 34996665 DOI: 10.1016/j.ejso.2021.12.466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
425 Shao W, Lu Z, Xu J, Shi X, Tan T, Xing C, Song J. Effects of Total Pancreatectomy on Survival of Patients With Pancreatic Ductal Adenocarcinoma: A Population-Based Study. Front Surg 2021;8:804785. [PMID: 34957210 DOI: 10.3389/fsurg.2021.804785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
426 Dong L, Lu D, Chen R, Lin Y, Zhu H, Zhang Z, Cai S, Cui P, Song G, Rao D, Yi X, Wu Y, Song N, Liu F, Zou Y, Zhang S, Zhang X, Wang X, Qiu S, Zhou J, Wang S, Zhang X, Shi Y, Figeys D, Ding L, Wang P, Zhang B, Rodriguez H, Gao Q, Gao D, Zhou H, Fan J. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell 2021:S1535-6108(21)00659-0. [PMID: 34971568 DOI: 10.1016/j.ccell.2021.12.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 19.5] [Reference Citation Analysis]
427 Zhao D, Zhang R, Yang L, Huang Z, Lin Y, Wen Y, Zhang X, Wang G, Guo G, Yu X, Wang W, Xi K, Zhang L. The Independent Prognostic Effect of Lymph Node Dissection on Patients With Stage IA NSCLC With Different T Stages. Front Surg 2021;8:798046. [PMID: 34957209 DOI: 10.3389/fsurg.2021.798046] [Reference Citation Analysis]
428 Lin YW, Kang WP, Huang BL, Qiu ZH, Wei LF, Zhang B, Ding TY, Luo Y, Liu CT, Chu LY, Guo HP, Xu YW, Peng YH. Nomogram based on clinical characteristics and serological inflammation markers to predict overall survival of oral tongue squamous cell carcinoma patient after surgery. BMC Oral Health 2021;21:667. [PMID: 34961504 DOI: 10.1186/s12903-021-02028-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
429 Xie M, Yu X, Chu X, Xie H, Zhou J, Zhao J, Su C. Low baseline plasma PCSK9 level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non‐small cell lung cancer. Thoracic Cancer. [DOI: 10.1111/1759-7714.14259] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
430 Gulay KCM, Aoshima K, Kim S, Kitaguchi R, Kobayashi A, Kimura T. The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression. Vet Comparative Oncology. [DOI: 10.1111/vco.12796] [Reference Citation Analysis]
431 Panoutsopoulou K, Dreyer T, Dorn J, Obermayr E, Mahner S, Gorp TV, Braicu I, Zeillinger R, Magdolen V, Avgeris M, Scorilas A. tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression. Cancers (Basel) 2021;14:24. [PMID: 35008188 DOI: 10.3390/cancers14010024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
432 Erber R, Spoerl S, Mamilos A, Krupar R, Hartmann A, Ruebner M, Taxis J, Wittenberg M, Reichert TE, Spanier G, Spoerl S. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma. Int J Mol Sci 2021;23:87. [PMID: 35008509 DOI: 10.3390/ijms23010087] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
433 Li M, Shen Y, Xiong Y, Bai J, Wang S, Li C, Zhang Y. High Red Cell Distribution Width Independently Predicts Adverse Survival in Patients with Newly Diagnosed Skull Base Chordoma. Onco Targets Ther 2021;14:5435-45. [PMID: 34924760 DOI: 10.2147/OTT.S335454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
434 Li Y, Liu Y, Yin P, Hao C, Sun C, Chen L, Wang S, Hong N. MRI-Based Bone Marrow Radiomics Nomogram for Prediction of Overall Survival in Patients With Multiple Myeloma. Front Oncol 2021;11:709813. [PMID: 34926240 DOI: 10.3389/fonc.2021.709813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
435 Wu W, Li D, Ma W, Zheng S, Han D, Xu F, Yan H, Lyu J. Examining More Lymph Nodes May Improve the Prognosis of Patients With Right Colon Cancer: Determining the Optimal Minimum Lymph Node Count. Cancer Control 2021;28:10732748211064034. [PMID: 34928724 DOI: 10.1177/10732748211064034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
436 Huang X, Niu X, You Z, Long Y, Luo F, Ye H. Comparison of Four Lymph Node Stage Methods for Predicting the Prognosis of Distal Cholangiocarcinoma Patients After Surgery. Front Oncol 2021;11:779761. [PMID: 34926292 DOI: 10.3389/fonc.2021.779761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
437 Zhuang H, Wang S, Chen B, Zhang Z, Ma Z, Li Z, Liu C, Zhou Z, Gong Y, Huang S, Hou B, Chen Y, Zhang C. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Front Immunol 2021;12:790661. [PMID: 34925373 DOI: 10.3389/fimmu.2021.790661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
438 Zhou Y, Tang L, Chen Y, Zhang Y, Zhuang W. An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment. Front Cell Dev Biol 2021;9. [DOI: 10.3389/fcell.2021.797984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
439 Li L, Liu ZP. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models. J Transl Med 2021;19:514. [PMID: 34930307 DOI: 10.1186/s12967-021-03180-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
440 Yang Y, Zhang T, Zhou Z, Liang J, Chen D, Feng Q, Xiao Z, Hui Z, Lv J, Deng L, Wang X, Wang W, Wang J, Liu W, Zhai Y, Wang J, Bi N, Wang L. Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy. Thorac Cancer 2021. [PMID: 34927371 DOI: 10.1111/1759-7714.14218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
441 Liu R, Jiang Z, Kong W, Zheng S, Dai T, Wang G. A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma. Front Genet 2021;12:730732. [PMID: 34917126 DOI: 10.3389/fgene.2021.730732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
442 Chen E, Zhang F, Jia C. Commentary: "Long-Term Outcomes and Prognostic Analysis of Computed Tomography-Guided Radioactive 125 I Seed Implantation for Locally Recurrent Rectal Cancer After External Beam Radiotherapy or Surgery": Letter to the Editor. Front Oncol 2021;11:750922. [PMID: 34917505 DOI: 10.3389/fonc.2021.750922] [Reference Citation Analysis]
443 Dinh HQ, Pan F, Wang G, Huang QF, Olingy CE, Wu ZY, Wang SH, Xu X, Xu XE, He JZ, Yang Q, Orsulic S, Haro M, Li LY, Huang GW, Breunig JJ, Koeffler HP, Hedrick CC, Xu LY, Lin DC, Li EM. Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment. Nat Commun 2021;12:7335. [PMID: 34921160 DOI: 10.1038/s41467-021-27599-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
444 Xu W, Wu W, Zheng Y, Chen Z, Tao X, Zhang D, Zhao J, Wang K, Guo B, Luo Q, Han Q, Zhou Y, Ye S. A Computed Tomography Radiomics-Based Prediction Model on Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis. Front Med (Lausanne) 2021;8:768052. [PMID: 34912828 DOI: 10.3389/fmed.2021.768052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
445 Buentzel J, Klemp HG, Kraetzner R, Schulz M, Dihazi GH, Streit F, Bleckmann A, Menck K, Wlochowitz D, Binder C. Metabolomic Profiling of Blood-Derived Microvesicles in Breast Cancer Patients. Int J Mol Sci 2021;22:13540. [PMID: 34948336 DOI: 10.3390/ijms222413540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
446 Li Q, Yu J, Zhang H, Meng Y, Liu YF, Jiang H, Zhu M, Li N, Zhou J, Liu F, Fang X, Li J, Feng X, Lu J, Shao C, Bian Y. Prediction of Tumor-Infiltrating CD20+ B-Cells in Patients with Pancreatic Ductal Adenocarcinoma Using a Multilayer Perceptron Network Classifier Based on Non-contrast MRI. Acad Radiol 2021:S1076-6332(21)00541-9. [PMID: 34922828 DOI: 10.1016/j.acra.2021.11.013] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
447 Duan F, Li J, Huang J, Hua X, Song C, Wang L, Bi X, Xia W, Yuan Z. Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer. Front Cell Dev Biol 2021;9:770115. [PMID: 34901016 DOI: 10.3389/fcell.2021.770115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
448 Cai Z, Wang Y, Li L, Wang H, Song C, Yin D, Song W, Dou K. Development and Validation of a Nomogram for Predicting the Risk of Adverse Cardiovascular Events in Patients with Coronary Artery Ectasia. J Cardiovasc Dev Dis 2021;8:186. [PMID: 34940541 DOI: 10.3390/jcdd8120186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
449 Huang C, Zhang C, Sheng J, Wang D, Zhao Y, Qian L, Xie L, Meng Z. Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis. Front Genet 2021;12:717319. [PMID: 34899826 DOI: 10.3389/fgene.2021.717319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
450 Zhou X, Qiu S, Jin K, Yuan Q, Jin D, Zhang Z, Zheng X, Li J, Wei Q, Yang L. Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study. Front Surg 2021;8:770169. [PMID: 34901145 DOI: 10.3389/fsurg.2021.770169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
451 Zhang C, Zhao S, Wang X. A Prognostic Nomogram for T3N0 Rectal Cancer After Total Mesorectal Excision to Help Select Patients for Adjuvant Therapy. Front Oncol 2021;11:698866. [PMID: 34900666 DOI: 10.3389/fonc.2021.698866] [Reference Citation Analysis]
452 Ma T, Wu Z, Zhang X, Xu H, Feng Y, Zhang C, Xie M, Yang Y, Zhang Y, Feng C, Sun G. Development and validation of a prognostic scoring model for mortality risk stratification in patients with recurrent or metastatic gastric carcinoma. BMC Cancer 2021;21:1326. [PMID: 34895168 DOI: 10.1186/s12885-021-09079-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
453 Jia Y, Tian C, Wang H, Yu F, Lv W, Duan Y, Cheng Z, Wang X, Wang Y, Liu T, Wang J, Liu L. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin. Mol Cancer 2021;20:162. [PMID: 34893064 DOI: 10.1186/s12943-021-01455-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
454 Fu N, Jiang Y, Qin K, Chen H, Deng X, Shen B. Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: a real-world study of 2010 patients. BMC Cancer 2021;21:1318. [PMID: 34886801 DOI: 10.1186/s12885-021-09056-0] [Reference Citation Analysis]
455 Liu Y, Zhang H, Zheng M, Wang C, Hu Z, Wang Y, Xiong H, Fan B, Wang Y, Hu H, Tang Q, Wang G. Nomogram to Predict the Occurrence and Prognosis of Distant Metastasis in T1N0 Colon Cancer: A SEER Data-Based Study. Int J Gen Med 2021;14:9131-43. [PMID: 34876846 DOI: 10.2147/IJGM.S335151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
456 Wang B, Xu C, Ying K, Chu J, Geng W. Prognostic value of hemoglobin combined with Geriatric Nutritional Risk Index scores in patients undergoing postoperative radiotherapy for esophageal squamous cell carcinoma. Future Oncol 2022;18:179-91. [PMID: 34870444 DOI: 10.2217/fon-2021-0439] [Reference Citation Analysis]
457 Deng L, Chen B, Zhan C, Yu H, Zheng J, Bao W, Deng T, Zheng C, Wu L, Yang Y, Yu Z, Wang Y, Chen G. A Novel Clinical-Radiomics Model Based on Sarcopenia and Radiomics for Predicting the Prognosis of Intrahepatic Cholangiocarcinoma After Radical Hepatectomy. Front Oncol 2021;11:744311. [PMID: 34868941 DOI: 10.3389/fonc.2021.744311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
458 Qian J, Wang W, Wang L, Lu J, Zhang L, Zhang B, Wang S, Nie W, Zhang Y, Lou Y, Han B. The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus. Front Oncol 2021;11:745150. [PMID: 34868942 DOI: 10.3389/fonc.2021.745150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
459 Chen S, Tang Y, Li N, Jiang J, Jiang L, Chen B, Fang H, Qi S, Hao J, Lu N, Wang S, Song Y, Liu Y, Li Y, Jin J. Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy. Front Oncol 2021;11:784156. [PMID: 34869040 DOI: 10.3389/fonc.2021.784156] [Reference Citation Analysis]
460 Jia X, Cheng X, Wu N, Xiang Y, Wu L, Xu B, Li C, Zhang Z, Tong S, Zhong L, Li Y. Prognostic value of interleukin-6 in atrial fibrillation: A cohort study and meta-analysis. Anatol J Cardiol 2021;25:872-9. [PMID: 34866581 DOI: 10.5152/AnatolJCardiol.2021.69299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
461 Xiao J, Mcgill JR, Nasir A, Lekan A, Johnson B, Wilkins DJ, Pearson GW, Tanner K, Goodarzi H, Glasgow E, Schlegel R, Agarwal S. Zebrafish xenografts to isolate unique human breast cancer metastatic cell populations.. [DOI: 10.1101/2021.12.07.471608] [Reference Citation Analysis]
462 Papanota AM, Karousi P, Kontos CK, Artemaki PI, Liacos CI, Papadimitriou MA, Bagratuni T, Eleutherakis-Papaiakovou E, Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kastritis E, Avgeris M, Dimopoulos MA, Scorilas A, Terpos E. A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma. Int J Mol Sci 2021;22:13144. [PMID: 34884950 DOI: 10.3390/ijms222313144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
463 Huang W, Zhang H, Zhang Z, Zhang B, Sun X, Huo Y, Feng Y, Tian P, Mo H, Wang C. A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma. J Surg Oncol 2021. [PMID: 34862621 DOI: 10.1002/jso.26760] [Reference Citation Analysis]
464 Zhou R, Chen X, Liang J, Chen Q, Tian H, Yang C, Liu C. A circadian rhythm-related gene signature associated with tumor immunity, cisplatin efficacy, and prognosis in bladder cancer. Aging (Albany NY) 2021;13:25153-79. [PMID: 34862329 DOI: 10.18632/aging.203733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
465 Luo RZ, Chen SL, Li M, Li Y, Yang X, Liu LL. HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis. Cancer Cell Int 2021;21:643. [PMID: 34861873 DOI: 10.1186/s12935-021-02349-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
466 Bai X, Ni J, Beretov J, Wang S, Dong X, Graham P, Li Y. THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer. Adv Sci (Weinh) 2021;8:e2102658. [PMID: 34708581 DOI: 10.1002/advs.202102658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
467 Duan W, Peng Y, Jin W, Ouyang S, Yang H. Tacrolimus as Single-Agent Immunotherapy and Minimal Manifestation Status in Nonthymoma Myasthenia Gravis. J Immunol Res 2021;2021:9138548. [PMID: 34845439 DOI: 10.1155/2021/9138548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
468 Hu X, Yang Z, Chen S, Xue J, Duan S, Yang L, Yang P, Peng S, Dong Y, Yuan L, He X, Bao G. Development and external validation of a prognostic nomogram for patients with gastric cancer after radical gastrectomy. Ann Transl Med 2021;9:1742. [PMID: 35071436 DOI: 10.21037/atm-21-6359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
469 Karousi P, Papanota AM, Artemaki PI, Liacos CI, Patseas D, Mavrianou-Koutsoukou N, Liosi AA, Kalioraki MA, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Scorilas A, Terpos E, Kontos CK. tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature. Biomedicines 2021;9:1811. [PMID: 34944627 DOI: 10.3390/biomedicines9121811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
470 Jiang H, Yang Y, Qian Y, Shao C, Lu J, Bian Y, Zheng J. Tumor Budding Score Is a Strong and Independent Prognostic Factor in Patients With Pancreatic Ductal Adenocarcinoma: An Evaluation of Whole Slide Pathology Images of Large Sections. Front Oncol 2021;11:740212. [DOI: 10.3389/fonc.2021.740212] [Reference Citation Analysis]
471 Cao C, Shou J, Shi H, Jiang W, Kang X, Xie R, Shang B, Bi X, Zhang J, Zheng S, Zhou A, Li C, Ma J. Novel cut-off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long-term, follow-up, retrospective study. Int J Urol 2021. [PMID: 34847622 DOI: 10.1111/iju.14751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
472 Lin J, Tang B, Feng Z, Hao W, Hu W. Decreased B lymphocytes subpopulations are associated with higher atherosclerotic risk in elderly patients with moderate-to-severe chronic kidney diseases. BMC Nephrol 2021;22:396. [PMID: 34844574 DOI: 10.1186/s12882-021-02613-6] [Reference Citation Analysis]
473 Yang Z, Li K, Qiu P, Ma Y, Wang B, Yan Y, Meng D, Feng C, Ren Y, Li Y, Li P, Zhou C. Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or oder with low-risk invasive breast carcinoma: Results based on the SEER database. Breast 2021;60:287-94. [PMID: 34844175 DOI: 10.1016/j.breast.2021.11.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
474 Hu T, Chen Z, Hou M, Lin K. Overall and cancer-specific survival in patients with breast Paget disease: A population-based study. Exp Biol Med (Maywood) 2021;:15353702211056264. [PMID: 34842487 DOI: 10.1177/15353702211056264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
475 Zeng C, Yan C, Guo S, Zhu H, Chen Y, Zhan X. High-density lipoprotein cholesterol to apolipoprotein A1 ratio and all-cause mortality among incident peritoneal dialysis patients. Nutr Metab Cardiovasc Dis 2021;31:3457-63. [PMID: 34656383 DOI: 10.1016/j.numecd.2021.09.008] [Reference Citation Analysis]
476 Zhang T, Zhu L. Nomogram for predicting postoperative cancer-specific early death in patients with epithelial ovarian cancer based on the SEER database: a large cohort study. Arch Gynecol Obstet. [DOI: 10.1007/s00404-021-06342-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
477 Li S, Liu X, Chen X. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study. BMC Urol 2021;21:162. [PMID: 34823525 DOI: 10.1186/s12894-021-00929-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
478 Mi JL, Xu M, Liu C, Wang RS. Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma. Medicine (Baltimore) 2021;100:e27947. [PMID: 34964774 DOI: 10.1097/MD.0000000000027947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
479 Peng H, Wu X, Zhong R, Yu T, Cai X, Liu J, Wen Y, Ao Y, Chen J, Li Y, He M, Li C, Zheng H, Chen Y, Pan Z, He J, Liang W. Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence. Front Immunol 2021;12:750046. [PMID: 34804034 DOI: 10.3389/fimmu.2021.750046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
480 Shen Y, Xu H, Long M, Guo M, Li P, Zhan M, Wang Z. Screening to Identify an Immune Landscape-Based Prognostic Predictor and Therapeutic Target for Prostate Cancer. Front Oncol 2021;11:761643. [PMID: 34804963 DOI: 10.3389/fonc.2021.761643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
481 Mao S, Yu X, Shan Y, Fan R, Wu S, Lu C. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1355-65. [PMID: 34805014 DOI: 10.2147/JHC.S339707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
482 Meng D, Wei Y, Feng X, Kang B, Wang X, Qi J, Zhao X, Zhu Q. CT-Based Radiomics Score Can Accurately Predict Esophageal Variceal Rebleeding in Cirrhotic Patients. Front Med (Lausanne) 2021;8:745931. [PMID: 34805214 DOI: 10.3389/fmed.2021.745931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
483 Shang QX, Yang YS, Xu LY, Yang H, Li Y, Li Y, Wu ZY, Fu JH, Yao XD, Xu XE, Wu JY, Chen LQ. Prognostic impact of lymph node harvest for patients with node-negative esophageal squamous cell carcinoma: a large-scale multicenter study. J Gastrointest Oncol 2021;12:1951-62. [PMID: 34790363 DOI: 10.21037/jgo-20-371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
484 Guo T, Wang Z, Liu Y. Establishment and verification of a prognostic tumor microenvironment-based and immune-related gene signature in colon cancer. J Gastrointest Oncol 2021;12:2172-91. [PMID: 34790383 DOI: 10.21037/jgo-21-522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
485 Zhang X, Yang W, Chen K, Zheng T, Guo Z, Peng Y, Yang Z. The potential prognostic values of the ADAMTS-like protein family: an integrative pan-cancer analysis. Ann Transl Med 2021;9:1562. [PMID: 34790768 DOI: 10.21037/atm-21-4946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
486 Yang Y, Zhou Y, Zhou C, Ma X. Deep learning radiomics based on contrast enhanced computed tomography predicts microvascular invasion and survival outcome in early stage hepatocellular carcinoma. Eur J Surg Oncol 2021:S0748-7983(21)00927-6. [PMID: 34862094 DOI: 10.1016/j.ejso.2021.11.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
487 Jiang RR, Feng XL, Zhu WT, Guo MX, Tan XL, Jiang XJ, Dou XM, Liu L. A Rare Subtype of Non-small Cell Lung Cancer: Report of 159 Resected Pathological Stage I-IIIA Pulmonary Lymphoepithelioma-Like Carcinoma Cases. Front Surg 2021;8:757085. [PMID: 34778364 DOI: 10.3389/fsurg.2021.757085] [Reference Citation Analysis]
488 Zhang H, Wang Y, Ni J, Shi H, Zhang T, Zhang Y, Guo J, Wang K, Mao W, Peng B. Prognostic Value of Lymphocyte-C-Reactive Protein Ratio in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study. Front Oncol 2021;11:760389. [PMID: 34778081 DOI: 10.3389/fonc.2021.760389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
489 Lu X, Tian Y, Huang J, Li F, Shao T, Huang G, Lv X. Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index. Oral Dis 2021. [PMID: 34773352 DOI: 10.1111/odi.14074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
490 Qiu X, He H, Zeng H, Tong X, Liu Q. The Role of Radiotherapy in Soft Tissue Sarcoma on Extremities With Lymph Nodes Metastasis: An IPTW Propensity Score Analysis of the SEER Database. Front Oncol 2021;11:751180. [PMID: 34745979 DOI: 10.3389/fonc.2021.751180] [Reference Citation Analysis]
491 Li N, Li Y, Zheng P, Zhan X. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Front Endocrinol (Lausanne) 2021;12:755805. [PMID: 34745015 DOI: 10.3389/fendo.2021.755805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
492 Jiang Y, Su Z, Lin Y, Xiong Y, Li C, Li J, Wang R, Zhong R, Cheng B, He J, Xie Z, Liang W. Prognostic and predictive impact of creatine kinase level in non-small cell lung cancer treated with tyrosine kinase inhibitors. Transl Lung Cancer Res 2021;10:3771-81. [PMID: 34733627 DOI: 10.21037/tlcr-21-600] [Reference Citation Analysis]
493 Chen X, Rong D, Zhang L, Ni C, Han G, Lu Y, Chen X, Gao Y, Wang X. Evaluation of nodal status in intrahepatic cholangiocarcinoma: a population-based study. Ann Transl Med 2021;9:1359. [PMID: 34733911 DOI: 10.21037/atm-21-2785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
494 Chen Y, Wu S, Ye J, Wu M, Xiao Z, Ni X, Wang B, Chen C, Chen Y, Tan X, Liu R. Predicting All-Cause Mortality Risk in Atrial Fibrillation Patients: A Novel LASSO-Cox Model Generated From a Prospective Dataset. Front Cardiovasc Med 2021;8:730453. [PMID: 34733891 DOI: 10.3389/fcvm.2021.730453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
495 Feng W, Chen X, Guan SX, Ruan HL, Huang Y, Zhang HZ, Yang YP, Fang WF, Zhao HY, Zhuang W, Xin S, Chen YH, Wang F, Gao Y, Huang M, Wang XD, Zhang L. Rational application of gefitinib in NSCLC patients with sensitive EGFR mutations based on pharmacokinetics and metabolomics. Acta Pharmacol Sin 2021. [PMID: 34737420 DOI: 10.1038/s41401-021-00791-5] [Reference Citation Analysis]
496 Yan D, Shen Z, Zhang S, Hu L, Sun Q, Xu K, Jin Y, Sang W. Prognostic values of geriatric nutritional risk index (GNRI) and prognostic nutritional index (PNI) in elderly patients with Diffuse Large B-Cell Lymphoma. J Cancer 2021;12:7010-7. [PMID: 34729103 DOI: 10.7150/jca.62340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
497 Ren F, Wang S, Li F, Gao J, Xu H, Li X, Zhu L. Clinical Nomograms for Predicting the Overall Survival and Cancer-specific Survival of patients with Ovarian Carcinosarcoma patients after Primary Surgery. J Cancer 2021;12:7223-36. [PMID: 34729123 DOI: 10.7150/jca.63224] [Reference Citation Analysis]
498 Lee JH, Kim S, Lee HS, Park EJ, Baik SH, Jeon TJ, Lee KY, Ryu YH, Kang J. Different prognostic impact of glucose uptake in visceral adipose tissue according to sex in patients with colorectal cancer. Sci Rep 2021;11:21556. [PMID: 34732810 DOI: 10.1038/s41598-021-01086-9] [Reference Citation Analysis]
499 Deng GC, Sun DC, Zhou Q, Lv Y, Yan H, Han QL, Dai GH. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer. BMC Genomics 2021;22:791. [PMID: 34732125 DOI: 10.1186/s12864-021-08097-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
500 Wang T, She Y, Yang Y, Liu X, Chen S, Zhong Y, Deng J, Zhao M, Sun X, Xie D, Chen C. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer. Radiology 2021;:210109. [PMID: 34726531 DOI: 10.1148/radiol.2021210109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
501 Liu Y, Zhao S, Wang J, Zhu Z, Luo L, Xiang Q, Zhou M, Ma Y, Wang Z, Zhao Z. MiR-629-5p Promotes Prostate Cancer Development and Metastasis by Targeting AKAP13. Front Oncol 2021;11:754353. [PMID: 34722307 DOI: 10.3389/fonc.2021.754353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
502 Liang J, Zhou H, Huang XQ, Liu YF, Zhang L, He D, Cui Y, Guo J, Hu K, Wu C. A Myeloid Signature-Based Nomogram Predicts the Postoperative Recurrence of Intrahepatic Cholangiocarcinoma. Front Mol Biosci 2021;8:742953. [PMID: 34722632 DOI: 10.3389/fmolb.2021.742953] [Reference Citation Analysis]
503 Zhang T, Wang J, Wang D, Xu K, Wu L, Wang X, Wang W, Deng L, Liang J, Lv J, Hui Z, Zhou Z, Feng Q, Xiao Z, Chen D, Wang J, Wang L, Bi N. The Time-series Behavior of Systemic Inflammation-immune Status in Predicting Survival of Locally Advanced Non-small Cell Lung Cancer Treated with Chemoradiotherapy. Journal of the National Cancer Center 2021. [DOI: 10.1016/j.jncc.2021.11.003] [Reference Citation Analysis]
504 Ho SY, Liu PH, Hsu CY, Ko CC, Huang YH, Su CW, Lee RC, Tsai PH, Hou MC, Huo TI. Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. J Gastroenterol Hepatol 2021;36:3196-203. [PMID: 34159651 DOI: 10.1111/jgh.15593] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
505 Li J, Liang X, You S, Feng T, Zhou X, Zhu B, Luo J, Xin J, Jiang J, Shi D, Lu Y, Ren K, Wu T, Yang L, Li J, Li T, Cai Q, Sun S, Guo B, Zhou X, Chen J, He L, Li P, Yang H, Hu W, An Z, Jin X, Tian J, Wang B, Chen X, Xin S, Li J; Chinese Group on the Study of Severe Hepatitis B (COSSH). Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure. J Hepatol 2021;75:1104-15. [PMID: 34090929 DOI: 10.1016/j.jhep.2021.05.026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
506 Wang L, Chang N, Wu L, Li J, Zhang L, Chen Y, Zhou Z, Hao J, Wang Q, Jiao S. A nomogram-based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer. Mol Clin Oncol 2021;15:257. [PMID: 34712487 DOI: 10.3892/mco.2021.2419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
507 Geng Q, Wei Q, Shen Z, Zheng Y, Wang L, Xue W, Li L, Zhao J. Comprehensive Analysis of the Prognostic Value and Immune Infiltrates of the Three-m5C Signature in Colon Carcinoma. Cancer Manag Res 2021;13:7989-8002. [PMID: 34707405 DOI: 10.2147/CMAR.S331549] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
508 Li L, Pi C, Yan X, Lu J, Yang X, Wang C, Li X, Zhang S, Zhang Z, Sun Y, Hu Y. Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy. Front Oncol 2021;11:697865. [PMID: 34692478 DOI: 10.3389/fonc.2021.697865] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
509 Zhao C, Chen J, Liu Y, Ju S, Wang G, Wang X. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer. Bioengineered 2021. [PMID: 34699318 DOI: 10.1080/21655979.2021.1996513] [Reference Citation Analysis]
510 Zhang DY, Huang GR, Ku JW, Zhao XK, Song X, Xu RH, Han WL, Zhou FY, Wang R, Wei MX, Wang LD. Development and validation of a prognostic nomogram model for Chinese patients with primary small cell carcinoma of the esophagus. World J Clin Cases 2021; 9(30): 9011-9022 [PMID: 34786384 DOI: 10.12998/wjcc.v9.i30.9011] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
511 Ding T, Liu C, Huang B, Chu L, Wei L, Lin Y, Luo Y, Zhang B, Hong C, Xu Y, Peng Y. A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery. Cancer Manag Res 2021;13:7771-82. [PMID: 34675672 DOI: 10.2147/CMAR.S329687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
512 Wu H, Jiang S, Zhong P, Li W, Zhang S. Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary. J Ovarian Res 2021;14:137. [PMID: 34674727 DOI: 10.1186/s13048-021-00896-9] [Reference Citation Analysis]
513 Liao J, Liu C, Long Q, Wu X, Wang H, Yu H, Sun S, Zhang Y, Lin Y, Zhao X, Wang J. Direct Comparison Between the Addition of Pembrolizumab or Bevacizumab for Chemotherapy-Based First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer Lacking Driver Mutations. Front Oncol 2021;11:752545. [PMID: 34660317 DOI: 10.3389/fonc.2021.752545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
514 Zhang Y, Zhang Y, Shi Y, Dong W, Mu Y, Wang J, Gao Y, Hu R, Xu Y, Chen Y, Ma J. Influence of Waist-to-Hip Ratio on the Prognosis of Heart Failure Patients With Revascularized Coronary Heart Disease. Front Cardiovasc Med 2021;8:732200. [PMID: 34660733 DOI: 10.3389/fcvm.2021.732200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
515 Wang S, Wei J, Guo Y, Xu Q, Lv X, Yu Y, Liu M. Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Lung Neuroendocrine Tumors.. [DOI: 10.1101/2021.10.12.21264905] [Reference Citation Analysis]
516 Dimitrakopoulos FI, Kottorou AE, Rodgers K, Sherwood JT, Koliou GA, Lee B, Yang A, Brahmer JR, Baylin SB, Yang SC, Orita H, Hulbert A, Brock MV. Clinical Significance of Plasma CD9-Positive Exosomes in HIV Seronegative and Seropositive Lung Cancer Patients. Cancers (Basel) 2021;13:5193. [PMID: 34680341 DOI: 10.3390/cancers13205193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
517 Zhou B, Gao S. Comprehensive Analysis of Clinical Significance, Immune Infiltration and Biological Role of m6A Regulators in Early-Stage Lung Adenocarcinoma. Front Immunol 2021;12:698236. [PMID: 34650549 DOI: 10.3389/fimmu.2021.698236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
518 Shen ZY, He CL, Sun Q, Zhang S, Hu LL, Liu QH, Zhang H, Liu X, Miao YQ, Gu WY, Wang F, Wang CL, Shi YY, Wang L, Jiao J, Ye JJ, Xu LY, Yan DM, Li ZY, Jin YL, Huang SP, Xu KL, Sang W. [Clinical prognostic analysis of 124 adult patients with hemophagocytic lymphohistiocytosis: a multicenter retrospective study of the Huaihai Lymphoma Working Group]. Zhonghua Xue Ye Xue Za Zhi 2021;42:800-6. [PMID: 34788918 DOI: 10.3760/cma.j.issn.0253-2727.2021.10.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
519 Luo X, Liu S, Chen Y, Qiu X, Huang D, Zhang D, Liang Q, Yang Y, Zeng X. Predicting cancer-specific mortality in patients with parotid gland carcinoma by competing risk nomogram. Head Neck 2021;43:3888-98. [PMID: 34632674 DOI: 10.1002/hed.26890] [Reference Citation Analysis]
520 Feng Z, Chen P, Li K, Lou J, Wu Y, Li T, Peng C. A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma. Front Mol Biosci 2021;8:650264. [PMID: 34631790 DOI: 10.3389/fmolb.2021.650264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
521 Li J, Li H, Zhang C, Zhang C, Jiang L, Wang H, Liu H. Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma. Front Oncol 2021;11:732841. [PMID: 34631565 DOI: 10.3389/fonc.2021.732841] [Reference Citation Analysis]
522 Su YL, Tsai KL, Chiu TJ, Lin YM, Lee KC, Lu CC, Chen HH, Wu CC, Hsu HC. Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment. Cancers (Basel) 2021;13:5080. [PMID: 34680230 DOI: 10.3390/cancers13205080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
523 Zhang X, Li X, Shi H, Zhang K, Zhang Q, Tang M, Li W, Zhou F, Liu M, Cong M, Shi H. Association of the fat-free mass index with mortality in patients with cancer: A multicenter observational study. Nutrition 2021;94:111508. [PMID: 34813982 DOI: 10.1016/j.nut.2021.111508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
524 Liu X, Yue S, Huang H, Duan M, Zhao B, Liu J, Xiang T. Risk Stratification Model for Predicting the Overall Survival of Elderly Triple-Negative Breast Cancer Patients: A Population-Based Study. Front Med (Lausanne) 2021;8:705515. [PMID: 34621757 DOI: 10.3389/fmed.2021.705515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
525 Chen S, Li N, Tang Y, Chen B, Fang H, Qi S, Lu N, Yang Y, Song Y, Liu Y, Wang S, Li YX, Jin J. Radiomics Analysis of Fat-Saturated T2-Weighted MRI Sequences for the Prediction of Prognosis in Soft Tissue Sarcoma of the Extremities and Trunk Treated With Neoadjuvant Radiotherapy. Front Oncol 2021;11:710649. [PMID: 34604050 DOI: 10.3389/fonc.2021.710649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
526 Yu X, Ma C, Wang M, Ying Y, Zhang Z, Ai X, Wang L, Zeng S, Xu C. Construction and Validation of Novel Prediction Tools Based on Large Population-Based Database to Predict the Prognosis of Urachal Cancer After Surgery. Front Oncol 2021;11:718691. [PMID: 34595114 DOI: 10.3389/fonc.2021.718691] [Reference Citation Analysis]
527 Bian Y, Liu YF, Jiang H, Meng Y, Liu F, Cao K, Zhang H, Fang X, Li J, Yu J, Feng X, Li Q, Wang L, Lu J, Shao C. Machine learning for MRI radiomics: a study predicting tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma. Abdom Radiol (NY) 2021;46:4800-16. [PMID: 34189612 DOI: 10.1007/s00261-021-03159-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
528 Li Z, Wei J, Cao H, Song M, Zhang Y, Jin Y. A predictive web-based nomogram for the early death of patients with lung adenocarcinoma and bone metastasis: a population-based study. J Int Med Res 2021;49:3000605211047771. [PMID: 34590874 DOI: 10.1177/03000605211047771] [Reference Citation Analysis]
529 Jiang R, He S, Sun H, Gong H, Yang X, Cai X, Wei H, Xiao J. Identifying the Risk Factors and Estimating the Prognosis in Patients with Pelvis and Spine Ewing Sarcoma: A Population-Based Study. Spine (Phila Pa 1976) 2021;46:1315-25. [PMID: 34517400 DOI: 10.1097/BRS.0000000000004022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
530 Yang F, Xie H, Wang Y. Prognostic Nomogram and a Risk Classification System for Predicting Overall Survival of Elderly Patients with Fibrosarcoma: A Population-Based Study. J Oncol 2021;2021:9984217. [PMID: 34589127 DOI: 10.1155/2021/9984217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
531 Nomoto D, Baba Y, Akiyama T, Okadome K, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients. Ann Gastroenterol Surg 2021;5:669-76. [PMID: 34585051 DOI: 10.1002/ags3.12464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
532 Qi F, Du X, Zhao Z, Zhang D, Huang M, Bai Y, Yang B, Qin W, Xia J. Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma. Front Oncol 2021;11:729340. [PMID: 34568062 DOI: 10.3389/fonc.2021.729340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
533 Xiong Z, Lin Y, Yu Y, Zhou X, Fan J, Rog CJ, Cai K, Wang Z, Chang Z, Wang G, Tao K, Cai M. Exploration of Lipid Metabolism in Gastric Cancer: A Novel Prognostic Genes Expression Profile. Front Oncol 2021;11:712746. [PMID: 34568042 DOI: 10.3389/fonc.2021.712746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
534 Hu Q, Pan S, Guo Z. A novel pN3 gastric cancer staging system with superior prognostic utility based upon the examination of over 31 lymph nodes: a propensity score-matching analysis. BMC Gastroenterol 2021;21:352. [PMID: 34563111 DOI: 10.1186/s12876-021-01928-w] [Reference Citation Analysis]
535 Zhou M, Chen QX, Yang YZ, Liang ZZ, Li YL, Huang ZY, Weng ZJ, Zhang XF, Guan JX, Tang LY, Ren ZF. Prognostic value of glutaminase 1 in breast cancer depends on H3K27me3 expression and menopausal status. Virchows Arch 2021. [PMID: 34562173 DOI: 10.1007/s00428-021-03210-6] [Reference Citation Analysis]
536 Yang K, Zhang Q, Zhang M, Xie W, Li M, Zeng L, Wang Q, Zhao J, Li Y, Li G. A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II-IVa Nasopharyngeal Carcinoma. Front Oncol 2021;11:640077. [PMID: 34552862 DOI: 10.3389/fonc.2021.640077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
537 Huo J, Wu L, Zang Y. Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma. BMC Med Genomics 2021;14:232. [PMID: 34544391 DOI: 10.1186/s12920-021-01081-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
538 Luo F, Zeng KM, Cao JX, Zhou T, Lin SX, Ma WJ, Yang YP, Zhang ZH, Lu FT, Huang Y, Zhao HY, Zhang L. Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study. Lipids Health Dis 2021;20:109. [PMID: 34544437 DOI: 10.1186/s12944-021-01538-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
539 Zhang M, Cui M, Zuo Q, Wang L, Wang J, Zhu L, Yan R, Lu N, Yan H, Zhang L. Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment. J Gastrointest Oncol 2021;12:1241-54. [PMID: 34532084 DOI: 10.21037/jgo-21-429] [Reference Citation Analysis]
540 Li XY, Yao S, He YT, Ke SQ, Ma YF, Lu P, Nie SF, Wei SZ, Liang XJ, Liu L. Inflammation-Immunity-Nutrition Score: A Novel Prognostic Score for Patients with Resectable Colorectal Cancer. J Inflamm Res 2021;14:4577-88. [PMID: 34531673 DOI: 10.2147/JIR.S322260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
541 Chen YR, Wang MQ, Li YT, Li P, Ouyang SS, Xu HW, Zhu SL. Prognostic performance of different lymph node classification systems in young gastric cancer. J Gastrointest Oncol 2021;12:1285-300. [PMID: 34532088 DOI: 10.21037/jgo-21-185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
542 Li Y, Wang WB, Yang L, Wang QY, Dai J, Xia L, Peng J, Zhou FX, Wei YC, Shi HP. The combination of body composition conditions and systemic inflammatory markers has prognostic value for patients with gastric cancer treated with adjuvant chemoradiotherapy. Nutrition 2021;93:111464. [PMID: 34678715 DOI: 10.1016/j.nut.2021.111464] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
543 Li P, Yuan J, Ahmed FS, McHenry A, Fu K, Yu G, Cheng H, Xu ML, Rimm DL, Pan Z. High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis. Front Oncol 2021;11:701492. [PMID: 34527580 DOI: 10.3389/fonc.2021.701492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
544 Kim JH, Lee JH, Lee HS, Shin SJ, Park EJ, Cho ES, Baik SH, Lee KY, Kang J. Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer. J Inflamm Res 2021;14:4457-66. [PMID: 34522115 DOI: 10.2147/JIR.S327443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
545 Sun Q, Chen Y, Liang C, Zhao Y, Lv X, Zou Y, Yan K, Zheng H, Liang D, Li ZC. Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma. Radiology 2021;301:654-63. [PMID: 34519578 DOI: 10.1148/radiol.2021203281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
546 Xu Q, Chen S, Hu Y, Huang W. Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer. Front Immunol 2021;12:711433. [PMID: 34512634 DOI: 10.3389/fimmu.2021.711433] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
547 Shen X, Wang W, Niu X. Neutrophil Lymphocyte Ratio to Albumin Ratio and White Blood Cell to Hemoglobin Ratio as Prognostic Markers for Hepatocellular Carcinoma Patients Who Underwent Curative Hepatectomy. Int J Gen Med 2021;14:5029-38. [PMID: 34511986 DOI: 10.2147/IJGM.S329911] [Reference Citation Analysis]
548 Zhang C, Wang K, Wang H. Loss of heterozygosity related to TMB and TNB may predict PFS for patients with SCLC received the first line setting. J Transl Med 2021;19:385. [PMID: 34496866 DOI: 10.1186/s12967-021-03019-6] [Reference Citation Analysis]
549 Luo M, Lin Y, Liang R, Li Y, Ge L. Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment. J Inflamm Res 2021;14:4217-28. [PMID: 34483677 DOI: 10.2147/JIR.S324336] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
550 Liu B, Xiao K, Yan P, Sun T, Wang J, Xie F, Mo G, Xie L. Albumin-Globulin Ratio Is an Independent Determinant of 28-Day Mortality in Patients with Critical Illness. Dis Markers 2021;2021:9965124. [PMID: 34484470 DOI: 10.1155/2021/9965124] [Reference Citation Analysis]
551 Li J, Zuo M, Zhou X, Xiang Y, Zhang S, Feng W, Liu Y. Prognostic Significance of Preoperative Albumin to Alkaline Phosphatase Ratio in Patients with Glioblastoma. J Cancer 2021;12:5950-9. [PMID: 34476009 DOI: 10.7150/jca.61866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
552 Pan LJ, Chen JL, Wu ZX, Wu YM. Exportin-T: A Novel Prognostic Predictor and Potential Therapeutic Target for Neuroblastoma. Technol Cancer Res Treat 2021;20:15330338211039132. [PMID: 34469238 DOI: 10.1177/15330338211039132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
553 Sun LY, Cen WJ, Tang WT, Long YK, Yang XH, Ji XM, Yang JJ, Zhang RJ, Wang F, Shao JY, Du ZM. Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non-small cell lung cancer. Cancer Med 2021;10:6610-7. [PMID: 34469045 DOI: 10.1002/cam4.4197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
554 Yu X, Li J, Ye L, Zhao J, Xie M, Zhou J, Shen Y, Zhou F, Wu Y, Han C, Qian J, Chu T, Su C. Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy. Transl Lung Cancer Res 2021;10:3782-92. [PMID: 34733628 DOI: 10.21037/tlcr-21-681] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
555 Todorović-Raković N, Milovanović J, Greenman J, Radulovic M. The significance of HOXB7 and IL17RB serum levels in prognosis of hormonally dependent breast cancer: A pilot study. Adv Med Sci 2021;66:359-65. [PMID: 34304115 DOI: 10.1016/j.advms.2021.07.007] [Reference Citation Analysis]
556 Lai J, Lin X, Cao F, Mok H, Chen B, Liao N. CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients. J Cell Mol Med 2021;25:9390-401. [PMID: 34464504 DOI: 10.1111/jcmm.16880] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
557 Fu J, Singhrao K, Zhong X, Gao Y, Qi SX, Yang Y, Ruan D, Lewis JH. An Automatic Deep Learning-Based Workflow for Glioblastoma Survival Prediction Using Preoperative Multimodal MR Images: A Feasibility Study. Adv Radiat Oncol 2021;6:100746. [PMID: 34458648 DOI: 10.1016/j.adro.2021.100746] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
558 Liu L, DU C, Wei X, Liao R. [Correlation of peritumoral circWDR25 expression with the prognosis of patients with hepatocellular carcinoma after curative resection]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1388-93. [PMID: 34658354 DOI: 10.12122/j.issn.1673-4254.2021.09.14] [Reference Citation Analysis]
559 Zhang S, Lv J, Fan B, Fan Z, Li C, Gu B, Yu W, Zhang T. Constructing Tumor Immune Microenvironment and Identifying the Immune-Related Prognostic Signatures in Colorectal Cancer Using Multi-omics Data.. [DOI: 10.1101/2021.08.30.21262762] [Reference Citation Analysis]
560 Althobiti M, El-Sharawy KA, Joseph C, Aleskandarany M, Toss MS, Green AR, Rakha EA. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer. Breast Cancer Res Treat 2021;189:621-30. [PMID: 34453638 DOI: 10.1007/s10549-021-06336-y] [Reference Citation Analysis]
561 Luo F, Cao J, Lu F, Zeng K, Ma W, Huang Y, Zhang L, Zhao H. Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes. Cancer Cell Int 2021;21:458. [PMID: 34454491 DOI: 10.1186/s12935-021-02162-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
562 Liu CT, Xu YW, Guo H, Hong CQ, Huang XY, Luo YH, Yang SH, Chu LY, Li EM, Peng YH. Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma. Gut Liver 2020;14:727-34. [PMID: 31822054 DOI: 10.5009/gnl19135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
563 Pan YH, Zhang JX, Chen X, Liu F, Cao JZ, Chen Y, Chen W, Luo JH. Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy. Front Immunol 2021;12:643282. [PMID: 34421886 DOI: 10.3389/fimmu.2021.643282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
564 Xu JH, Guan YJ, Zhang YC, Qiu ZD, Zhou Y, Chen C, Yu J, Wang WX. ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma. Aging (Albany NY) 2021;13:20395-417. [PMID: 34426560 DOI: 10.18632/aging.203425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
565 Wang XQ, Bao M, Zhang C. Prognostic value of different lymph node staging methods for node-positive cardia gastric cancer: a register-based retrospective cohort study. BMJ Open 2021;11:e050378. [PMID: 34426469 DOI: 10.1136/bmjopen-2021-050378] [Reference Citation Analysis]
566 Zhou YF, Song SS, Tian MX, Tang Z, Wang H, Fang Y, Qu WF, Jiang XF, Tao CY, Huang R, Zhou PY, Zhu SG, Zhou J, Fan J, Liu WR, Shi YH. Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis. J Immunother Cancer 2021;9:e003031. [PMID: 34413167 DOI: 10.1136/jitc-2021-003031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
567 Ji GW, Fan Y, Sun DW, Wu MY, Wang K, Li XC, Wang XH. Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection. J Hepatocell Carcinoma 2021;8:913-23. [PMID: 34414136 DOI: 10.2147/JHC.S320172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
568 Liu SL, Bian LJ, Liu ZX, Chen QY, Sun XS, Sun R, Luo DH, Li XY, Xiao BB, Yan JJ, Lu ZJ, Yan SM, Yuan L, Tang LQ, Li JM, Mai HQ. Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma. J Immunother Cancer 2020;8:e000205. [PMID: 32303611 DOI: 10.1136/jitc-2019-000205] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
569 Jin B, Hu W, Su S, Xu H, Lu X, Sang X, Yang H, Mao Y, Du S. The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients. Cancer Manag Res 2021;13:6263-77. [PMID: 34408489 DOI: 10.2147/CMAR.S317954] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
570 Al-Kawaz A, Ali R, Toss MS, Miligy IM, Mohammed OJ, Green AR, Madhusudan S, Rakha EA. The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS). Breast Cancer Res Treat 2021;190:39-51. [PMID: 34406589 DOI: 10.1007/s10549-021-06357-7] [Reference Citation Analysis]
571 Zhang Y, Jiang Q, Xie J, Qi C, Li S, Wang Y, Him YH, Chen Z, Zhang S, Li Q, Zhu Y, Li R, Liang X, Bai X, Wang W. Modified arteriosclerosis score predicts the outcomes of diabetic kidney disease. BMC Nephrol 2021;22:281. [PMID: 34407751 DOI: 10.1186/s12882-021-02492-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
572 Liu W, Xie L, He YH, Wu ZY, Liu LX, Bai XF, Deng DX, Xu XE, Liao LD, Lin W, Heng JH, Xu X, Peng L, Huang QF, Li CY, Zhang ZD, Wang W, Zhang GR, Gao X, Wang SH, Li CQ, Xu LY, Liu W, Li EM. Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting. Nat Commun 2021;12:4961. [PMID: 34400640 DOI: 10.1038/s41467-021-25202-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
573 Pan L, Cheng C, Duan P, Chen K, Wu Y, Wu Z. XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor. J Exp Clin Cancer Res 2021;40:255. [PMID: 34384466 DOI: 10.1186/s13046-021-02044-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
574 Ye Z, Wei S, Zeng Y, Wang Y, Lin Z, Chen S, Xie Y, Zheng Q, Chen L. Prognostic value of preoperative body mass index for diabetic patients with non-metastasis gastric cancer: a single center experience. BMC Surg 2021;21:320. [PMID: 34372800 DOI: 10.1186/s12893-021-01316-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
575 Wang Y, Li W, Jin X, Jiang X, Guo S, Xu F, Su X, Wang G, Zhao Z, Gu X. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. BMC Cancer 2021;21:905. [PMID: 34364366 DOI: 10.1186/s12885-021-08629-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
576 Li N, Feng LW, Li ZN, Wang J, Yang L. Construction and Validation of a Nomogram to Predict Overall Survival in Very Young Female Patients with Curatively Resected Breast Cancer. Cancer Manag Res 2021;13:6181-90. [PMID: 34393511 DOI: 10.2147/CMAR.S321917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
577 Xue GQ, Li CP, Lv A, Tian XY, Wu JH, Qiu H, Hao CY. Predictive Value of Preoperative Controlling Nutritional Status Score Combined with Fibrinogen-Albumin Ratio in Postoperative Local Recurrence-Free Survival of Patients with Retroperitoneal Liposarcoma. Cancer Manag Res 2021;13:6157-67. [PMID: 34385843 DOI: 10.2147/CMAR.S307920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
578 Chen P, Zhao L, Wang H, Zhang L, Zhang W, Zhu J, Yu J, Zhao S, Li W, Sun C, Wu C, He Y, Zhou C. Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancer. J Immunother Cancer 2021;9:e002554. [PMID: 34362829 DOI: 10.1136/jitc-2021-002554] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
579 Zhang T, Dong X, Zhou Y, Liu M, Hang J, Wu L. Development and validation of a radiomics nomogram to discriminate advanced pancreatic cancer with liver metastases or other metastatic patterns. Cancer Biomark 2021;32:541-50. [PMID: 34334383 DOI: 10.3233/CBM-210190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
580 Jiang WM, Wu LL, Wei HY, Ma QL, Zhang Q. A Parsimonious Prognostic Model and Heat Map for Predicting Survival Following Adjuvant Radiotherapy in Parotid Gland Carcinoma With Lymph Node Metastasis. Technol Cancer Res Treat 2021;20:15330338211035257. [PMID: 34342241 DOI: 10.1177/15330338211035257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
581 Zhou R, Liang J, Chen Q, Tian H, Yang C, Liu C. Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq. Aging (Albany NY) 2021;13:19415-41. [PMID: 34339395 DOI: 10.18632/aging.203353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
582 Yu Q, Wang X, Yang Y, Chi P, Huang J, Qiu S, Zheng X, Chen X. Upregulated NLGN1 predicts poor survival in colorectal cancer. BMC Cancer 2021;21:884. [PMID: 34340665 DOI: 10.1186/s12885-021-08621-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
583 Papanota AM, Tsiakanikas P, Kontos CK, Malandrakis P, Liacos CI, Ntanasis-Stathopoulos I, Kanellias N, Gavriatopoulou M, Kastritis E, Avgeris M, Dimopoulos MA, Scorilas A, Terpos E. A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma. Cancers (Basel) 2021;13:3877. [PMID: 34359778 DOI: 10.3390/cancers13153877] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
584 Yang Y, Zhou Y, Zhang X, Xin Y, Chen Y, Fan Q, Li X, Wei X, Li Q, Zhou X, Zhou J. Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study. J Hepatocell Carcinoma 2021;8:837-50. [PMID: 34350139 DOI: 10.2147/JHC.S308587] [Reference Citation Analysis]
585 Fan Z, Huang Z, Tong Y, Zhu Z, Huang X, Sun H. Sites of Synchronous Distant Metastases, Prognosis, and Nomogram for Small Cell Lung Cancer Patients with Bone Metastasis: A Large Cohort Retrospective Study. J Oncol 2021;2021:9949714. [PMID: 34367286 DOI: 10.1155/2021/9949714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
586 Liao Y, He D, Wen F. Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy. Immunogenetics 2021. [PMID: 34302518 DOI: 10.1007/s00251-021-01223-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
587 Hou R, Li X, Xiong J, Shen T, Yu W, Schwartz LH, Zhao B, Zhao J, Fu X. Predicting Tyrosine Kinase Inhibitor Treatment Response in Stage IV Lung Adenocarcinoma Patients With EGFR Mutation Using Model-Based Deep Transfer Learning. Front Oncol 2021;11:679764. [PMID: 34354943 DOI: 10.3389/fonc.2021.679764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
588 Zhuang H, Chen X, Wang Y, Huang S, Chen B, Zhang C, Hou B. Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq. Cancer Immunol Immunother 2021. [PMID: 34279685 DOI: 10.1007/s00262-021-03019-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
589 Huang J, Bao L, Pan Y, Lu Q, Huang Y, Ding Q, Shen F, Huang Q, Ruan X. The predictive value of coronary artery calcification score combined with bone mineral density for the 2-year risk of cardiovascular events in maintenance hemodialysis patients. Int Urol Nephrol 2021. [PMID: 34279820 DOI: 10.1007/s11255-021-02961-0] [Reference Citation Analysis]
590 Wang J, Li Z, Liao Y, Li J, Dong H, Peng H, Xu W, Fan Z, Gao F, Liu C, Liu D, Zhang Y. Prediction of Survival and Analysis of Prognostic Factors for Patients With Combined Hepatocellular Carcinoma and Cholangiocarcinoma: A Population-Based Study. Front Oncol 2021;11:686972. [PMID: 34336671 DOI: 10.3389/fonc.2021.686972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
591 Yu W, Huang L, Zhong Z, Song T, Xu H, Jia Y, Hu J, Shou H. A Nomogram-Based Risk Classification System Predicting the Overall Survival of Patients With Newly Diagnosed Stage IVB Cervix Uteri Carcinoma. Front Med (Lausanne) 2021;8:693567. [PMID: 34336897 DOI: 10.3389/fmed.2021.693567] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
592 Li Z, Lin Y, Cheng B, Zhang Q, Cai Y. Prognostic Model for Predicting Overall and Cancer-Specific Survival Among Patients With Cervical Squamous Cell Carcinoma: A SEER Based Study. Front Oncol 2021;11:651975. [PMID: 34336651 DOI: 10.3389/fonc.2021.651975] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
593 Zhang H, Zhou Y, Qu M, Yu Y, Chen Z, Zhu S, Guo K, Chen W, Miao C. Tissue Factor-Enriched Neutrophil Extracellular Traps Promote Immunothrombosis and Disease Progression in Sepsis-Induced Lung Injury. Front Cell Infect Microbiol 2021;11:677902. [PMID: 34336711 DOI: 10.3389/fcimb.2021.677902] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
594 Wang J, Shi L, Chen J, Wang B, Qi J, Chen G, Kang M, Zhang H, Jin X, Huang Y, Zhao Z, Chen J, Song B, Chen J. A novel risk score system for prognostic evaluation in adenocarcinoma of the oesophagogastric junction: a large population study from the SEER database and our center. BMC Cancer 2021;21:806. [PMID: 34256714 DOI: 10.1186/s12885-021-08558-1] [Reference Citation Analysis]
595 Kao CN, Moi SH, Hou MF, Luo CW, Chen FM, Pan MR. RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J Pers Med 2021;11:655. [PMID: 34357122 DOI: 10.3390/jpm11070655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
596 Lu Y, Yu J, Gong W, Su L, Sun X, Bai O, Zhou H, Guan X, Zhang T, Li L, Qiu L, Qian Z, Zhou S, Meng B, Ren X, Wang X, Zhang H. An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy. Front Oncol 2021;11:708784. [PMID: 34336695 DOI: 10.3389/fonc.2021.708784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
597 Guo H, Li B, Diao L, Wang H, Chen P, Jiang M, Zhao L, He Y, Zhou C. An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC). Oncoimmunology 2021;10:1947665. [PMID: 34290908 DOI: 10.1080/2162402X.2021.1947665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
598 Cai Y, Zhang B, Li J, Li H, Liu H, Xie K, Du C, Wu H. A Novel Nomogram Based on Hepatic and Coagulation Function for Evaluating Outcomes of Intrahepatic Cholangiocarcinoma After Curative Hepatectomy: A Multi-Center Study of 653 Patients. Front Oncol 2021;11:711061. [PMID: 34322394 DOI: 10.3389/fonc.2021.711061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
599 Chen F, Li Y, Ye G, Zhou L, Bian X, Liu J. Development and Validation of a Prognostic Model for Cognitive Impairment in Parkinson's Disease With REM Sleep Behavior Disorder. Front Aging Neurosci 2021;13:703158. [PMID: 34322014 DOI: 10.3389/fnagi.2021.703158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
600 Tang J, Jiang S, Gao Q, Xi X, Gao L, Zhao R, Lai X, Zhang B, Jiang Y. Development and validation of a nomogram based on stromal score to predict progression-free survival of patients with papillary thyroid carcinoma. Cancer Med 2021;10:5488-98. [PMID: 34240816 DOI: 10.1002/cam4.4112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
601 Zhang M, Ding C, Xu L, Ou B, Feng S, Wang G, Wang W, Liang Y, Chen Y, Zhou Z, Qiu H. Comparison of a Tumor-Ratio-Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer. Front Oncol 2021;11:595421. [PMID: 34307116 DOI: 10.3389/fonc.2021.595421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
602 Liu F, Hardiman T, Wu K, Quist J, Gazinska P, Ng T, Purushotham A, Salgado R, Guo X, Pinder SE, Grigoriadis A. Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication. NPJ Breast Cancer 2021;7:86. [PMID: 34226563 DOI: 10.1038/s41523-021-00292-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
603 Xu H, Xu Q, Yin L. Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysis. Cancer Cell Int 2021;21:344. [PMID: 34217290 DOI: 10.1186/s12935-021-02048-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
604 Xin H, Liang D, Zhang M, Ren D, Chen H, Zhang H, Li S, Ding G, Zhang C, Ding Z, Wu L, Han W, Zhou W, Chen Y, Luo H, Wang Y, Zhang H, Liu S, Li N. The CD68+ macrophages to CD8+ T-cell ratio is associated with clinical outcomes in hepatitis B virus (HBV)-related hepatocellular carcinoma. HPB (Oxford) 2021;23:1061-71. [PMID: 33309570 DOI: 10.1016/j.hpb.2020.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
605 Chen S, Huang F, Chen S, Chen Y, Li J, Li Y, Lian G, Huang K. Bioinformatics-Based Identification of Tumor Microenvironment-Related Prognostic Genes in Pancreatic Cancer. Front Genet 2021;12:632803. [PMID: 34276760 DOI: 10.3389/fgene.2021.632803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
606 Yan X, Chen M, Xiao C, Fu J, Sun X, Hu Z, Zhou H. Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer. Ann Med 2021;53:1048-58. [PMID: 34187252 DOI: 10.1080/07853890.2021.1918346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
607 Corrao G, Zaffaroni M, Bergamaschi L, Augugliaro M, Volpe S, Pepa M, Bonizzi G, Pece S, Amodio N, Mistretta FA, Luzzago S, Musi G, Alessi S, La Fauci FM, Tordonato C, Tosoni D, Cattani F, Gandini S, Petralia G, Pravettoni G, De Cobelli O, Viale G, Orecchia R, Marvaso G, Jereczek-Fossa BA. Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review. Cancers (Basel) 2021;13:3278. [PMID: 34208918 DOI: 10.3390/cancers13133278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
608 Li Y, Zhao X, Liu Q, Liu Y. Bioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis. Ann Med 2021;53:1019-31. [PMID: 34187256 DOI: 10.1080/07853890.2021.1914343] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
609 Lu Z, Sun Z, Liu C, Shi X, Li R, Shao W, Zheng Y, Li Y, Song J. Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study. BMC Cancer 2021;21:751. [PMID: 34187430 DOI: 10.1186/s12885-021-08505-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
610 Pan Y, Meng Y, Zhai Z, Xiong S. Identification of a three-gene-based prognostic model in multiple myeloma using bioinformatics analysis. PeerJ 2021;9:e11320. [PMID: 34249481 DOI: 10.7717/peerj.11320] [Reference Citation Analysis]
611 Zhang CD, Li M, Hong YJ, Cai ZM, Huang KC, Lin ZX, Yang ZN. Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy. Front Oncol 2021;11:682271. [PMID: 34262866 DOI: 10.3389/fonc.2021.682271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
612 Zhang Y, Fu Y. Comprehensive Analysis and Identification of an Immune-Related Gene Signature with Prognostic Value for Prostate Cancer. Int J Gen Med 2021;14:2931-42. [PMID: 34234523 DOI: 10.2147/IJGM.S321319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
613 Luo Y, Deng R, Zhong Q, Luo D, Li X, Chen X, Tao S, Feng Z, Jiayi L, Huang Y, Li J, Liu W. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments. Medicine (Baltimore) 2021;100:e26437. [PMID: 34160435 DOI: 10.1097/MD.0000000000026437] [Reference Citation Analysis]
614 Liu G, Xu Z, Zhang Y, Jiang B, Zhang L, Wang L, de Bock GH, Vliegenthart R, Xie X. Machine-Learning-Derived Nomogram Based on 3D Radiomic Features and Clinical Factors Predicts Progression-Free Survival in Lung Adenocarcinoma. Front Oncol 2021;11:692329. [PMID: 34249741 DOI: 10.3389/fonc.2021.692329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
615 Saleem I, Mirza S, Sarkar A, Raza M, Mohapatra B, Mushtaq I, Kim JH, Mishra NK, Alsaleem MA, Rakha EA, Qiu F, Guda C, Band H, Band V. The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export. Mol Cell Biol 2021;41:e0010321. [PMID: 33941617 DOI: 10.1128/MCB.00103-21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
616 Zhang Q, Liu XJ, Li Y, Ying XW, Chen L. Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma. Technol Cancer Res Treat 2021;20:15330338211011966. [PMID: 34159865 DOI: 10.1177/15330338211011966] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
617 Cho YA, Choi S, Park S, Park CK, Ha SY. Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase (PNCK) in Hepatocellular Carcinoma. Cancer Genomics Proteomics 2020;17:747-55. [PMID: 33099476 DOI: 10.21873/cgp.20229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
618 Zhang Y, Chen P, Zhou Q, Wang H, Hua Q, Wang J, Zhong H. A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma. Front Genet 2021;12:570336. [PMID: 34220923 DOI: 10.3389/fgene.2021.570336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
619 Zhang H, Qu M, Gorur A, Sun Z, Cata JP, Chen W, Miao C. Association of Mu-Opioid Receptor(MOR) Expression and Opioids Requirement With Survival in Patients With Stage I-III Pancreatic Ductal Adenocarcinoma. Front Oncol 2021;11:686877. [PMID: 34222012 DOI: 10.3389/fonc.2021.686877] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
620 Zhuang H, Zhou Z, Ma Z, Huang S, Gong Y, Li Z, Liu C, Wang S, Chen B, Zhang C, Hou B. Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy. Clin Med Insights Oncol 2021;15:11795549211024149. [PMID: 34211308 DOI: 10.1177/11795549211024149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
621 Li Y, Zhang W, Zhang H, Hu J, Zhou C, Zhang X, Fan W. Prognostic Significance of Regional/Systemic Metabolic Parameters on 18F-FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma. Front Oncol 2021;11:675961. [PMID: 34221995 DOI: 10.3389/fonc.2021.675961] [Reference Citation Analysis]
622 Feng R, Guo X, Kou Y, Xu X, Hong C, Zhang W, An Y, Philips CA, Mancuso A, Qi X. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis. Postgrad Med 2021;133:626-38. [PMID: 33993838 DOI: 10.1080/00325481.2021.1930560] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
623 Jiang T, Liu S, Wu X, Liu X, Li W, Yang S, Cai P, Xi S, Zeng Z, Gao Y, Chen G, Xiao W. Nomogram to Predict Distant Metastasis Probability for Pathological Complete Response Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy. Cancer Manag Res 2021;13:4751-61. [PMID: 34163249 DOI: 10.2147/CMAR.S313113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
624 Ruchong P, Haiping T, Xiang W. A Five-Gene Prognostic Nomogram Predicting Disease-Free Survival of Differentiated Thyroid Cancer. Dis Markers 2021;2021:5510780. [PMID: 34221185 DOI: 10.1155/2021/5510780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
625 Al-Kawaz A, Miligy IM, Toss MS, Mohammed OJ, Green AR, Madhusudan S, Rakha EA. The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ. Breast Cancer Res Treat 2021;188:53-63. [PMID: 34117958 DOI: 10.1007/s10549-021-06271-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
626 Zheng BW, Zheng BY, Niu HQ, Wang XB, Li J. Letter to the Editor concerning the article "Clinical outcomes of chondroblastoma treated using synthetic bone substitute: risk factors for developing radiographic joint degeneration". World J Surg Oncol 2021;19:171. [PMID: 34118947 DOI: 10.1186/s12957-021-02235-0] [Reference Citation Analysis]
627 Hu X, Wang B, Chen Q, Huang A, Fu W, Liu L, Zhang Y, Tang G, Cheng H, Ni X, Gao L, Chen J, Chen L, Zhang W, Yang J, Cao S, Yu L, Wang J. A clinical prediction model identifies a subgroup with inferior survival within intermediate risk acute myeloid leukemia. J Cancer 2021;12:4912-23. [PMID: 34234861 DOI: 10.7150/jca.57231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
628 Wen YL, Yan SM, Wei W, Yang X, Zhang SW, Yun JP, Liu LL, Luo RZ. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma. Mol Med 2021;27:60. [PMID: 34134633 DOI: 10.1186/s10020-021-00298-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
629 Xiao N, Zhu X, Li K, Chen Y, Liu X, Xu B, Lei M, Xu J, Sun HC. Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma. Exp Hematol Oncol 2021;10:36. [PMID: 34112250 DOI: 10.1186/s40164-021-00230-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
630 Lee JH, Lee HS, Kim S, Park EJ, Baik SH, Jeon TJ, Lee KY, Ryu YH, Kang J. Prognostic significance of bone marrow and spleen 18F-FDG uptake in patients with colorectal cancer. Sci Rep 2021;11:12137. [PMID: 34108552 DOI: 10.1038/s41598-021-91608-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
631 Han S, Wang PF, Cai HQ, Wan JH, Li SW, Lin ZH, Yu CJ, Yan CX. Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas. Aging (Albany NY) 2021;13:15444-58. [PMID: 34100771 DOI: 10.18632/aging.203102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
632 Chen C, Wu Z, Wu Z, Wu C, Wang Q, Zhan T, Dong L, Fang S, Wu M. Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database. BMC Cancer 2021;21:666. [PMID: 34088283 DOI: 10.1186/s12885-021-08399-y] [Reference Citation Analysis]
633 Wan J, Zou G, He B, Zhang C, Zhu Y, Yin L, Lu Z. Development and External Validation a Novel Inflammation-Based Score for Acute Kidney Injury and Prognosis in Intensive Care Unit Patients. Int J Gen Med 2021;14:2215-26. [PMID: 34103975 DOI: 10.2147/IJGM.S311021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
634 Yang YC, Wang JJ, Huang Y, Cai WX, Tao Q. Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma. Cancer Manag Res 2021;13:4403-16. [PMID: 34103995 DOI: 10.2147/CMAR.S307517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
635 Dai HT, Chen B, Tang KY, Zhang GY, Wen CY, Xiang XH, Yang JY, Guo Y, Lin R, Huang YH. Prognostic value of splenic volume in hepatocellular carcinoma patients receiving transarterial chemoembolization. J Gastrointest Oncol 2021;12:1141-51. [PMID: 34295563 DOI: 10.21037/jgo-21-226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
636 Li TT, Sun J, Wang Q, Li WG, He WP, Yang RC, Duan XZ. The effects of stereotactic body radiotherapy on peripheral natural killer and CD3(+)CD56(+) NKT-like cells in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2021;20:240-50. [PMID: 33454220 DOI: 10.1016/j.hbpd.2020.12.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
637 Xing C, Li Y, Ding C, Wang S, Zhang H, Chen L, Li P, Dai M. CD44+ Circulating Tumor Endothelial Cells Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After Radical Surgery: A Pilot Study. Cancer Manag Res 2021;13:4417-31. [PMID: 34103996 DOI: 10.2147/CMAR.S309115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
638 Huang J, Zhao L, Wang K, Sun J, Tai S, Hua R, Yu Y, Fan Y. Controlling Nutritional Status Score Evaluates Prognosis in Patients With Non-Muscle Invasive Bladder Cancer. Cancer Control 2021;28:10732748211021078. [PMID: 34060373 DOI: 10.1177/10732748211021078] [Reference Citation Analysis]
639 Guo H, Diao L, Zhou X, Chen JN, Zhou Y, Fang Q, He Y, Dziadziuszko R, Zhou C, Hirsch FR. Artificial intelligence-based analysis for immunohistochemistry staining of immune checkpoints to predict resected non-small cell lung cancer survival and relapse. Transl Lung Cancer Res 2021;10:2452-74. [PMID: 34295654 DOI: 10.21037/tlcr-21-96] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
640 Shi H, Wei Y, Cheng S, Lu Z, Zhang K, Jiang K, Xu Q. Survival prediction after upfront surgery in patients with pancreatic ductal adenocarcinoma: Radiomic, clinic-pathologic and body composition analysis. Pancreatology 2021;21:731-7. [PMID: 33678581 DOI: 10.1016/j.pan.2021.02.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
641 Li L, Zeng Q, Xue N, Wu M, Liang Y, Xu Q, Feng L, Xing S, Chen S. A Nomogram Based on Aspartate Aminotransferase/Alanine Aminotransferase (AST/ALT) Ratio to Predict Prognosis After Surgery in Gastric Cancer Patients. Cancer Control 2020;27:1073274820954458. [PMID: 32959672 DOI: 10.1177/1073274820954458] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
642 Peng H, Wu X, Zhong R, Yu T, Cai X, Liu J, Wen Y, Ao Y, Chen J, Li Y, Zheng H, Chen Y, Pan Z, He J, Liang W. Profiling tumor immune microenvironment of non-small cell lung cancer using multiplex immunofluorescence.. [DOI: 10.1101/2021.05.28.446005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
643 Tang F, Lu Z, He C, Zhang H, Wu W, He Z. 53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database. BMC Cancer 2021;21:638. [PMID: 34051738 DOI: 10.1186/s12885-021-08376-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
644 Liu M, Xu Y, Zhou Y, Lang R, Shi Z, Zhao J, Meng Y, Bao L. Integrated Analyses Reveal the Multi-Omics and Prognostic Characteristics of ATP5B in Breast Cancer. Front Genet 2021;12:652474. [PMID: 34122507 DOI: 10.3389/fgene.2021.652474] [Reference Citation Analysis]
645 Xie JB, Pang YS, Li X, Wu XT. Critical prognostic value of the log odds of negative lymph nodes/tumor size in rectal cancer patients. World J Clin Cases 2021; 9(15): 3531-3545 [PMID: 34046453 DOI: 10.12998/wjcc.v9.i15.3531] [Reference Citation Analysis]
646 Wang P, Wang H, Qiu G, Liu J, Fan L, Liao X, Che X. A Nomogram Model Involving Preoperative Fibrinogen and Prognostic Nutritional Index Score for Predicting Postoperative Outcome in Patients with Gastric Cancer. Cancer Manag Res 2021;13:4191-201. [PMID: 34079372 DOI: 10.2147/CMAR.S311347] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
647 Kong S, Chen C, Zheng G, Yao H, Li J, Ye H, Wang X, Qu X, Zhou X, Lu Y, Zhou H. A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. BMC Cardiovasc Disord 2021;21:253. [PMID: 34022791 DOI: 10.1186/s12872-021-02051-0] [Reference Citation Analysis]
648 Parvathareddy SK, Siraj AK, Masoodi T, Annaiyappanaidu P, Al-Badawi IA, Al-Dayel F, Al-Kuraya KS. Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer. J Ovarian Res 2021;14:69. [PMID: 34011401 DOI: 10.1186/s13048-021-00827-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
649 Siraj AK, Parvathareddy SK, Annaiyappanaidu P, Ahmed SO, Siraj N, Tulbah A, Al-Dayel F, Ajarim D, Al-Kuraya KS. High Expression of Cyclin D1 is an Independent Marker for Favorable Prognosis in Middle Eastern Breast Cancer. Onco Targets Ther 2021;14:3309-18. [PMID: 34040395 DOI: 10.2147/OTT.S309091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
650 Li J, Shi Z, Liu F, Fang X, Cao K, Meng Y, Zhang H, Yu J, Feng X, Li Q, Liu Y, Wang L, Jiang H, Lu J, Shao C, Bian Y. XGBoost Classifier Based on Computed Tomography Radiomics for Prediction of Tumor-Infiltrating CD8+ T-Cells in Patients With Pancreatic Ductal Adenocarcinoma. Front Oncol 2021;11:671333. [PMID: 34094971 DOI: 10.3389/fonc.2021.671333] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
651 Benitez JC, Campayo M, Díaz T, Ferrer C, Acosta-Plasencia M, Monzo M, Cirera L, Besse B, Navarro A. Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer. J Pers Med 2021;11:420. [PMID: 34065723 DOI: 10.3390/jpm11050420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
652 Saidy B, Kotecha S, Butler A, Rakha EA, Ellis IO, Green AR, Martin SG, Storr SJ. PP1, PKA and DARPP-32 in breast cancer: A retrospective assessment of protein and mRNA expression. J Cell Mol Med 2021;25:5015-24. [PMID: 33991172 DOI: 10.1111/jcmm.16447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
653 Chen H, Wu S, Hu J, Zhang K, Hu K, Lu Y, He J, Pan T, Chen Y. Prognostic Models for Nonmetastatic Triple-Negative Breast Cancer Based on the Pretreatment Serum Tumor Markers with Machine Learning. J Oncol 2021;2021:6641421. [PMID: 34054955 DOI: 10.1155/2021/6641421] [Reference Citation Analysis]
654 Luo, Kuang F, Du J, Zhou M, Peng F, Gan Y, Fang C, Yang X, Li B, Su S. Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy. Front Oncol 2021;11:677609. [PMID: 34055645 DOI: 10.3389/fonc.2021.677609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
655 Wei M, Gu B, Song S, Zhang B, Wang W, Xu J, Yu X, Shi S. A Novel Validated Recurrence Stratification System Based on 18F-FDG PET/CT Radiomics to Guide Surveillance After Resection of Pancreatic Cancer. Front Oncol 2021;11:650266. [PMID: 34055620 DOI: 10.3389/fonc.2021.650266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
656 Liu J, Wu M, Xie E, Chen L, Su S, Zeng H, Geng Q, Yang F, Luo J. Assessment of Liver Function for Evaluation of Short- and Long-Term Outcomes in Type B Aortic Dissection Patients Undergoing Thoracic Endovascular Aortic Repair. Front Cardiovasc Med 2021;8:643127. [PMID: 34124186 DOI: 10.3389/fcvm.2021.643127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
657 Chen J, Xia YJ, Liu TY, Lai YH, Yu JS, Zhang TH, Ooi S, He YL. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data. BMC Cancer 2021;21:532. [PMID: 33971833 DOI: 10.1186/s12885-021-08249-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
658 Tremblay D, Rapp JL, Alpert N, Lieberman-Cribbin W, Mascarenhas J, Taioli E, Ghaffari S. Mild anemia as a single independent predictor of mortality in patients with COVID-19. EJHaem 2021. [PMID: 34226904 DOI: 10.1002/jha2.167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
659 Wang J, Jiang YH, Yang PY, Liu F. Increased Collagen Type V α2 (COL5A2) in Colorectal Cancer is Associated with Poor Prognosis and Tumor Progression. Onco Targets Ther 2021;14:2991-3002. [PMID: 33981148 DOI: 10.2147/OTT.S288422] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
660 Zhu K, Ren P, Yang Y, Wang Y, Xiao W, Zhang H, Yu Z. Role of chemotherapy after curative esophagectomy in squamous cell carcinoma of the thoracic esophagus: A propensity score-matched analysis. Thorac Cancer 2021;12:1800-9. [PMID: 33943011 DOI: 10.1111/1759-7714.13981] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
661 Yang M, Wu X, Li L, Li S, Li N, Mao M, Pan S, Du R, Wang X, Chen M, Xiao N, Zhu X, He G, Zhang L, Huang W, Pan H, Deng L, Chen L, Liang L, Guan J. COMMD10 inhibits tumor progression and induces apoptosis by blocking NF-κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma. Clin Transl Med 2021;11:e403. [PMID: 34047468 DOI: 10.1002/ctm2.403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
662 Jiao X, Wei X, Li S, Liu C, Chen H, Gong J, Li J, Zhang X, Wang X, Peng Z, Qi C, Wang Z, Wang Y, Wang Y, Zhuo N, Zhang H, Lu Z, Shen L. A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer. NPJ Precis Oncol 2021;5:36. [PMID: 33947957 DOI: 10.1038/s41698-021-00172-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
663 Chen Q, Shao Z, Liu K, Zhou X, Wang L, Jiang E, Luo T, Shang Z. Salivary Porphyromonas gingivalis predicts outcome in oral squamous cell carcinomas: a cohort study. BMC Oral Health 2021;21:228. [PMID: 33941164 DOI: 10.1186/s12903-021-01580-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
664 Li Z, Wei J, Gan X, Song M, Zhang Y, Cao H, Jin Y, Yang J. Construction, validation and, visualization of a web-based nomogram for predicting the overall survival and cancer-specific survival of leiomyosarcoma patients with lung metastasis. J Thorac Dis 2021;13:3076-92. [PMID: 34164199 DOI: 10.21037/jtd-21-598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
665 Bian J, Long J, Yang X, Yang X, Xu Y, Lu X, Guan M, Sang X, Zhao H. Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma. Ann Transl Med 2021;9:765. [PMID: 34268378 DOI: 10.21037/atm-20-7101] [Reference Citation Analysis]
666 Xu M, Wu Q, Cai L, Sun X, Xie X, Sun P. Systemic Inflammatory Score predicts Overall Survival in patients with Cervical Cancer. J Cancer 2021;12:3671-7. [PMID: 33995642 DOI: 10.7150/jca.56170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
667 Xiong L, Chen H, Tang X, Chen B, Jiang X, Liu L, Feng Y, Liu L, Li L. Ultrasound-Based Radiomics Analysis for Predicting Disease-Free Survival of Invasive Breast Cancer. Front Oncol 2021;11:621993. [PMID: 33996546 DOI: 10.3389/fonc.2021.621993] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
668 Hou GM, Liu HL, Wu H, Zeng Y. Prediction of Prognosis for cHCC-CC Patients After Surgery: Comparison of Tumor Marker Score Based on AFP, CEA, CA19-9, and Other Clinical Stages. Ann Surg Oncol 2021. [PMID: 33900502 DOI: 10.1245/s10434-021-09949-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
669 Qiu J, Cai D, Wang Z, Zhou J, Gong Y, Cai L, Gong K. Prognostic Models for Patients With Gleason Score 9 Prostate Cancer: A Population-Based Study. Front Oncol 2021;11:633312. [PMID: 33981602 DOI: 10.3389/fonc.2021.633312] [Reference Citation Analysis]
670 Zhang Z, Yu Y, Zhang P, Ma G, Zhang M, Liang Y, Jiao W, Niu H. Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer. BMC Cancer 2021;21:458. [PMID: 33894748 DOI: 10.1186/s12885-021-08229-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
671 Li C, Xu F, Huang Q, Han D, Zheng S, Wu W, Zhao F, Feng X, Lyu J. Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model. JNCI Cancer Spectr 2021;5:pkab038. [PMID: 34159295 DOI: 10.1093/jncics/pkab038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
672 Li X, Xu H, Yan L, Gao J, Zhu L. A Novel Clinical Nomogram for Predicting Cancer-Specific Survival in Adult Patients After Primary Surgery for Epithelial Ovarian Cancer: A Real-World Analysis Based on the Surveillance, Epidemiology, and End Results Database and External Validation in a Tertiary Center. Front Oncol 2021;11:670644. [PMID: 33959514 DOI: 10.3389/fonc.2021.670644] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
673 Deng T, He Z, Duan X, Gu D, Cai C, Wu W, Liu Y, Zeng G. STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival via Inhibiting Cell Growth and Invasion. Front Oncol 2021;11:611081. [PMID: 33959493 DOI: 10.3389/fonc.2021.611081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
674 Hou N, Zhang J, Yang L, Wu Y, Wang Z, Zhang M, Yang L, Hou G, Wu J, Wang Y, Dong B, Guo L, Shi M, Ling R. A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1-2 Breast Cancer With 1-3 Positive Axillary Lymph Nodes. Front Oncol 2021;11:640268. [PMID: 33954110 DOI: 10.3389/fonc.2021.640268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
675 Wushouer A, Li W, Zhang M, Lei D, Pan X. Comparison of treatment modalities for selected advanced laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2021. [PMID: 33864482 DOI: 10.1007/s00405-021-06780-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
676 Ding Y, Jiang R, Chen Y, Jing J, Yang X, Wu X, Zhang X, Xu J, Xu P, LiuHuang SC, Lu Z. Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study. BMC Cancer 2021;21:420. [PMID: 33863315 DOI: 10.1186/s12885-021-08105-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
677 Guo Q, Wu Y, Wen H, Ju X, Wu X. Effect of the Number of Removed Lymph Nodes on Survival in Patients with FIGO Stage IB-IIA Cervical Squamous Cell Carcinoma following Open Radical Hysterectomy with Pelvic Lymphadenectomy: A Retrospective Cohort Study. J Oncol 2021;2021:6201634. [PMID: 33936201 DOI: 10.1155/2021/6201634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
678 Liu X, Zheng S, Peng Y, Zhuang J, Yang Y, Xu Y, Guan G. Construction of the Prediction Model for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy Based on Pretreatment Tumor-Infiltrating Macrophage-Associated Biomarkers. Onco Targets Ther 2021;14:2599-610. [PMID: 33880038 DOI: 10.2147/OTT.S297263] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
679 Jiang Y, Yu X, Zhao Y, Huang J, Li T, Chen H, Zhou J, Huang Z, Yang Z. ADAMTS19 Suppresses Cell Migration and Invasion by Targeting S100A16 via the NF-κB Pathway in Human Gastric Cancer. Biomolecules 2021;11:561. [PMID: 33921267 DOI: 10.3390/biom11040561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
680 Sugawara T, Ban D, Nishino J, Watanabe S, Maekawa A, Ishikawa Y, Akahoshi K, Ogawa K, Ono H, Kudo A, Tanaka S, Tanabe M. Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection. PLoS One 2021;16:e0249885. [PMID: 33844700 DOI: 10.1371/journal.pone.0249885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
681 Yu S, Cai L, Liu C, Gu R, Cai L, Zhuo L. Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma. Mol Med 2021;27:36. [PMID: 33832428 DOI: 10.1186/s10020-021-00294-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
682 Sun Y, Wan J, Song Q, Luo C, Li X, Luo Y, Huang X, Ding R, Li H, Hou Y, Huang Y, Xie M, Huang Z, Zhang Y, Ma Y, Wu G, Xu S, Chen J. Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia. Biomed Res Int 2021;2021:1929357. [PMID: 33928145 DOI: 10.1155/2021/1929357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
683 Yang X, Lei P, Huang L, Tang X, Wei B, Wei H. Prognostic value of LRRC4C in Colon and Gastric Cancers correlates with Tumour Microenvironment Immunity. Int J Biol Sci 2021;17:1413-27. [PMID: 33867855 DOI: 10.7150/ijbs.58876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
684 Dou XM, Zhang N, Fang YY, Zhang BH, Liao JJ, Cai JS, Li JB. Prognostic nomograms and risk-stratifying systems for predicting survival in patients with resected pT2-4aN0M0 esophageal carcinoma. J Thorac Dis 2021;13:2363-77. [PMID: 34012585 DOI: 10.21037/jtd-20-3393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
685 Zhang Y, Yu C. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in elderly patients with gastric cancer after surgery. J Gastrointest Oncol 2021;12:278-96. [PMID: 34012626 DOI: 10.21037/jgo-20-536] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
686 Sun Y, Wu X, Lin H, Lu X, Huang Y, Chi P. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model. J Gastrointest Surg 2021;25:1019-28. [PMID: 32219686 DOI: 10.1007/s11605-020-04566-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
687 Pateras IS, Kotsakis A, Avgeris M, Baliou E, Kouroupakis P, Patsea E, Georgoulias V, Menez-Jamet J, Kinet JP, Kosmatopoulos K. Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in "Immune Desert" NSCLC. Cancers (Basel) 2021;13:1658. [PMID: 33916194 DOI: 10.3390/cancers13071658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
688 Martín J, Castellano JJ, Marrades RM, Canals J, Viñolas N, Díaz T, Molins L, Martinez D, Han B, Moisés J, He Y, Monzó M, Navarro A. Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer. Transl Lung Cancer Res 2021;10:1804-18. [PMID: 34012794 DOI: 10.21037/tlcr-20-920] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
689 Zheng L, Zhou ZR, Shi M, Chen H, Yu QQ, Yang Y, Liu L, Zhang L, Guo Y, Zhou X, Li C, Wei Q. Nomograms for predicting progression-free survival and overall survival after surgery and concurrent chemoradiotherapy for glioblastoma: a retrospective cohort study. Ann Transl Med 2021;9:571. [PMID: 33987269 DOI: 10.21037/atm-21-673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
690 Zhang X, Zhang J, Liu Y, Li J, Tan J, Song Z. Bcl-2 Associated Athanogene 2 (BAG2) is Associated With Progression and Prognosis of Hepatocellular Carcinoma: A Bioinformatics-Based Analysis. Pathol Oncol Res 2021;27:594649. [PMID: 34257542 DOI: 10.3389/pore.2021.594649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
691 Lv Y, Wang Z, Li K, Wang Q, Bai W, Yuan X, Yu T, Niu J, Yang Z, Zhu X, Zhao J, Xue H, Jiang Z, Zhuge Y, Zhang C, Sun J, Ding P, Ren W, Li Y, Zhang K, Zhang W, Guo W, Luo B, Li X, Yuan J, Han N, Zhu Y, He C, Yin Z, Fan D, Han G. Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding. Hepatology 2021;73:1478-93. [PMID: 32706906 DOI: 10.1002/hep.31478] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
692 MingHua Z, KeCheng Z, ZhenYu C, Lin C, ChunXi W, ZeLong Y. Impact of Lymph Nodes Examined on Survival in ypN0 Gastric Cancer Patients: a Population-Based Study. J Gastrointest Surg 2021;25:919-25. [PMID: 32318943 DOI: 10.1007/s11605-020-04579-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
693 Pu N, Gao S, Beckman R, Ding D, Wright M, Chen Z, Zhu Y, Hu H, Yin L, Beckman M, Thompson E, Hruban RH, Cameron JL, Gage MM, Lafaro KJ, Burns WR, Wolfgang CL, He J, Yu J, Burkhart RA. Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinoma. HPB (Oxford) 2021;23:575-86. [PMID: 32900612 DOI: 10.1016/j.hpb.2020.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
694 Li X, Bi X, Zhao J, Li Z, Zhou J, Huang Z, Zhang Y, Zhao H, Cai J. A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma. Transl Cancer Res 2021;10:1773-86. [PMID: 35116501 DOI: 10.21037/tcr-20-3411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
695 Zhu H, Ji K, Wu W, Zhao S, Zhou J, Zhang C, Tang R, Miao L. Describing Treatment Patterns for Elderly Patients with Intrahepatic Cholangiocarcinoma and Predicting Prognosis by a Validated Model: A Population-Based Study. J Cancer 2021;12:3114-25. [PMID: 33976721 DOI: 10.7150/jca.53978] [Reference Citation Analysis]
696 Zhuang H, Zhang C, Hou B. GTF2IRD1 overexpression promotes tumor progression and correlates with less CD8+ T cells infiltration in pancreatic cancer. Biosci Rep 2020;40:BSR20202150. [PMID: 32936232 DOI: 10.1042/BSR20202150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
697 Li Y, Yan L, Li Y, Wan Z, Bai Y, Wang X, Hu S, Wu X, Yang C, Fan J, Xu H, Wang L, Shi Y. Development and validation of routine clinical laboratory data derived marker-based nomograms for the prediction of 5-year graft survival in kidney transplant recipients. Aging (Albany NY) 2021;13:9927-47. [PMID: 33795527 DOI: 10.18632/aging.202748] [Reference Citation Analysis]
698 Dai S, Ren P, Ren J, Yang L, Li W. The Relationship between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective Study. Int J Med Sci 2021;18:2228-34. [PMID: 33859531 DOI: 10.7150/ijms.56928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
699 Feng Z, Li K, Wu Y, Peng C. Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. Front Mol Biosci 2021;8:659168. [PMID: 33834039 DOI: 10.3389/fmolb.2021.659168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
700 Lv Z, Liang Y, Liu H, Mo D. Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study. BMC Cancer 2021;21:306. [PMID: 33757442 DOI: 10.1186/s12885-021-08057-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
701 Yang J, Ma J, Jin Y, Cheng S, Huang S, Zhang N, Wang Y. Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial-mesenchymal transition. Sci Rep 2021;11:6540. [PMID: 33753862 DOI: 10.1038/s41598-021-86122-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
702 Chang QH, Mao T, Tao Y, Dong T, Tang XX, Ge GH, Xu ZJ. Pan-cancer analysis identifies ITIH1 as a novel prognostic indicator for hepatocellular carcinoma. Aging (Albany NY) 2021;13:11096-119. [PMID: 33744857 DOI: 10.18632/aging.202765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
703 Song Z, Zhou Y, Bai X, Zhang D. A Practical Nomogram to Predict Early Death in Advanced Epithelial Ovarian Cancer. Front Oncol 2021;11:655826. [PMID: 33816311 DOI: 10.3389/fonc.2021.655826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
704 Zhao S, Chen X, Wen D, Zhang C, Wang X. Oncologic Nomogram for Stage I Rectal Cancer to Assist Patient Selection for Adjuvant (Chemo)Radiotherapy Following Local Excision. Front Oncol 2021;11:632085. [PMID: 33816269 DOI: 10.3389/fonc.2021.632085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
705 Wang Y, Chen L, Zhang B, Song W, Zhou G, Xie L, Yu D. Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer. Front Oncol 2021;11:639909. [PMID: 33816284 DOI: 10.3389/fonc.2021.639909] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
706 Zhu Y, Pu X, Dong X, Ji C, Guo H, Li D, Zhao X, Gan W. Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis. Cancer Manag Res 2021;13:2419-31. [PMID: 33758541 DOI: 10.2147/CMAR.S297457] [Reference Citation Analysis]
707 Hou ZL, Kang Y, Yang GZ, Wang Z, Wang F, Yu YX, Chen WM, Shi HZ. Pleural effusion-based nomogram to predict outcomes in unselected patients with multiple myeloma: a large single center experience. Ann Hematol 2021;100:1789-801. [PMID: 33715037 DOI: 10.1007/s00277-021-04484-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
708 Sneha S, Baker SC, Green A, Storr S, Aiyappa R, Martin S, Pors K. Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies. Biomedicines 2021;9:290. [PMID: 33809117 DOI: 10.3390/biomedicines9030290] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
709 Wang J, Wang C, Xu P, Li X, Lu Y, Jin D, Yin X, Jiang H, Huang J, Xiong H, Ye F, Jin J, Chen Y, Xie Y, Chen Z, Ding H, Zhang H, Liu R, Jiang H, Chen K, Yao Z, Luo C, Huang Y, Zhang Y, Zhang J. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Theranostics 2021;11:5387-403. [PMID: 33859753 DOI: 10.7150/thno.42345] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
710 Xie C, Wu H, Pan T, Zheng X, Yang X, Zhang G, Lian Y, Lin J, Peng L. A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma. Aging (Albany NY) 2021;13:8563-87. [PMID: 33714200 DOI: 10.18632/aging.202670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
711 Xi K, Yu H. Proposed Modification of the pN2 Classification of the 8th Edition AJCC Staging System for Esophageal Squamous Cell Carcinoma: A Preliminary Study Based on the Chinese Population. J Oncol 2021;2021:8871884. [PMID: 33777143 DOI: 10.1155/2021/8871884] [Reference Citation Analysis]
712 Gao B, Zhou D, Qian X, Jiang Y, Liu Z, Zhang W, Wang W. Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms. Front Endocrinol (Lausanne) 2021;12:613755. [PMID: 33746899 DOI: 10.3389/fendo.2021.613755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
713 Feng Z, Li K, Lou J, Ma M, Wu Y, Peng C. A Novel DNA Replication-Related Signature Predicting Recurrence After R0 Resection of Pancreatic Ductal Adenocarcinoma: Prognostic Value and Clinical Implications. Front Cell Dev Biol 2021;9:619549. [PMID: 33748108 DOI: 10.3389/fcell.2021.619549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
714 Liu Y, Wu Y, Zhang P, Xu C, Liu Z, He C, Liu Y, Kang Z. CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes. Front Oncol 2021;11:636870. [PMID: 33747959 DOI: 10.3389/fonc.2021.636870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
715 Yue G, Deyu L, Lianyuan T, Fengmin S, Mei G, Yajun H, Wenwen Z, Lei Y. Clinical features and prognostic factors of patients with metastatic renal cell carcinoma stratified by age. Aging (Albany NY) 2021;13:8290-305. [PMID: 33686965 DOI: 10.18632/aging.202637] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
716 Li C, Li J, Huang Q, Feng X, Zhao F, Xu F, Han D, Lyu J. Developing and validating a novel nomogram used a competing-risks model for predicting the prognosis of primary fallopian tube carcinoma: a retrospective study based on the SEER database. Ann Transl Med 2021;9:378. [PMID: 33842599 DOI: 10.21037/atm-20-5398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
717 Ma E, Li J, Xing H, Li R, Shen C, Zhang Q, Ma Z, Tao Y, Qin L, Zhao J, Wang Z. Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation. Ann Transl Med 2021;9:468. [PMID: 33850865 DOI: 10.21037/atm-21-334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
718 Li X, Chen Q, Bi X, Zhao J, Li Z, Zhou J, Huang Z, Zhang Y, Mao R, Zhao H, Cai J. Preoperatively elevated RDW-SD and RDW-CV predict favorable survival in intrahepatic cholangiocarcinoma patients after curative resection. BMC Surg 2021;21:105. [PMID: 33648470 DOI: 10.1186/s12893-021-01094-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
719 Lianyuan T, Deyu L, Haibo Y, Yadong D, Guanjing T. Clinical features and prognostic factors of elderly patients with metastatic pancreatic cancer: a population-based study. Aging (Albany NY) 2021;13:7133-46. [PMID: 33639615 DOI: 10.18632/aging.202570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
720 Liu C, Hu C, Huang J, Xiang K, Li Z, Qu J, Chen Y, Yang B, Qu X, Liu Y, Zhang G, Wen T. A Prognostic Nomogram of Colon Cancer With Liver Metastasis: A Study of the US SEER Database and a Chinese Cohort. Front Oncol 2021;11:591009. [PMID: 33738248 DOI: 10.3389/fonc.2021.591009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
721 Guo J, Zhang S, Li H, Hassan MOO, Lu T, Zhao J, Zhang L. Lung Metastases in Newly Diagnosed Esophageal Cancer: A Population-Based Study. Front Oncol 2021;11:603953. [PMID: 33718154 DOI: 10.3389/fonc.2021.603953] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
722 Jiang S, Wu H, Fu R, Mai J, Yao J, Hua X, Chen H, Liu J, Lu M, Li N. The Outcome of Primary Hepatic Carcinoid Tumor: A Retrospective Study Based on Propensity Score Matched Survival Analysis. Front Oncol 2021;11:609397. [PMID: 33718162 DOI: 10.3389/fonc.2021.609397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
723 Li WC, Wang Z, Gao J, Zhou H, Li J, Zhu XX. Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer. Cancer Manag Res 2021;13:1887-96. [PMID: 33654433 DOI: 10.2147/CMAR.S287993] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
724 Zhang Q, Qiao L, Liao J, Liu Q, Liu P, Liu L. A novel hypoxia gene signature indicates prognosis and immune microenvironments characters in patients with hepatocellular carcinoma. J Cell Mol Med 2021;25:3772-84. [PMID: 33616276 DOI: 10.1111/jcmm.16249] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
725 Zhou Z, Liang M, Wu H, Huang S, Weng R, Hou J, Wu Z. Preoperative Lymphocyte-to-Monocyte Ratio as a Prognostic Predictor of Long-Term Mortality in Cardiac Surgery Patients: A Propensity Score Matching Analysis. Front Cardiovasc Med 2021;8:639890. [PMID: 33693038 DOI: 10.3389/fcvm.2021.639890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
726 Zheng ZY, Yang PL, Luo W, Yu SX, Xu HY, Huang Y, Li RY, Chen Y, Xu XE, Liao LD, Wang SH, Huang HC, Li EM, Xu LY. STAT3β Enhances Sensitivity to Concurrent Chemoradiotherapy by Inducing Cellular Necroptosis in Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2021;13:901. [PMID: 33670049 DOI: 10.3390/cancers13040901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
727 Huang J, Yang Y, Xia Y, Liu FC, Liu L, Zhu P, Yuan SX, Gu FM, Fu SY, Zhou WP, Liu H, Jiang BG, Pan ZY. Prediction of Patient Survival Following Hepatic Resection in Early-Stage Hepatocellular Carcinoma with Indexed Ratios of Aspartate Aminotransferase to Platelets: A Retrospective Cohort Study. Cancer Manag Res 2021;13:1733-46. [PMID: 33642875 DOI: 10.2147/CMAR.S284950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
728 Zhuang H, Chen X, Dong F, Zhang Z, Zhou Z, Ma Z, Huang S, Chen B, Zhang C, Hou B. Prognostic values and immune suppression of the S100A family in pancreatic cancer. J Cell Mol Med 2021;25:3006-18. [PMID: 33580614 DOI: 10.1111/jcmm.16343] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
729 Liu S, Yu G, Liu L, Zou X, Zhou L, Hu E, Song Y. Identification of Prognostic Stromal-Immune Score-Based Genes in Hepatocellular Carcinoma Microenvironment. Front Genet 2021;12:625236. [PMID: 33643387 DOI: 10.3389/fgene.2021.625236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
730 Dong W, Yan K, Yu H, Huo L, Xian Z, Zhao Y, Li J, Zhang Y, Cao Z, Fu Y, Cong W, Dong H. Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy. Front Oncol 2020;10:605057. [PMID: 33643907 DOI: 10.3389/fonc.2020.605057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
731 Guo T, Bai YH, Cheng XJ, Han HB, Du H, Hu Y, Jia SQ, Xing XF, Ji JF. Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4. Cancer Commun (Lond) 2021;41:258-72. [PMID: 33570246 DOI: 10.1002/cac2.12141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
732 Wu C, Lin J, Weng Y, Zeng DN, Xu J, Luo S, Xu L, Liu M, Hua Q, Liu CQ, Li JQ, Liao J, Sun C, Zhou J, Chen MS, Liu C, Guo Z, Zhuang SM, Huang JH, Zheng L. Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma. J Clin Invest 2020;130:4679-93. [PMID: 32497024 DOI: 10.1172/JCI135048] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
733 Yu ZL, Chen YF, Zheng B, Cai ZR, Zou YF, Ke J, Lan P, Gao F, Wu XJ. Protein-protein interaction analysis reveals a novel cancer stem cell related target TMEM17 in colorectal cancer. Cancer Cell Int 2021;21:94. [PMID: 33549114 DOI: 10.1186/s12935-021-01794-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
734 Tsilimigras DI, Sahara K, Wu L, Moris D, Bagante F, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Moro A, Sasaki K, Aucejo F, Zhang XF, Matsuyama R, Endo I, Pawlik TM. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches. JAMA Surg 2020;155:823-31. [PMID: 32639548 DOI: 10.1001/jamasurg.2020.1973] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 27.0] [Reference Citation Analysis]
735 Liu B, Chen X, Zhan Y, Wu B, Pan S. Identification of a Gene Signature for Renal Cell Carcinoma-Associated Fibroblasts Mediating Cancer Progression and Affecting Prognosis. Front Cell Dev Biol 2020;8:604627. [PMID: 33634098 DOI: 10.3389/fcell.2020.604627] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
736 Zhao L, Zhang J, Xuan S, Liu Z, Wang Y, Zhao P. Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma. Front Cell Dev Biol 2021;9:600506. [PMID: 33614641 DOI: 10.3389/fcell.2021.600506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
737 Liang JY, Lin HC, Liu J, Wang DS, Yuan YF, Li BK, Zheng Y, Wu XJ, Chen G, Wang FH, Wang ZQ, Pan ZZ, Wan DS, Xu RH, Li YH. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy. Cancer Med 2021;10:1535-44. [PMID: 33539664 DOI: 10.1002/cam4.3697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
738 Liu J, Lian T, Chen H, Wang X, Quan X, Deng Y, Yao J, Lu M, Ye Q, Feng Q, Zhao Y. Pretreatment Prediction of Relapse Risk in Patients with Osteosarcoma Using Radiomics Nomogram Based on CT: A Retrospective Multicenter Study. Biomed Res Int 2021;2021:6674471. [PMID: 33614787 DOI: 10.1155/2021/6674471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
739 Zhu Z, Song Z, Jiao W, Mei W, Xu C, Huang Q, An C, Shi J, Wang W, Yu G, Sun P, Zhang Y, Shen J, Song Y, Qian J, Yao W, Yang H; written on behalf of AME Lung Cancer Collaborative Group. A large real-world cohort study of examined lymph node standards for adequate nodal staging in early non-small cell lung cancer. Transl Lung Cancer Res 2021;10:815-25. [PMID: 33718024 DOI: 10.21037/tlcr-20-1024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
740 Li W, Jin X, Guo S, Xu F, Su X, Jiang X, Wang G. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer. Aging (Albany NY) 2021;13:5506-24. [PMID: 33536348 DOI: 10.18632/aging.202479] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
741 Ni X, Ma X, Qiu J, Zhou S, Cheng W, Luo C. Development and validation of a novel nomogram to predict cancer-specific survival in patients with uterine cervical adenocarcinoma. Ann Transl Med 2021;9:293. [PMID: 33708920 DOI: 10.21037/atm-20-6201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
742 Chen C, Yang H, Cai D, Xiang L, Fang W, Wang R. Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer. Transl Lung Cancer Res 2021;10:866-77. [PMID: 33718028 DOI: 10.21037/tlcr-20-997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
743 Zhang Y, Xu M, Sun Y, Chen Y, Chi P, Xu Z, Lu X. Identification of LncRNAs Associated With FOLFOX Chemoresistance in mCRC and Construction of a Predictive Model. Front Cell Dev Biol 2020;8:609832. [PMID: 33585448 DOI: 10.3389/fcell.2020.609832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
744 Peng X, Lei C, He A, Luo R, Cai Y, Dong W. Upregulation of phosphatidylinositol glycan anchor biosynthesis class C is associated with unfavorable survival prognosis in patients with hepatocellular carcinoma. Oncol Lett 2021;21:237. [PMID: 33613726 DOI: 10.3892/ol.2021.12498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
745 Gu J, Zhang S, He X, Chen S, Wang Y. High expression of PIG11 correlates with poor prognosis in gastric cancer. Exp Ther Med 2021;21:249. [PMID: 33603857 DOI: 10.3892/etm.2021.9680] [Reference Citation Analysis]
746 Lebovitz C, Wretham N, Osooly M, Milne K, Dash T, Thornton S, Tessier-Cloutier B, Sathiyaseelan P, Bortnik S, Go NE, Halvorsen E, Cederberg RA, Chow N, Dos Santos N, Bennewith KL, Nelson BH, Bally MB, Lam WL, Gorski SM. Loss of Parkinson's susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis. Sci Rep 2021;11:2097. [PMID: 33483550 DOI: 10.1038/s41598-021-81639-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
747 Trejo-Avila M, Bozada-Gutiérrez K, Valenzuela-Salazar C, Herrera-Esquivel J, Moreno-Portillo M. Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2021;36:1077-96. [PMID: 33481108 DOI: 10.1007/s00384-021-03839-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 22.5] [Reference Citation Analysis]
748 Kang J, Lee JH, Lee HS, Cho ES, Park EJ, Baik SH, Lee KY, Park C, Yeu Y, Clemenceau JR, Park S, Xu H, Hong C, Hwang TH. Radiomics Features of 18F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer. Cancers (Basel) 2021;13:392. [PMID: 33494345 DOI: 10.3390/cancers13030392] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
749 Kawata A, Taguchi A, Baba S, Miyamoto Y, Tanikawa M, Sone K, Tsuruga T, Mori M, Oda K, Kawana K, Osuga Y, Fujii T. A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancer. Int J Clin Oncol 2021;26:980-5. [PMID: 33479852 DOI: 10.1007/s10147-021-01861-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
750 Cao Y, Deng S, Yan L, Gu J, Yang J, Yang M, Liu L, Cai K. A nomogram based on pretreatment levels of serum bilirubin and total bile acid levels predicts survival in colorectal cancer patients. BMC Cancer 2021;21:85. [PMID: 33478423 DOI: 10.1186/s12885-021-07805-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
751 Wu M, Li S, Han J, Liu R, Yuan H, Xu X, Li X, Liu Z. Progression Risk Assessment of Post-surgical Papillary Thyroid Carcinoma Based on Circular RNA-Associated Competing Endogenous RNA Mechanisms. Front Cell Dev Biol 2020;8:606327. [PMID: 33553144 DOI: 10.3389/fcell.2020.606327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
752 Sun Y, Zhang Y, Huang Z, Lin H, Lu X, Huang Y, Chi P. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy. World J Surg 2020;44:1975-84. [PMID: 32020327 DOI: 10.1007/s00268-020-05407-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
753 Huang RD, Sun Z, Wang XH, Tian YM, Peng YL, Wang JY, Xiao WW, Chen CY, Deng XW, Han F. Development of a Comorbidity-Based Nomogram to Predict Survival After Salvage Reirradiation of Locally Recurrent Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era. Front Oncol 2020;10:625184. [PMID: 33552995 DOI: 10.3389/fonc.2020.625184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
754 Xi K, Yu H. A Comparison of the Current N2 Classification and a Modified N2 Categorization in TNM Staging of Esophageal Cancer Patients. Front Oncol 2020;10:561363. [PMID: 33552951 DOI: 10.3389/fonc.2020.561363] [Reference Citation Analysis]
755 He LN, Zhang X, Li H, Chen T, Chen C, Zhou Y, Lin Z, Du W, Fang W, Yang Y, Huang Y, Zhao H, Hong S, Zhang L. Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy. Front Oncol 2020;10:621329. [PMID: 33552993 DOI: 10.3389/fonc.2020.621329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
756 Kai L, Zhoumiao C, Shaohua X, Zhao C, Zhijun L, Zhengfu H, Xiujun C. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis. J Cardiothorac Surg 2021;16:13. [PMID: 33468199 DOI: 10.1186/s13019-020-01390-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
757 Zhong Q, Shi Y. Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma. Front Oncol 2020;10:582567. [PMID: 33520698 DOI: 10.3389/fonc.2020.582567] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
758 Cao Y, Deng S, Yan L, Gu J, Mao F, Xue Y, Zheng C, Yang M, Liu H, Liu L, Liu Q, Cai K. An Oxidative Stress Index-Based Score for Prognostic Prediction in Colorectal Cancer Patients Undergoing Surgery. Oxid Med Cell Longev 2021;2021:6693707. [PMID: 33505587 DOI: 10.1155/2021/6693707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
759 Shen M, Zhang Z, Wang P. GLI3 Promotes Invasion and Predicts Poor Prognosis in Colorectal Cancer. Biomed Res Int 2021;2021:8889986. [PMID: 33506047 DOI: 10.1155/2021/8889986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
760 Li Y, Zhang Y, Fang Q, Zhang X, Hou P, Wu H, Wang X. Radiomics analysis of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 2021;48:2599-614. [PMID: 33416951 DOI: 10.1007/s00259-020-05119-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
761 Chen D, Liu Z, Liu W, Fu M, Jiang W, Xu S, Wang G, Chen F, Lu J, Chen H, Dong X, Li G, Chen G, Zhuo S, Yan J. Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram. Nat Commun 2021;12:179. [PMID: 33420057 DOI: 10.1038/s41467-020-20429-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
762 Wang J, Zheng X, Zhang J, Xue H, Wang L, Jing R, Chen S, Che F, Heng X, Li G, Xue F. An MRI-based radiomics signature as a pretreatment noninvasive predictor of overall survival and chemotherapeutic benefits in lower-grade gliomas. Eur Radiol 2021;31:1785-94. [PMID: 33409797 DOI: 10.1007/s00330-020-07581-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
763 Zhao CC, Guo H, Wang Y, Li JH. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma. Hum Cell 2021;34:654-66. [PMID: 33400243 DOI: 10.1007/s13577-020-00473-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
764 Cui Y, Li Q, Li W, Wang Y, Lv F, Shi X, Tang Z, Shen Z, Hou Y, Zhang H, Mao B, Liu T. NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer. Front Oncol 2020;10:574937. [PMID: 33479597 DOI: 10.3389/fonc.2020.574937] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
765 Mo X, Zhou M, Yan H, Chen X, Wang Y. Competing risk analysis of cardiovascular/cerebrovascular death in T1/2 kidney cancer: a SEER database analysis. BMC Cancer 2021;21:13. [PMID: 33402111 DOI: 10.1186/s12885-020-07718-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
766 Tian P, He B, Mu W, Liu K, Liu L, Zeng H, Liu Y, Jiang L, Zhou P, Huang Z, Dong D, Li W. Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images. Theranostics 2021;11:2098-107. [PMID: 33500713 DOI: 10.7150/thno.48027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
767 Chen Q, Li X, Zhao J, Bi X, Li Z, Huang Z, Zhang Y, Zhou J, Zhao H, Cai J. What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases? Ann Transl Med 2021;9:7. [PMID: 33553300 DOI: 10.21037/atm-20-4289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
768 Zhao S, Hou D, Zheng X, Song W, Liu X, Wang S, Zhou L, Tao X, Lv L, Sun Q, Jin Y, Ding L, Mao L, Wu N. MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer. Transl Lung Cancer Res 2021;10:368-80. [PMID: 33569319 DOI: 10.21037/tlcr-20-361] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
769 Chen Q, Fu WJ, Tang XP, Wang L, Niu Q, Wang S, Lin Y, Cao MF, Hu R, Wen HY, Wang Y, Zhang X, Yao XH. ADP-Ribosylation Factor Like GTPase 4C (ARL4C) augments stem-like traits of glioblastoma cells by upregulating ALDH1A3. J Cancer 2021;12:818-26. [PMID: 33403039 DOI: 10.7150/jca.45052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
770 Yu B, Liang H, Ye Q, Wang Y. Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection. J Gastrointest Surg 2021;25:112-24. [PMID: 32128678 DOI: 10.1007/s11605-020-04554-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
771 Li P, Song L. A novel prognostic nomogram for patients with surgically resected perihilar cholangiocarcinoma: a SEER-based study. Ann Transl Med 2021;9:54. [PMID: 33553347 DOI: 10.21037/atm-20-3130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
772 Wu W, Zhang H, Fang Z, Li F. Primary tumor surgery improves survival of cancer patients with synchronous solitary bone metastasis: a large population-based study. Ann Transl Med 2021;9:31. [PMID: 33553324 DOI: 10.21037/atm-20-4764] [Reference Citation Analysis]
773 Yao JH, Shao Y, Wang JJ, Li YL, Yang HQ, Liu J, Yang Y. Evaluation of diagnostic and predictive values of the serum VEGF-A level and systemic immune-inflammation index in small cell lung cancer. J Cancer 2021;12:1356-64. [PMID: 33531980 DOI: 10.7150/jca.51972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
774 Ma Y, Lin J, Lin J, Hou J, Xiao Q, Yu F, Ma Z, Li P, Tu R, Xie J, Zheng C, Yan S, Huang C. A novel prognosis marker based on combined preoperative carcinoembryonic antigen and systemic inflammatory response for resectable gastric cancer. J Cancer 2021;12:927-35. [PMID: 33403049 DOI: 10.7150/jca.52299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
775 Lin Z, Lin H, Chen Y, Xu Y, Chen X, Fan H, Wu X, Ke X, Lin C. Long-term survival trend after primary total laryngectomy for patients with locally advanced laryngeal carcinoma. J Cancer 2021;12:1220-30. [PMID: 33442420 DOI: 10.7150/jca.50404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
776 Lin JX, Wang ZK, Huang YQ, Xie JW, Wang JB, Lu J, Chen QY, Lin M, Tu RH, Huang ZN, Lin JL, Zheng CH, Huang CM, Li P. Dynamic Changes in Pre- and Postoperative Levels of Inflammatory Markers and Their Effects on the Prognosis of Patients with Gastric Cancer. J Gastrointest Surg 2021;25:387-96. [PMID: 32016671 DOI: 10.1007/s11605-020-04523-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
777 Tan X, Chen D, Guo S, Wang Y, Zou Y, Wu Z, Zhou F, Qin Z, Liu Z, Cao Y, Lin C, Yuan G, Yao K. Molecular stratification by BCL2A1 and AIM2 provides additional prognostic value in penile squamous cell carcinoma. Theranostics 2021;11:1364-76. [PMID: 33391539 DOI: 10.7150/thno.51725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
778 Xie JB, Pang YS, Li X, Wu XT. Role of Removed Lymph Nodes on the Prognosis of M0 Small-Bowel Neuroendocrine Tumors: a Propensity Score Matching Analysis from SEER Database. J Gastrointest Surg 2021;25:3188-97. [PMID: 34109533 DOI: 10.1007/s11605-021-04994-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
779 Hui Y, Li Y, Tong X, Wang Z, Mao X, Huang L, Zhang D. The risk factors for mortality of diabetic patients with severe COVID-19: A retrospective study of 167 severe COVID-19 cases in Wuhan. PLoS One 2020;15:e0243602. [PMID: 33382747 DOI: 10.1371/journal.pone.0243602] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
780 Martinez-Morilla S, Zugazagoitia J, Wong PF, Kluger HM, Rimm DL. Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy. Oncoimmunology 2020;10:1864909. [PMID: 33457084 DOI: 10.1080/2162402X.2020.1864909] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
781 Chen YH, Wang TF, Chu SC, Lin CB, Wang LY, Lue KH, Liu SH, Chan SC. Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma. PLoS One 2020;15:e0244502. [PMID: 33370365 DOI: 10.1371/journal.pone.0244502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
782 Fu J, Zhu J, Du F, Zhang L, Li D, Huang H, Tian T, Liu Y, Zhang L, Liu Y, Zhang Y, Xu J, Meng S, Jia C, Sun S, Li X, Zhao L, Zhang D, Kang L, Gao L, Zheng T, Cai S, Liu Y, Zhao Y. Prognostic Inflammatory Index Based on Preoperative Peripheral Blood for Predicting the Prognosis of Colorectal Cancer Patients. Cancers (Basel) 2020;13:E3. [PMID: 33374924 DOI: 10.3390/cancers13010003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
783 Ni XC, Yi Y, Fu YP, Cai XY, Liu G, Huang JL, Gan W, Xu J, Qiu SJ. Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection. Onco Targets Ther 2020;13:12867-80. [PMID: 33376344 DOI: 10.2147/OTT.S279997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
784 Song Z, Wang Y, Zhou Y, Zhang D. A Novel Predictive Tool for Determining the Risk of Early Death From Stage IV Endometrial Carcinoma: A Large Cohort Study. Front Oncol 2020;10:620240. [PMID: 33381462 DOI: 10.3389/fonc.2020.620240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
785 Wang J, Zheng H, Han Y, Wang G, Li Y. A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer. Int J Genomics 2020;2020:4535820. [PMID: 33381538 DOI: 10.1155/2020/4535820] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
786 Parvathareddy SK, Siraj AK, Annaiyappanaidu P, Al-Sobhi SS, Al-Dayel F, Al-Kuraya KS. Prognostic Significance of COX-2 Overexpression in BRAF-Mutated Middle Eastern Papillary Thyroid Carcinoma. Int J Mol Sci 2020;21:E9498. [PMID: 33327467 DOI: 10.3390/ijms21249498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
787 Wu C, Rao X, Lin W. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma. Cancer Med 2021;10:806-23. [PMID: 33314730 DOI: 10.1002/cam4.3655] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
788 Tang L, Chen Y, Peng X, Zhou Y, Jiang H, Wang G, Zhuang W. Identification and Validation of Potential Pathogenic Genes and Prognostic Markers in ESCC by Integrated Bioinformatics Analysis. Front Genet 2020;11:521004. [PMID: 33362844 DOI: 10.3389/fgene.2020.521004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
789 Jia B, Zhang X, Mo Y, Chen B, Long H, Rong T, Su X. The Study of Tumor Volume as a Prognostic Factor in T Staging System for Non-Small Cell Lung Cancer: An Exploratory Study. Technol Cancer Res Treat 2020;19:153303382098010. [DOI: 10.1177/1533033820980106] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
790 Li M, Hu J, Jin R, Cheng H, Chen H, Li L, Guo K. Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2020;7:361-76. [PMID: 33324588 DOI: 10.2147/JHC.S279123] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
791 Wang M, Jing X, Cao W, Zeng Y, Wu C, Zeng W, Chen W, Hu X, Zhou Y, Cai X. A non-lab nomogram of survival prediction in home hospice care patients with gastrointestinal cancer. BMC Palliat Care 2020;19:185. [PMID: 33287827 DOI: 10.1186/s12904-020-00690-2] [Reference Citation Analysis]
792 Gong PJ, Shao YC, Huang SR, Zeng YF, Yuan XN, Xu JJ, Yin WN, Wei L, Zhang JW. Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer. Front Oncol 2020;10:579868. [PMID: 33344235 DOI: 10.3389/fonc.2020.579868] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
793 Song J, Wang L, Ng NN, Zhao M, Shi J, Wu N, Li W, Liu Z, Yeom KW, Tian J. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer. JAMA Netw Open 2020;3:e2030442. [PMID: 33331920 DOI: 10.1001/jamanetworkopen.2020.30442] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
794 Zhu C, Wang X, Yang X, Sun J, Pan B, Zhang W, Chen X, Shen X. Preoperative Albumin-Bilirubin Grade as a Prognostic Predictor in Colorectal Cancer Patients Who Undergo Radical Resection. Cancer Manag Res 2020;12:12363-74. [PMID: 33293863 DOI: 10.2147/CMAR.S285212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
795 Tsilimigras DI, Moris D, Mehta R, Paredes AZ, Sahara K, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Endo I, Pawlik TM. The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis. HPB (Oxford) 2020;22:1667-74. [PMID: 32265108 DOI: 10.1016/j.hpb.2020.03.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
796 Fan R, Papatheodoridis G, Sun J, Innes H, Toyoda H, Xie Q, Mo S, Sypsa V, Guha IN, Kumada T, Niu J, Dalekos G, Yasuda S, Barnes E, Lian J, Suri V, Idilman R, Barclay ST, Dou X, Berg T, Hayes PC, Flaherty JF, Zhou Y, Zhang Z, Buti M, Hutchinson SJ, Guo Y, Calleja JL, Lin L, Zhao L, Chen Y, Janssen HLA, Zhu C, Shi L, Tang X, Gaggar A, Wei L, Jia J, Irving WL, Johnson PJ, Lampertico P, Hou J. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. J Hepatol 2020;73:1368-78. [PMID: 32707225 DOI: 10.1016/j.jhep.2020.07.025] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 24.0] [Reference Citation Analysis]
797 Wu H, Huang Y. Negative lymph node count is an independent prognostic factor for female patients with node positive breast cancer. Transl Cancer Res 2020;9:7450-7. [PMID: 35117345 DOI: 10.21037/tcr-20-2351] [Reference Citation Analysis]
798 Huang J, Wu N, Xiang Y, Wu L, Li C, Yuan Z, Jia X, Zhang Z, Zhong L, Li Y. Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation. Int J Cardiol 2020;320:83-9. [PMID: 32603741 DOI: 10.1016/j.ijcard.2020.06.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
799 Zhu C, Wang X, Chen S, Yang X, Sun J, Pan B, Zhang W, Chen X, Huang Y. Efficacy of the Preoperative Albumin-Bilirubin Grade for Predicting Survival and Outcomes of Postoperative Chemotherapy for Advanced Gastric Cancer. Cancer Manag Res 2020;12:11921-32. [PMID: 33244269 DOI: 10.2147/CMAR.S279782] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
800 Song Z, Wang Y, Zhang D, Zhou Y. A Novel Tool to Predict Early Death in Uterine Sarcoma Patients: A Surveillance, Epidemiology, and End Results-Based Study. Front Oncol 2020;10:608548. [PMID: 33324570 DOI: 10.3389/fonc.2020.608548] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
801 Yu Y, Liu Y, Ling X, Huang R, Wang S, Min J, Xiao J, Zhang Y, Wang Z. The Neutrophil Percentage-to-Albumin Ratio as a New Predictor of All-Cause Mortality in Patients with Cardiogenic Shock. Biomed Res Int 2020;2020:7458451. [PMID: 33294452 DOI: 10.1155/2020/7458451] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
802 Parks RM, Albanghali MA, Syed BM, Green AR, Ellis IO, Cheung KL. Patterns of biomarker expression in patients treated with primary endocrine therapy - a unique insight using core needle biopsy tissue microarray. Breast Cancer Res Treat 2021;185:647-55. [PMID: 33226492 DOI: 10.1007/s10549-020-06023-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
803 Chen L, Wang Y, Zhao K, Wang Y, He X. Postoperative Nomogram for Predicting Cancer-Specific and Overall Survival among Patients with Medullary Thyroid Cancer. Int J Endocrinol 2020;2020:8888677. [PMID: 33299412 DOI: 10.1155/2020/8888677] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
804 Wang X, Xu W, Chi Z, Si L, Sheng X, Kong Y, Zhou L, Mao L, Lian B, Tang B, Yan X, Bai X, Cui C, Guo J. Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy. Transl Oncol 2021;14:100949. [PMID: 33221685 DOI: 10.1016/j.tranon.2020.100949] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
805 Xing L, Xia M, Jiao X, Fan L. Hsa_circ_0004831 serves as a blood-based prognostic biomarker for colorectal cancer and its potentially circRNA-miRNA-mRNA regulatory network construction. Cancer Cell Int 2020;20:557. [PMID: 33292256 DOI: 10.1186/s12935-020-01651-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
806 Yang L, Zhang J, Song Y, Yang G, Xu H, Li J, Guo L, Li X, Shi X, Mao B, Yang Y, Wu L, Wei J, Zhang H, Ying J, Wang Y. Genomic profile and immune microenvironment in patients with relapsed stage IA lung adenocarcinoma. Transl Oncol 2021;14:100942. [PMID: 33221686 DOI: 10.1016/j.tranon.2020.100942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
807 Zhuang H, Zhou Z, Ma Z, Huang S, Gong Y, Zhang Z, Hou B, Yu W, Zhang C. Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection. Front Oncol 2020;10:556489. [PMID: 33312945 DOI: 10.3389/fonc.2020.556489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
808 Fan J, Qin K, Li K, Li X, Huang Q, Liao Y, Liang H, Xie J, Yang Y, Li Q. Modified endometriosis fertility index is more accurate to predict the non-ART pregnancy rate following surgery: a cohort of Chinese women. Arch Gynecol Obstet 2021;303:1353-61. [PMID: 33200306 DOI: 10.1007/s00404-020-05871-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
809 Liu YZ, Han DT, Shi DR, Hong B, Qian Y, Wu ZG, Yao SH, Tang TM, Wang MH, Xu XM, Yao HP. Pathological significance of abnormal recepteur d’origine nantais and programmed death ligand 1 expression in colorectal cancer. World J Gastrointest Oncol 2020; 12(11): 1216-1236 [PMID: 33250957 DOI: 10.4251/wjgo.v12.i11.1216] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
810 Xu S, Chen T, Dong L, Li T, Xue H, Gao B, Ding X, Wang H, Li H. Fatty acid synthase promotes breast cancer metastasis by mediating changes in fatty acid metabolism. Oncol Lett 2021;21:27. [PMID: 33240433 DOI: 10.3892/ol.2020.12288] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
811 Verma R, Correa R, Hill VB, Statsevych V, Bera K, Beig N, Mahammedi A, Madabhushi A, Ahluwalia M, Tiwari P. Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study. Radiol Artif Intell 2020;2:e190168. [PMID: 33330847 DOI: 10.1148/ryai.2020190168] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
812 Lin H, Wu Y, Liang G, Chen L. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery. PLoS One 2020;15:e0242155. [PMID: 33170907 DOI: 10.1371/journal.pone.0242155] [Reference Citation Analysis]
813 Pan B, Liu L, Li W. A prognostic risk model based on immune-related genes predicts overall survival of patients with hepatocellular carcinoma. Health Sci Rep 2020;3:e202. [PMID: 33204848 DOI: 10.1002/hsr2.202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
814 Liu H, Lv L, Qu Y, Zheng Z, Zhao J, Liu B, Zhang D, Wang H, Zhang J. Prediction of cancer-specific survival and overall survival in middle-aged and older patients with rectal adenocarcinoma using a nomogram model. Transl Oncol 2021;14:100938. [PMID: 33186890 DOI: 10.1016/j.tranon.2020.100938] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
815 Chen NB, Li QW, Zhu ZF, Wang YM, Cheng ZJ, Hui ZG, Guo SP, He HQ, Wang B, Huang XY, Li JB, Guo JY, Hu N, Ai XL, Zhou Y, Wang DQ, Liu FJ, Xie CM, Qiu B, Liu H. Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. Radiat Oncol 2020;15:260. [PMID: 33168045 DOI: 10.1186/s13014-020-01704-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
816 Liu F, Guo X, Dong W, Zhang W, Wei S, Zhang S, Zhu X, Zhou W, Zhang J, Liu H. Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein Tumor Thrombus after Liver Resection. Int J Biol Sci 2020;16:3210-20. [PMID: 33162826 DOI: 10.7150/ijbs.46896] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
817 Elsharawy KA, Althobiti M, Mohammed OJ, Aljohani AI, Toss MS, Green AR, Rakha EA. Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer. Breast Cancer Res Treat 2021;185:615-27. [PMID: 33161513 DOI: 10.1007/s10549-020-05999-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
818 Ha SY, Yeo SY, Lee KW, Kim SH. Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma. J Cancer Res Clin Oncol 2021;147:423-33. [PMID: 33161447 DOI: 10.1007/s00432-020-03437-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
819 Qi X, Fu Y, Zhang M, Lu C, Wang Y, Peng J, Li G. An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer. Biomed Res Int 2020;2020:8882576. [PMID: 33224983 DOI: 10.1155/2020/8882576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
820 Bian J, Long JY, Yang X, Yang XB, Xu YY, Lu X, Sang XT, Zhao HT. Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer. World J Gastroenterol 2020; 26(41): 6414-6430 [PMID: 33244202 DOI: 10.3748/wjg.v26.i41.6414] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
821 Mu W, Liang Y, Hall LO, Tan Y, Balagurunathan Y, Wenham R, Wu N, Tian J, Gillies RJ. 18F-FDG PET/CT Habitat Radiomics Predicts Outcome of Patients with Cervical Cancer Treated with Chemoradiotherapy. Radiol Artif Intell 2020;2:e190218. [PMID: 33937845 DOI: 10.1148/ryai.2020190218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
822 Zhang Y, Wu Z, Chang J, Jiang W, Wang Y, Wang H, Li J, Li C, Li X. An updated incidence trends of soft-tissue sarcoma and cancer-specific survival of patients with primary soft-tissue sarcoma of liver: a population-based study. Expert Rev Gastroenterol Hepatol 2021;15:689-98. [PMID: 33115276 DOI: 10.1080/17474124.2021.1842193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
823 Gao (高静伟) JW, Hao (郝卿鋆) QY, Zhang (张海峰) HF, Li (李雄志) XZ, Yuan (袁智敏) ZM, Guo (郭颖) Y, Wang (王景峰) JF, Zhang (张少玲) SL, Liu (刘品明) PM. Low-Carbohydrate Diet Score and Coronary Artery Calcium Progression: Results From the CARDIA Study. Arterioscler Thromb Vasc Biol 2021;41:491-500. [PMID: 33115269 DOI: 10.1161/ATVBAHA.120.314838] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
824 Zheng Y, Huang Y, Bi G, Chen Z, Lu T, Xu S, Zhan C, Wang Q. Enlarged Mediastinal Lymph Nodes in Computed Tomography are a Valuable Prognostic Factor in Non-Small Cell Lung Cancer Patients with Pathologically Negative Lymph Nodes. Cancer Manag Res 2020;12:10875-86. [PMID: 33149692 DOI: 10.2147/CMAR.S271365] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
825 Liu Y, Huang H, Fu J, Zhang Y, Xu J, Zhang L, Sun S, Zhao L, Zhang D, Onwuka JU, Sun H, Cui B, Zhao Y. Colorectal cancer patients with CASK promotor heterogeneous and homogeneous methylation display different prognosis. Aging (Albany NY) 2020;12:20561-86. [PMID: 33113509 DOI: 10.18632/aging.103928] [Reference Citation Analysis]
826 Zhao LY, Zhao YL, Wang JJ, Zhao QD, Yi WQ, Yuan Q, Chen XZ, Li Y, Yang K, Chen XL, Zhang WH, Liu K, Pang HY, Galiullin D, Wang H, Sun LF, Song XH, Zheng JB, Yao XQ, Zhou ZG, Yu PW, Hu JK. Is Preoperative Fibrinogen Associated with the Survival Prognosis of Gastric Cancer Patients? A Multi-centered, Propensity Score-Matched Retrospective Study. World J Surg 2020;44:213-22. [PMID: 31637507 DOI: 10.1007/s00268-019-05191-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
827 Vercellino L, Cottereau AS, Casasnovas O, Tilly H, Feugier P, Chartier L, Fruchart C, Roulin L, Oberic L, Pica GM, Ribrag V, Abraham J, Simon M, Gonzalez H, Bouabdallah R, Fitoussi O, Sebban C, López-Guillermo A, Sanhes L, Morschhauser F, Trotman J, Corront B, Choufi B, Snauwaert S, Godmer P, Briere J, Salles G, Gaulard P, Meignan M, Thieblemont C. High total metabolic tumor volume at baseline predicts survival independent of response to therapy. Blood 2020;135:1396-405. [PMID: 31978225 DOI: 10.1182/blood.2019003526] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 17.0] [Reference Citation Analysis]
828 Tang B, Zhu J, Li J, Fan K, Gao Y, Cheng S, Kong C, Zheng L, Wu F, Weng Q, Lu C, Ji J. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Commun Signal 2020;18:174. [PMID: 33115468 DOI: 10.1186/s12964-020-00663-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 20.7] [Reference Citation Analysis]
829 Mu Z, Dong D, Sun M, Li L, Wei N, Hu B. Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma. Front Oncol 2020;10:1566. [PMID: 33102202 DOI: 10.3389/fonc.2020.01566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
830 Peng L, Mao YP, Huang CL, Guo R, Ma J, Wen WP, Tang LL. A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma. Front Oncol 2020;10:551255. [PMID: 33102218 DOI: 10.3389/fonc.2020.551255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
831 Huang W, Yan YG, Wang WJ, Ouyang ZH, Li XL, Zhang TL, Wang XB, Wang B, Lv GH, Li J, Zou MX. Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma. Front Oncol 2020;10:556902. [PMID: 33194623 DOI: 10.3389/fonc.2020.556902] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citati